This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
ILD, hospital admission 2, with pulmonary infections
ILD_HOSPITAL_PULM_INFECT
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditions
|
182556 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
4506 |
6. Filter based on genotype QC (FinnGen only) |
4379 |
Control definitions (FinnGen only)
- Control conditions
- not PULM_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
ILD, hospital admission 2, with pulmonary infections
based on the number of shared cases.
Similar with more cases:
- ILD, hospital admissions
- Other interstitial pulmonary diseases
- Interstitial lung disease
- Interstitial lung disease endpoints
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4379 | 1754 | 2625 |
| Unadjusted period prevalence (%) | 0.97 | 0.62 | 1.20 |
| Median age at first event (years) | 69.82 | 67.45 | 71.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4505
- Matched controls
- 45050
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
7.7
320.5
475
678
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.4
320.2
944
2541
L01EX09
ATC
nintedanib; oral
47.0
315.6
185
41
J47
ICD-10 Finland
Bronchiectasis
16.6
308.4
263
168
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
9.5
307.7
418
478
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.9
307.7
1715
1418
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
307.7
1435
4477
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.6
307.7
2384
10616
L04AA06
ATC
mycophenolic acid; systemic
24.6
307.7
403
179
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.5
307.7
684
1207
L04AX01
ATC
azathioprine; systemic
11.5
307.7
568
558
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
22.7
307.7
744
390
L04AX05
ATC
pirfenidone; oral
58.9
307.7
256
46
XG410
NOMESCO Finland
Flow-volume spirometry
11.5
307.7
625
623
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
103.2
307.7
1206
159
284
Kela drug reimbursment
Nintedanib and pirfenidone
55.7
307.7
383
75
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
33.9
307.7
259
81
TGC00
NOMESCO Finland
Bronchial lavation
54.3
307.7
1105
268
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
36.1
307.7
1770
793
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
181.6
307.7
2443
292
R81
ICPC
Pneumonia
12.6
307.7
382
329
H02AB06
ATC
prednisolone; systemic
10.5
307.7
3707
13857
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.0
307.7
623
881
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.0
307.7
1129
2385
C03CA01
ATC
furosemide; systemic
3.3
307.7
2327
11082
R03AC02
ATC
salbutamol; inhalant
3.9
307.7
2969
14924
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
5.9
307.7
1349
3051
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
45.5
307.7
221
51
J01MA12
ATC
levofloxacin; systemic
4.1
307.7
1381
4357
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.4
307.7
3493
15796
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
11.0
307.7
1715
2387
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
12.7
307.7
441
383
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
8.9
307.7
711
933
R03BB04
ATC
tiotropium bromide; inhalant
5.9
307.7
958
1960
J18.9
ICD-10 Finland
Pneumonia, unspecified
94.7
307.7
3446
1496
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
205.9
307.7
1482
107
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
8.1
307.7
869
1297
R06.0
ICD-10 Finland
Dyspnoea
4.7
307.7
2199
7572
GD1AD
NOMESCO Finland
Thorax CT examination
11.5
307.7
1060
1171
J01MA14
ATC
moxifloxacin; systemic
11.5
307.7
975
1057
356
Kela drug reimbursment
Nintedanib and pirfenidone
55.3
307.7
376
74
J96.1
ICD-10 Finland
Chronic respiratory failure
23.4
307.7
467
222
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
144.3
307.7
2137
280
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
14.0
307.7
494
393
R50.9
ICD-10 Finland
Fever, unspecified
4.1
307.0
1017
2978
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
54.2
302.4
172
33
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
11.5
300.2
320
298
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
133.3
282.1
142
11
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.3
272.7
814
2195
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
6.0
272.0
522
970
P01BA02
ATC
hydroxychloroquine; oral
4.8
262.1
654
1530
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.9
261.1
899
2683
I50.9
ICD-10 Finland
Heart failure, unspecified
3.4
259.3
1205
4378
L01XE31
ATC
[U] nintedanib
83.1
258.5
137
17
J45.9
ICD-10 Finland
Asthma, unspecified
3.5
255.4
1106
3841
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.8
243.7
2465
13636
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.8
240.5
1898
9231
R02
ICPC
Shortness of breath/dyspnoea
3.6
239.6
979
3264
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
8.0
235.4
331
442
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
231.4
813
2447
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.1
229.0
523
1132
A02BC02
ATC
pantoprazole; systemic
3.1
223.7
3526
24071
127
Kela drug reimbursment
Transplant complication
17.9
222.2
181
105
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
19.4
213.2
167
89
M05BA04
ATC
alendronic acid; oral
3.8
213.0
737
2188
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
210.7
1305
5518
J01FA06
ATC
roxithromycin; oral
2.6
205.9
1992
10530
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
13.9
200.4
187
140
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.0
197.0
1074
4214
J45.1
ICD-10 Finland
Nonallergic asthma
4.8
192.1
472
1081
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
190.4
1335
5981
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
189.8
462
1050
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
8.0
188.6
262
344
R03AK08
ATC
formoterol and beclometasone; inhalant
6.1
182.1
333
586
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
44.8
177.3
105
24
H02AB07
ATC
prednisone; oral
3.2
176.3
833
2994
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.4
175.4
482
1204
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
58.9
175.1
98
17
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
174.1
166
*
L04AX03
ATC
methotrexate; systemic
3.7
174.1
632
1925
L04AD01
ATC
ciclosporin; systemic
11.2
172.9
185
172
J01AA02
ATC
doxycycline; systemic
2.9
172.6
3663
27033
WX892
NOMESCO Finland
Monitored bed care
3.8
172.0
578
1670
R05
ICD-10 Finland
Cough
2.7
171.7
1224
5491
J43.9
ICD-10 Finland
Emphysema, unspecified
9.6
171.0
204
221
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
54.5
169.0
96
18
GX1K5
NOMESCO Finland
Diffusion capacity
19.9
168.3
130
67
R04.2
ICD-10 Finland
Haemoptysis
5.6
165.5
328
622
XG466
NOMESCO Finland
Sleep oxymetry
6.6
162.4
269
428
ZX108
NOMESCO Finland
Inhalation
28.6
162.4
109
39
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
+∞
159.3
152
*
L04AA13
ATC
[U] leflunomide
7.4
155.9
232
329
I50.0
ICD-10 Finland
Congestive heart failure
3.4
155.5
628
2042
TDM10
NOMESCO Finland
Puncture of maxillary antrum
8.5
154.4
203
249
GX1D5
NOMESCO Finland
Flow volume spirometry
38.0
150.8
93
25
J15.8
ICD-10 Finland
Other bacterial pneumonia
81.4
150.3
80
10
L01BA01
ATC
methotrexate; systemic
5.5
149.5
299
571
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
146.3
1467
7628
A03
ICPC
Fever
3.0
145.6
745
2782
A07EC01
ATC
sulfasalazine; oral, rectal
3.6
145.5
523
1575
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.1
145.1
262
454
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
144.9
1640
8974
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
6.2
144.4
254
429
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.0
143.1
432
1152
J01CA04
ATC
amoxicillin; systemic
2.6
142.4
3570
26974
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
12.9
142.2
138
110
J96.0
ICD-10 Finland
Acute respiratory failure
12.5
139.1
138
114
WX721
NOMESCO Finland
Oxygen concentrator therapy
43.9
137.8
82
19
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
136.2
1175
5688
WW200
NOMESCO Finland
Immunization
6.6
135.1
223
353
R28
ICPC
Limited function/disability (R)
9.8
134.7
158
167
Z94.2
ICD-10 Finland
Lung transplant status
344.8
134.4
135
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
134.1
798
3224
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.9
133.3
419
1149
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.9
131.7
207
311
R4110
NOMESCO Finland
Physiotherapy
2.3
130.6
1482
8049
ZX120
NOMESCO Finland
Intravenous
3.2
130.1
573
1955
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.0
129.3
236
413
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.7
128.7
208
322
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
128.0
938
4196
R05
ICPC
Cough
2.3
126.8
1230
6243
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.7
125.9
783
3228
R03BA08
ATC
ciclesonide; inhalant
3.4
125.2
487
1538
J46
ICD-10 Finland
Status asthmaticus
8.2
125.1
168
211
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.6
124.8
314
728
GDG10
NOMESCO Finland
Bilateral transplantation of lung
422.4
124.4
124
*
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
37.3
124.2
77
21
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
15.3
124.0
109
73
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.6
123.8
856
3718
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.9
123.2
194
292
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
48.1
121.7
71
15
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
120.6
919
4177
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
19.0
117.9
93
50
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.1
114.8
248
506
L04AD02
ATC
tacrolimus; systemic
14.4
114.4
104
74
N02AX02
ATC
tramadol; systemic, rectal
2.0
114.3
2135
13844
WX726
NOMESCO Finland
High-flow oxygen therapy
63.9
113.9
63
10
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
13.1
112.8
108
84
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
6.5
110.7
184
293
R03BA02
ATC
budesonide; inhalant
2.5
110.3
828
3723
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
+∞
109.8
105
*
R03BA05
ATC
fluticasone; inhalant
2.5
107.9
806
3612
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
165.5
107.7
113
7
R03DC03
ATC
montelukast; oral
2.6
106.5
687
2869
R99
ICPC
Respiratory disease other
6.3
105.3
181
298
L88
ICPC
Rheumatoid/seropositive arthritis
4.4
105.1
279
673
J01FF01
ATC
clindamycin; systemic
2.1
101.9
1265
6999
JN4AD
NOMESCO Finland
Body CT examination
2.5
101.7
737
3250
J12.8
ICD-10 Finland
Other viral pneumonia
344.9
101.5
102
*
A07AA02
ATC
nystatin; oral
3.4
101.4
386
1198
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
101.2
883
4233
Z3226
NOMESCO Finland
Physiotherapist
2.3
99.9
933
4602
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
98.6
587
2349
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
98.2
1157
6263
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.8
97.9
183
327
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
10.1
97.8
111
112
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
12.4
97.7
97
80
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
97.6
1407
8206
ZXE00
NOMESCO Finland
One hour or less
2.0
96.9
1795
11416
C07AB07
ATC
bisoprolol; oral
1.9
96.0
2586
18588
XX4BW, ,
NOMESCO Finland
35.8
95.6
60
17
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.4
93.2
359
1121
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
6.5
93.0
154
244
J01FA10
ATC
azithromycin; systemic
1.9
92.4
2170
14851
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
91.8
508
1954
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
10.4
90.8
101
99
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
90.8
705
3198
A02BC01
ATC
omeprazole; systemic
2.0
89.7
1373
8134
J80
ICD-10 Finland
Adult respiratory distress syndrome
28.9
89.7
60
21
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
446.4
88.5
88
*
J01DB01
ATC
cefalexin; oral
2.1
87.3
3564
28989
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
86.7
762
3643
L04AA01
ATC
[U] ciclosporin
8.5
85.8
111
133
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.4
85.4
318
971
A02BC05
ATC
esomeprazole; systemic
1.9
85.2
1844
12201
H02AB04
ATC
methylprednisolone; systemic
2.4
84.6
667
3039
Z3231
NOMESCO Finland
Registered nurse
2.0
84.4
1330
7929
N02AA01
ATC
morphine; systemic, rectal
4.8
83.5
194
420
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
82.8
684
3180
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
82.0
282
817
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
81.6
1928
13060
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
81.5
493
1980
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.5
81.1
161
304
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.1
80.4
366
1261
GX2C5
NOMESCO Finland
Short-lasting oximetry
15.0
80.2
71
48
J18
ICD-10 Finland
Pneumonia, organism unspecified
11.9
79.9
81
69
GDA10
NOMESCO Finland
Biopsy of lung
26.5
79.8
55
21
R5140
NOMESCO Finland
Monitoring the use of the aid
2.4
79.8
599
2666
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
11.1
79.0
84
77
R03DA04
ATC
theophylline; systemic, rectal
3.4
78.8
299
923
Z2446
NOMESCO Finland
Social worker
3.3
78.7
311
985
Z51.5
ICD-10 Finland
Palliative care
2.4
78.3
605
2727
48499
ICD-8 Finland
Acute interstitial pneumonia
140.9
78.2
83
6
R03BA01
ATC
beclometasone; inhalant
2.3
78.0
651
3034
J20
ICD-10 Finland
Acute bronchitis
2.7
77.8
472
1897
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
77.6
244
665
WX725
NOMESCO Finland
Noninvasive ventilation
3.2
76.8
323
1062
J43.8
ICD-10 Finland
Other emphysema
19.3
75.4
59
31
Z2221
NOMESCO Finland
Medical doctor
1.9
74.8
1230
7387
R03AC12
ATC
salmeterol; inhalant
3.7
74.6
244
683
J45.8
ICD-10 Finland
Mixed asthma
4.9
74.2
168
356
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.7
73.9
140
253
A10AB05
ATC
insulin aspart; parenteral
2.8
73.9
412
1585
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
73.2
1429
9056
N03AX16
ATC
[U] pregabalin
2.0
72.0
1041
5977
A10AC01
ATC
insulin (human); parenteral
2.7
71.1
422
1675
JN4BD
NOMESCO Finland
Extensive body CT
2.3
71.1
584
2698
J01FA09
ATC
clarithromycin; systemic
1.9
70.3
1201
7279
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
70.1
689
3428
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
32.5
69.6
45
14
N02AA05
ATC
oxycodone; systemic
1.9
68.5
1015
5865
N05CF01
ATC
zopiclone; oral
1.8
68.2
1521
9988
XG474
NOMESCO Finland
Exhalation nntrogen oxide
5.1
68.2
145
291
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
14.7
68.2
61
42
M04AA01
ATC
allopurinol; systemic
2.1
68.2
808
4315
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.3
67.9
177
420
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
67.8
221
617
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
67.8
613
2946
L04AA24
ATC
abatacept; parenteral
16.5
67.6
57
35
J01FA15
ATC
telithromycin; oral
2.6
67.1
407
1632
B01AA03
ATC
warfarin; systemic
1.9
66.8
1136
6858
D86.0
ICD-10 Finland
Sarcoidosis of lung
7.1
66.0
100
144
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
31.0
65.6
43
14
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
+∞
64.7
62
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
64.7
348
1311
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.7
64.4
152
333
R06AE07
ATC
cetirizine; oral
1.7
63.9
1686
11567
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
30.3
63.6
42
14
SPAT1263
SPAT
Sampling
1.7
63.5
1785
12454
F1246, ,
NOMESCO Finland
26.1
63.5
44
17
ZXD05
NOMESCO Finland
Urgent procedure
1.8
63.4
1297
8268
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.5
62.8
223
659
L04AB01
ATC
etanercept; parenteral
6.9
62.7
97
143
J01MA02
ATC
ciprofloxacin; systemic
1.7
62.6
1825
12846
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
62.6
421
1773
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
62.4
554
2637
J43.2
ICD-10 Finland
Centrilobular emphysema
15.0
62.2
55
37
F2680, ,
NOMESCO Finland
28.3
62.2
42
15
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
62.0
383
1547
M01CB01
ATC
sodium aurothiomalate; parenteral
6.0
61.9
110
187
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.4
61.8
235
725
R06.2
ICD-10 Finland
Wheezing
3.5
61.8
220
651
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
5.2
61.1
126
246
SPAT1255
SPAT
Intravenous administration of medicine
2.7
60.4
353
1387
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.7
60.3
201
569
WX722
NOMESCO Finland
PEEP
3.1
60.2
257
851
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
10.8
60.1
65
61
J86.9
ICD-10 Finland
Pyothorax without fistula
11.9
60.1
61
52
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
59.8
621
3144
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.9
59.5
295
1063
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
9.7
59.3
69
72
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
58.9
227
706
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.5
58.9
146
333
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.5
58.7
206
604
R03AC03
ATC
terbutaline; inhalant
2.2
58.6
556
2715
48609
ICD-8 Finland
Pneumonia, unspecified
+∞
58.5
56
*
G47.3
ICD-10 Finland
Sleep apnoea
1.9
58.5
1000
6014
H02AB09
ATC
hydrocortisone; systemic
4.8
58.4
133
283
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
58.3
1703
11930
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.2
58.2
121
238
N02BE01
ATC
paracetamol; systemic, rectal
2.1
58.2
3904
34239
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
154.6
58.0
61
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.7
58.0
345
1367
SPAT1262
SPAT
Handing over of treatment supplies
1.9
57.7
885
5137
R03AK11
ATC
formoterol and fluticasone; inhalant
4.8
57.7
131
278
M05BA07
ATC
risedronic acid; oral
3.5
57.5
205
607
A46
ICD-10 Finland
Erysipelas
2.0
57.4
750
4126
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.1
57.3
123
249
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
16.0
57.2
49
31
XX9XE
NOMESCO Finland
Other ultrasound examination
8.4
57.0
74
89
R03BB01
ATC
ipratropium bromide; inhalant
3.2
56.6
229
734
A01AB09
ATC
miconazole; local oral
2.4
56.6
421
1854
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
56.5
522
2521
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
56.4
1125
7077
J96.9
ICD-10 Finland
Respiratory failure, unspecified
10.5
56.2
62
60
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
10.1
55.8
63
63
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
17.2
55.7
46
27
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
55.5
247
837
J01DA01
ATC
[U] cefalexin
1.6
55.4
2529
19756
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
55.3
645
3403
C01DA14
ATC
isosorbide mononitrate; oral
1.8
55.1
998
6093
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
55.0
1580
10981
A02BC03
ATC
lansoprazole; oral
1.7
54.8
1302
8596
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
54.6
254
883
WX882
NOMESCO Finland
High dependency care
3.8
54.2
167
448
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
189.0
54.1
56
*
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
4.2
54.0
145
352
A28
ICPC
Limited function/disability NOS
1.8
53.4
1017
6298
46309
ICD-8 Finland
Acute tonsillitis, Unspecified
+∞
53.2
51
*
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
53.2
51
*
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
+∞
53.2
51
*
M13.9
ICD-10 Finland
Arthritis, unspecified
2.5
53.2
366
1554
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
52.8
1574
11013
WZC30
NOMESCO Finland
Teaching
1.9
52.7
803
4639
L04AB04
ATC
adalimumab; parenteral
5.1
52.6
112
225
R03AC13
ATC
formoterol; inhalant
3.0
52.6
239
820
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.5
52.4
188
559
D07AC01
ATC
betamethasone; topical
1.7
52.2
1597
11241
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.9
51.9
115
239
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
51.9
1738
12511
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
51.9
1255
8305
M81.4
ICD-10 Finland
Drug-induced osteoporosis
10.7
51.5
56
53
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
51.4
1398
9539
AN1
HP
Coronary angiography
2.0
51.0
653
3555
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
21.3
50.6
38
18
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
50.5
731
4148
L01AA01
ATC
cyclophosphamide; systemic
12.3
50.4
50
41
XG405
NOMESCO Finland
Education on PEF monitoring
5.8
49.9
92
162
XG460
NOMESCO Finland
Short time oxymetry
5.1
49.8
106
213
J45
ICD-10 Finland
Asthma
2.3
49.8
388
1741
WX872
NOMESCO Finland
Intensive care
2.6
49.2
289
1136
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.9
49.1
248
902
E0000UV, ,
ATC
1.6
48.4
1705
12369
GX2D5
NOMESCO Finland
Sleep oximetry
8.8
47.9
60
69
R74
ICPC
Upper respiratory infection acute
1.8
47.8
963
6035
R01AD08
ATC
fluticasone; nasal
1.7
47.0
1010
6441
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.4
46.6
119
278
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.8
46.3
142
380
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.4
46.1
173
529
R53
ICD-10 Finland
Malaise and fatigue
1.7
45.9
1039
6718
XJC10
NOMESCO Finland
Oesophageal pH monitoring
9.3
45.7
55
60
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.4
45.6
75
118
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
17.8
45.5
37
21
1XC02, ,
NOMESCO Finland
8.0
45.2
61
77
R01AD09
ATC
mometasone; nasal
1.6
45.1
1586
11450
C03DA01
ATC
spironolactone; oral
1.9
45.1
639
3590
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
7.8
45.1
62
80
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
44.7
407
1947
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.8
44.4
101
215
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
15.1
44.2
39
26
R29
ICPC
Respiratory symptom/complaint other
2.4
44.2
307
1307
M31.3
ICD-10 Finland
Wegener granulomatosis
14.4
44.2
40
28
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.7
44.1
62
82
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
5.4
44.1
88
167
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
72.4
44.0
50
7
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
5.9
43.4
78
134
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.6
43.4
253
990
R4190
NOMESCO Finland
Nutritional therapy
3.2
43.3
180
586
N03AX12
ATC
[U] gabapentin; oral
1.9
43.3
683
3968
WZA10
NOMESCO Finland
Extensive medical or dental certificate
5.5
43.2
83
152
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
43.1
1129
7568
AA1AD
NOMESCO Finland
CT of head and brain
1.6
42.9
1388
9799
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
42.8
1074
7118
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
42.7
926
5901
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
42.5
773
4685
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
6.7
42.4
67
101
SPAT1254
SPAT
Administration of medicine
1.8
42.1
677
3954
J05AB11
ATC
valaciclovir; oral
1.9
42.0
613
3473
ZXA10
NOMESCO Finland
Bilateral
1.7
41.9
869
5466
120
Kela drug reimbursment
Hypogammaglobulinaemia
217.0
41.9
43
*
RK110, ,
NOMESCO Finland
7.1
41.9
63
90
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.7
41.8
78
139
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
148.1
41.8
44
*
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
14.2
41.6
38
27
M34.1
ICD-10 Finland
CR(E)ST syndrome
11.1
41.5
44
40
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
8.2
41.4
55
68
SPAT1325
SPAT
Vaccination
1.6
41.3
1582
11590
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
41.1
1259
8756
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
77.6
40.9
46
6
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
11.1
40.6
43
39
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
40.6
246
981
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
40.5
796
4929
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
40.0
470
2471
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
39.8
511
2771
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
39.8
1893
14509
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.6
39.8
1078
7264
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
6.3
39.8
67
108
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.2
39.8
366
1756
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
39.6
1364
9731
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.0
39.5
112
283
UJF32
NOMESCO Finland
Coloscopy
1.6
39.5
1210
8399
B01AB05
ATC
enoxaparin; parenteral
1.6
39.4
1386
9936
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
39.4
1601
11854
R95
ICPC
Chron obstructive pulmonary disease
3.2
39.3
155
489
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.9
39.2
188
664
J02AC01
ATC
fluconazole; systemic
1.6
39.2
1269
8922
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
39.2
1250
8759
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
39.1
2799
23340
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.5
38.9
134
388
WX002
NOMESCO Finland
Sedation and analgesia
1.7
38.8
872
5595
I50
ICD-10 Finland
Heart failure
2.8
38.4
193
699
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
38.4
264
1118
5BA08, ,
NOMESCO Finland
8.5
38.2
49
58
M33.2
ICD-10 Finland
Polymyositis
14.1
38.2
35
25
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
37.8
246
1015
TK800
NOMESCO Finland
Hemodialysis
3.9
37.8
113
297
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.3
37.7
145
450
RK320, ,
NOMESCO Finland
6.0
37.2
66
112
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.3
37.2
288
1285
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
62.0
37.1
43
7
A06AD11
ATC
lactulose; oral
1.7
37.1
732
4526
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
4.6
37.1
88
194
L28
ICPC
Limited function/disability (L)
1.6
37.1
935
6174
J05AB01
ATC
aciclovir; systemic
1.7
36.8
889
5804
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
36.8
256
1090
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
100.9
36.8
40
*
J84
ICD-10 Finland
Other interstitial pulmonary diseases
100.9
36.8
40
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.1
36.7
378
1892
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.1
36.7
49
61
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
13.1
36.6
35
27
XX2RW, ,
NOMESCO Finland
4.1
36.3
101
252
GAA31
NOMESCO Finland
Thoracoscopy
10.1
36.3
41
41
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
36.0
615
3645
N18.8
ICD-10 Finland
Other chronic renal failure
3.2
36.0
148
479
M05.1
ICD-10 Finland
Rheumatoid lung disease
98.4
35.7
39
*
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
9.8
35.6
41
42
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
6.7
35.6
56
84
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
35.6
671
4093
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
35.4
338
1643
N06AX11
ATC
mirtazapine; oral
1.5
35.2
1319
9542
ZXA00
NOMESCO Finland
Right side
1.6
35.0
1174
8283
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
6.4
35.0
58
92
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
35.0
264
1165
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
8.0
35.0
47
59
M10.9
ICD-10 Finland
Gout, unspecified
2.0
34.9
389
2004
I50.1
ICD-10 Finland
Left ventricular failure
2.3
34.9
278
1256
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.3
34.9
132
406
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
34.8
825
5351
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
34.7
1380
10105
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
34.6
332
1618
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
34.5
1180
8356
48509
ICD-8 Finland
Bronchopneumonia, unspecified
+∞
34.4
33
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
34.3
593
3524
R01AD12
ATC
fluticasone furoate; nasal
1.6
34.1
973
6604
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
34.1
179
664
R05FB02
ATC
cough suppressants and expectorants; systemic
1.5
34.1
1518
11375
S97
ICPC
Chronic ulcer skin
2.1
34.0
335
1648
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.1
33.9
335
1650
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
33.7
245
1064
ZXA05
NOMESCO Finland
Left side
1.6
33.4
1087
7606
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
33.3
422
2273
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.6
33.3
193
753
TGD00
NOMESCO Finland
Needle biopsy of lung
7.5
33.1
47
63
B02.9
ICD-10 Finland
Zoster without complication
2.1
33.0
349
1763
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.2
33.0
89
217
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.2
33.0
129
405
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.7
32.9
107
298
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
32.7
393
2079
A04
ICPC
Weakness/tiredness general
1.7
32.7
656
4066
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
9.0
32.4
40
45
3AC01, ,
NOMESCO Finland
5.8
32.4
59
103
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.4
32.3
232
1001
4659X
ICD-9 Finland
Acute upper respiratory infections of multiple or unspecified sites, Unspecified site
+∞
32.3
31
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.7
32.3
45
59
M05BX04
ATC
denosumab; parenteral
2.1
32.0
315
1549
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
319.3
31.9
32
*
J93.8
ICD-10 Finland
Other pneumothorax
7.8
31.9
44
57
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
4.4
31.8
79
181
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
31.7
453
2536
5AB14, ,
NOMESCO Finland
88.2
31.7
35
*
J42
ICD-10 Finland
Unspecified chronic bronchitis
4.7
31.5
73
158
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.9
31.4
463
2619
318
Kela drug reimbursment
Teriparatide
7.4
31.4
45
61
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
+∞
31.3
30
*
L04AB06
ATC
golimumab; parenteral
7.5
31.0
44
59
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
5.7
30.8
57
101
R03BB07
ATC
umeclidinium bromide; inhalant
6.0
30.7
54
91
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
6.6
30.6
49
75
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.2
30.6
124
398
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
30.4
268
1261
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.5
30.3
197
812
L03AA02
ATC
filgrastim; parenteral
3.0
30.3
138
474
R96
ICPC
Asthma
2.0
30.3
368
1953
E000001, ,
ATC
1.6
30.2
733
4766
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
+∞
30.2
29
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.0
30.2
85
214
D07AC13
ATC
mometasone; topical
1.5
30.2
1138
8193
B01AC04
ATC
clopidogrel; oral
1.6
30.2
877
5959
H05AA02
ATC
teriparatide; parenteral
7.7
30.2
42
55
J01.1
ICD-10 Finland
Acute frontal sinusitis
6.8
30.1
47
70
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
30.0
1375
10300
R11
ICD-10 Finland
Nausea and vomiting
2.0
30.0
342
1775
L04AB05
ATC
certolizumab pegol; parenteral
12.1
29.9
30
25
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
29.8
230
1025
Z57.2
ICD-10 Finland
Occupational exposure to dust
7.8
29.8
41
53
C09AA05
ATC
ramipril; oral
1.5
29.7
1246
9166
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.2
29.4
79
192
WW500
NOMESCO Finland
Blood transfusion
2.5
29.4
187
763
A02BA02
ATC
ranitidine; systemic
1.6
29.1
843
5719
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
6.5
29.0
47
73
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
5.1
28.9
61
122
2AX04, ,
NOMESCO Finland
293.8
28.8
29
*
M35.1
ICD-10 Finland
Other overlap syndromes
8.5
28.7
37
44
J94.8
ICD-10 Finland
Other specified pleural conditions
3.5
28.7
100
292
C01AA05
ATC
digoxin; systemic
1.8
28.7
436
2487
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
151.0
28.7
30
*
R03BB06
ATC
glycopyrronium bromide; inhalant
9.8
28.5
33
34
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.9
28.5
84
219
ZX100
NOMESCO Finland
Oral
4.0
28.4
81
206
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
48.9
28.4
34
7
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.4
28.4
103
309
J32.4
ICD-10 Finland
Chronic pansinusitis
5.0
28.4
61
124
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.1
28.3
282
1392
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.6
28.1
165
648
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
28.1
535
3260
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
9.5
27.9
33
35
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
27.9
93
264
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
27.8
383
2117
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.1
27.6
113
365
ZY010
NOMESCO Finland
Hospital outpatient
2.6
27.5
162
637
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
27.5
960
6778
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
27.4
111
356
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.7
27.4
152
580
RS230, ,
NOMESCO Finland
9.2
27.4
33
36
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.0
27.2
123
421
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
27.2
350
1892
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.6
27.2
91
259
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
6.8
27.1
42
62
J99.0
ICD-10 Finland
Rheumatoid lung disease
+∞
27.1
26
*
ZX114
NOMESCO Finland
Intramuscular
4.4
27.1
67
153
R24
ICPC
Haemoptysis
5.9
26.9
48
82
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
26.8
198
865
P01AB01
ATC
metronidazole; oral, rectal
1.4
26.7
1408
10783
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
26.7
367
2028
M54.5
ICD-10 Finland
Low back pain
1.5
26.6
1320
9996
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
26.6
697
4609
207
Kela drug reimbursment
Chronic arrhythmias
1.5
26.6
844
5834
J01DA06
ATC
[U] cefuroxime
1.7
26.5
503
3059
WPA13
NOMESCO Finland
Palliative consultation
6.3
26.5
44
70
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.7
26.5
146
556
XQ800
NOMESCO Finland
Prick test
2.3
26.4
215
979
H26.3
ICD-10 Finland
Drug-induced cataract
7.9
26.4
36
46
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
26.1
25
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
25.9
162
656
N05CD07
ATC
temazepam; oral
1.7
25.8
528
3276
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
5.6
25.8
49
89
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.4
25.8
93
278
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
25.7
428
2506
SPAT1260
SPAT
Consultation of another employee
1.6
25.6
712
4769
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
25.5
109
361
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.1
25.5
108
356
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
25.5
308
1630
D07AB08
ATC
desonide; topical
1.8
25.4
419
2447
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.5
25.4
167
693
1240
FHL
Bronchoscopy
4.1
25.3
69
170
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
25.2
397
2288
WVA20
NOMESCO Finland
Medicine administration
2.7
25.0
133
497
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
25.0
24
*
J02AC03
ATC
voriconazole; systemic
30.2
25.0
33
11
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
24.9
117
409
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
24.9
180
779
R60.0
ICD-10 Finland
Localized oedema
1.6
24.9
573
3664
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.1
24.9
69
172
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.3
24.9
190
843
B34.9
ICD-10 Finland
Viral infection, unspecified
3.2
24.8
96
300
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.9
24.8
44
75
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
24.5
917
6551
WX730
NOMESCO Finland
Conventional respirator
3.8
24.5
75
201
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
24.5
592
3833
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
24.4
180
786
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
3.7
24.4
76
206
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
5.3
24.3
49
94
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.4
24.3
162
676
C10AA03
ATC
pravastatin; oral
1.8
24.3
379
2176
B01AF02
ATC
apixaban; oral
1.6
24.3
696
4691
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.1
24.2
101
330
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
24.2
687
4619
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.7
24.2
128
477
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
6.7
24.2
38
57
SPAT1060
SPAT
Administration of oxygen
8.9
24.2
30
34
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
24.1
369
2106
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
29.3
24.0
32
11
RS221, ,
NOMESCO Finland
4.2
24.0
64
155
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
5.6
23.9
45
81
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
5.5
23.8
46
85
R01
ICPC
Pain respiratory system
4.0
23.7
68
174
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
23.7
1715
13816
R03AC18
ATC
indacaterol; inhalant
5.8
23.6
43
75
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
8.6
23.6
30
35
R2110
NOMESCO Finland
Giving the first information
2.1
23.6
231
1132
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
6.2
23.6
40
65
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
23.6
711
4844
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
4.2
23.6
63
153
N06AA09
ATC
amitriptyline; systemic
1.8
23.6
377
2181
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
23.5
1139
8547
C10AA01
ATC
simvastatin; oral
1.4
23.4
2064
17158
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
23.3
469
2894
J94.1
ICD-10 Finland
Fibrothorax
33.5
23.3
30
9
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.7
23.2
74
204
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
23.2
1710
13804
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.0
23.2
241
1209
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
8.4
23.1
30
36
UDM02
NOMESCO Finland
Sinoscopy
3.4
23.1
81
238
R13
ICD-10 Finland
Dysphagia
1.9
23.1
303
1648
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
23.0
355
2031
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.6
23.0
75
210
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
23.0
1491
11776
A02BA03
ATC
famotidine; systemic
2.3
23.0
186
846
M05BA06
ATC
ibandronic acid; systemic
3.0
22.9
101
341
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
4.7
22.9
52
111
M79.6
ICD-10 Finland
Pain in limb
1.4
22.8
1650
13265
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
22.7
121
453
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.4
22.7
162
698
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.6
22.6
135
535
NDG30
NOMESCO Finland
Fusion of wrist, total
6.4
22.6
37
58
XF404
NOMESCO Finland
Ambulatory ECG
1.8
22.6
386
2275
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
120.6
22.6
24
*
N19
ICD-10 Finland
Unspecified kidney failure
2.2
22.6
199
937
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.8
22.5
69
185
R01AD58
ATC
fluticasone, combinations; nasal
1.6
22.5
681
4640
81
HP
Angiography of the heart and coronary arteries
1.8
22.5
344
1963
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.4
22.4
56
129
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
22.4
203
967
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.9
22.3
103
357
N17.8
ICD-10 Finland
Other acute renal failure
3.7
22.3
70
191
D11
ICPC
Diarrhoea
1.8
22.1
378
2228
XX1VW
NOMESCO Finland
Written report from radiologist
5.1
22.1
46
91
N05BA01
ATC
diazepam; systemic, rectal
1.7
22.1
472
2958
ED1AA
NOMESCO Finland
Mandibular X-ray examination
5.7
22.1
41
73
R4130
NOMESCO Finland
Speech therapy
2.6
22.0
126
489
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
22.0
2483
21375
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.7
21.9
118
444
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.1
21.9
92
302
J01XB01
ATC
colistin; inhalant, parenteral
+∞
21.9
21
*
3A006, ,
NOMESCO Finland
+∞
21.9
21
*
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
21.9
1469
11647
N05BA04
ATC
oxazepam; oral
1.5
21.9
970
7147
TFP20
NOMESCO Finland
Cardiodefibrillation
1.8
21.8
352
2040
XF402
NOMESCO Finland
ECG with work load test
1.7
21.8
481
3038
R04.0
ICD-10 Finland
Epistaxis
1.8
21.8
376
2222
Z94.0
ICD-10 Finland
Kidney transplant status
5.4
21.8
43
81
SPAT1059
SPAT
Spirometry at the office
2.1
21.7
210
1026
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.8
21.6
106
380
B03XA02
ATC
darbepoetin alfa; parenteral
3.0
21.6
98
337
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
8.8
21.5
27
31
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
21.5
122
472
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
21.5
316
1781
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.2
21.4
56
134
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
21.4
222
1113
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.8
21.4
105
377
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
21.3
290
1596
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
21.2
865
6267
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.8
21.1
103
368
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
21.1
842
6071
1CX01, ,
NOMESCO Finland
33.9
21.1
27
8
B01AB04
ATC
dalteparin; parenteral
2.0
21.1
225
1139
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
20.9
495
3182
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
20.9
186
880
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
20.8
321
1837
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.4
20.7
146
626
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
8.7
20.6
26
30
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
110.6
20.6
22
*
M01CB03
ATC
auranofin; oral
4.8
20.5
46
97
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
20.5
360
2137
R06AX27
ATC
desloratadine; oral
1.5
20.5
823
5938
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
20.5
538
3544
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
20.5
1060
8020
K77
ICPC
Heart failure
2.5
20.4
129
526
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
4.3
20.4
52
122
RS123, ,
NOMESCO Finland
20.1
20.3
30
15
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.4
20.3
51
118
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
20.3
340
1992
R51.80
ICD-10 Finland
Headache
1.6
20.2
470
3006
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.3
20.2
76
234
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
20.1
402
2473
RK120, ,
NOMESCO Finland
8.4
20.1
26
31
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
5.8
20.1
36
62
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
20.0
1591
12912
M48.0
ICD-10 Finland
Spinal stenosis
1.6
20.0
578
3893
-1, ,
NOMESCO Finland
1.4
20.0
1080
8230
R04
ICPC
Breathing problem other
2.3
20.0
160
725
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
20.0
277
1533
WX402
NOMESCO Finland
General anaesthesia
1.5
19.9
806
5822
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
57.8
19.9
23
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.7
19.8
107
404
K02.1
ICD-10 Finland
Caries of dentine
1.3
19.8
2035
17160
J01DC02
ATC
cefuroxime; systemic
2.2
19.7
165
761
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
19.7
784
5644
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
73.8
19.7
22
*
SPAT1229
SPAT
Assessment of need for aid
1.8
19.6
327
1913
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
5.6
19.6
37
67
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.8
19.6
95
339
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.0
19.6
228
1191
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
6.6
19.6
31
47
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
19.6
157
712
R07.3
ICD-10 Finland
Other chest pain
1.7
19.5
400
2477
R4120
NOMESCO Finland
Occupational therapy
1.9
19.5
254
1377
M34.0
ICD-10 Finland
Progressive systemic sclerosis
24.7
19.5
27
11
A11CC03
ATC
alfacalcidol; systemic
2.7
19.4
103
385
A07AA09
ATC
vancomycin; oral
3.6
19.4
63
176
R05CB01
ATC
acetylcysteine; inhalant, oral
3.3
19.4
74
230
N02BF02
ATC
pregabalin; oral
1.9
19.3
245
1318
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.2
19.2
76
241
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.9
19.2
55
141
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
19.1
190
937
EBA10
NOMESCO Finland
Operative extraction of tooth
1.7
19.1
353
2126
WPA11
NOMESCO Finland
Developing a plan for palliative care
7.2
19.1
28
39
N07BA03
ATC
varenicline; oral
2.3
19.0
143
631
C08CA01
ATC
amlodipine; oral
1.3
19.0
1772
14701
GDC00
NOMESCO Finland
Lobectomy of lung
5.4
19.0
37
69
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.7
19.0
103
390
J94.9
ICD-10 Finland
Pleural condition, unspecified
5.7
19.0
35
62
RS220, ,
NOMESCO Finland
4.1
18.9
51
125
E000003, ,
ATC
2.2
18.9
160
742
A01AB04
ATC
amphotericin B; local oral
2.0
18.8
200
1011
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
5.0
18.7
40
81
XF622
NOMESCO Finland
Measurement of minute volume of heart
6.6
18.7
30
46
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
18.7
192
959
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.8
18.7
284
1617
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
7.3
18.6
27
37
S18
ICPC
Laceration/cut
1.3
18.6
1979
16716
UDC00
NOMESCO Finland
Ear microscopy
1.8
18.6
296
1709
S22.3
ICD-10 Finland
Fracture of rib
1.8
18.6
300
1739
B59
ICD-10 Finland
Pneumocystosis
100.5
18.6
20
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
38.5
18.5
23
6
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
18.5
91
327
WX213
NOMESCO Finland
Lower leg blockade
4.4
18.5
46
106
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
6.6
18.3
29
44
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
18.2
284
1628
D72.1
ICD-10 Finland
Eosinophilia
7.1
18.2
27
38
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
19.4
18.2
27
14
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
18.1
307
1804
M25.5
ICD-10 Finland
Pain in joint
1.4
18.1
1118
8688
J01FA01
ATC
erythromycin; systemic
1.6
18.1
392
2461
M06
ICD-10 Finland
Other rheumatoid arthritis
5.0
18.1
38
76
N06AB04
ATC
citalopram; systemic
1.5
18.0
703
5033
GD1AA, ,
SPAT
1.6
18.0
449
2919
A04AA01
ATC
ondansetron; systemic, rectal
1.8
18.0
304
1785
M03BX02
ATC
tizanidine; oral
1.3
18.0
2135
18286
C08CA05
ATC
nifedipine; systemic
1.8
18.0
291
1688
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.7
17.9
55
148
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
17.8
1458
11837
E000002, ,
ATC
1.7
17.8
354
2175
TNG10
NOMESCO Finland
Puncture of knee
3.7
17.8
55
149
4630A
ICD-9 Finland
Acute tonsillitis[TONSILLITIS ACUTA]
+∞
17.7
17
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.4
17.7
117
488
R06AX22
ATC
ebastine; oral
1.6
17.6
500
3349
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.7
17.6
55
150
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.3
17.6
67
208
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
6.3
17.5
29
46
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.9
17.5
83
293
D07AA02
ATC
hydrocortisone; topical
1.6
17.5
451
2956
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.2
17.4
46
111
U08.9
ICD-10 Finland
Personal history of COVID-19, unspecified
7.8
17.4
24
31
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
17.4
964
7353
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.0
17.4
78
267
L04AA29
ATC
[U] tofacitinib
17.0
17.4
27
16
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.5
17.3
105
420
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
24.1
17.3
24
10
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.0
17.2
73
242
UJD02
NOMESCO Finland
Gastroscopy
1.9
17.2
207
1094
J01DA09
ATC
[U] cefadroxil
1.4
17.2
900
6798
M01AH02
ATC
rofecoxib; oral
1.5
17.1
515
3493
R78
ICPC
Acute bronchitis/bronchiolitis
2.9
17.1
82
291
291
Kela drug reimbursment
Tofacitinib
14.8
17.1
28
19
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.7
17.1
53
144
WX723
NOMESCO Finland
CPAP therapy
2.1
17.0
161
780
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
17.0
129
572
XPX04
NOMESCO Finland
Angioscopy
7.2
16.9
25
35
L04AK01
ATC
leflunomide; oral
5.1
16.9
35
69
J98.4
ICD-10 Finland
Other disorders of lung
13.3
16.9
29
22
ZY000
NOMESCO Finland
Hospital inpatient
4.2
16.9
44
105
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.6
16.9
56
159
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
25.7
16.9
23
9
K59.1
ICD-10 Finland
Functional diarrhoea
1.9
16.9
220
1194
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
16.8
105
426
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.3
16.8
127
562
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.3
16.8
63
194
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.9
16.8
77
267
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
16.7
336
2068
R03AC19
ATC
olodaterol
6.3
16.7
28
45
47099
ICD-8 Finland
Influenza, unqualified
+∞
16.7
16
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.0
16.6
175
882
J93.9
ICD-10 Finland
Pneumothorax, unspecified
5.5
16.6
32
59
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
16.6
418
2721
NG1DA
NOMESCO Finland
X-ray of knees
2.7
16.6
86
318
L04AC07
ATC
tocilizumab; parenteral
6.7
16.6
26
39
A01
ICPC
Pain general/multiple sites
1.6
16.5
385
2463
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
23.1
16.4
23
10
B37.0
ICD-10 Finland
Candidal stomatitis
4.0
16.4
45
112
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.6
16.3
363
2294
49099
ICD-8 Finland
Bronchitis, unspecified
4.1
16.3
44
108
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.3
16.3
119
519
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
14.3
16.3
27
19
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
16.3
460
3077
M02AA07
ATC
piroxicam; topical
1.3
16.3
1425
11647
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
16.2
489
3316
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
6.5
16.2
26
40
N06AX21
ATC
duloxetine; oral
1.6
16.2
371
2362
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
15.4
16.2
26
17
SPAT1301
SPAT
No procedures
1.3
16.1
1244
9977
J01DA08
ATC
[U] cefaclor
1.8
16.1
264
1536
L04AA17
ATC
[U] adalimumab
12.8
16.1
28
22
I20.09
ICD-10 Finland
Unstable angina
1.7
16.1
274
1613
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.1
16.1
67
220
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.5
16.0
104
430
R52.0
ICD-10 Finland
Acute pain
2.4
16.0
114
492
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
3.9
16.0
47
123
R03DC01
ATC
zafirlukast; oral
3.3
16.0
60
185
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
15.9
1158
9203
I26
ICD-10 Finland
Pulmonary embolism
3.9
15.9
46
119
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
15.8
368
2351
N06AX16
ATC
venlafaxine; oral
1.6
15.8
386
2497
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
60.2
15.8
18
*
WX720
NOMESCO Finland
Own respiration
1.9
15.7
208
1134
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.1
15.7
146
703
H03AA01
ATC
levothyroxine sodium; systemic
1.4
15.7
808
6073
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.5
15.7
30
55
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
15.7
159
791
ZX121
NOMESCO Finland
Central venous catheter
6.9
15.7
24
35
J67.0
ICD-10 Finland
Farmer lung
15.7
15.7
25
16
NHQ40
NOMESCO Finland
Amputation of toe
2.8
15.7
80
294
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.7
15.7
327
2033
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
15.6
15
*
AK3
HP
BLTX (both lung transplants)
+∞
15.6
15
*
D02AE01
ATC
carbamide; topical
1.8
15.6
225
1260
B01AB10
ATC
tinzaparin; parenteral
1.6
15.6
425
2817
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.4
15.6
56
168
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
2.2
15.6
125
568
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
85.4
15.6
17
*
L95
ICPC
Osteoporosis
2.0
15.6
174
897
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.6
15.5
51
144
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
15.5
379
2449
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
13.8
15.5
26
19
D07XC01
ATC
betamethasone; topical
1.5
15.4
470
3193
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
4.4
15.4
38
87
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.0
15.4
178
928
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
4.1
15.4
42
104
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
38.2
15.4
19
5
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
15.3
246
1423
A02BA04
ATC
nizatidine; systemic
1.7
15.3
316
1959
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
5.2
15.3
31
60
RD210, ,
NOMESCO Finland
3.3
15.3
56
170
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
15.3
119
534
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.8
15.3
234
1336
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
3.1
15.2
63
206
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
4.0
15.2
42
105
C02KX04
ATC
macitentan; oral
28.7
15.2
20
7
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.2
15.1
58
181
E66.8
ICD-10 Finland
Other obesity
2.1
15.1
140
673
J98.1
ICD-10 Finland
Pulmonary collapse
4.6
15.1
35
76
XA421
NOMESCO Finland
Nocturnal polygraphy
5.6
15.1
28
50
M01AB05
ATC
diclofenac; systemic, rectal
1.3
15.1
2468
21844
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
15.0
2283
20011
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
2.6
15.0
89
353
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
15.0
1473
12199
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.6
15.0
84
324
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
14.9
1431
11809
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
14.9
235
1352
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2.9
14.8
68
236
212
Kela drug reimbursment
Gout
2.3
14.8
107
465
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
56.9
14.8
17
*
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.6
14.8
87
344
C83.1
ICD-10 Finland
Mantle cell lymphoma
5.5
14.8
28
51
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
5.5
14.8
28
51
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
14.7
566
4030
R52.9
ICD-10 Finland
Pain, unspecified
1.6
14.7
363
2351
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
14.7
1011
7951
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.6
14.7
34
74
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
14.6
488
3379
JN6AD
NOMESCO Finland
CT of torso and neck
2.7
14.6
80
305
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
5.1
14.6
30
59
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
14.6
164
848
K07
ICPC
Swollen ankles/oedema
1.8
14.5
218
1238
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.2
14.5
55
171
SPAT1211
SPAT
Application of soft bandage
1.6
14.4
325
2059
DPA30
NOMESCO Finland
Sphenotomy
5.8
14.4
26
45
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
14.4
234
1358
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
14.4
479
3313
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
14.4
190
1036
W19
ICD-10 Finland
Unspecified fall
1.6
14.4
375
2461
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
14.4
183
986
L17
ICPC
Foot/toe symptom/complaint
1.3
14.3
1167
9405
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.6
14.3
47
133
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
14.3
1170
9435
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.5
14.3
27
49
A10AE04
ATC
insulin glargine; parenteral
1.6
14.3
366
2393
G53.0
ICD-10 Finland
Postzoster neuralgia
3.7
14.2
45
124
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
3.5
14.2
49
143
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.1
14.2
57
183
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
14.2
122
570
Z50.1
ICD-10 Finland
Other physical therapy
1.8
14.2
207
1164
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.8
14.2
70
253
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.8
14.1
71
259
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
14.1
254
1518
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
14.1
162
843
DHA10
NOMESCO Finland
Biopsy of cavity of nose
3.9
14.1
40
102
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.8
14.1
203
1137
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.7
14.1
241
1420
J98.6
ICD-10 Finland
Disorders of diaphragm
5.1
14.1
29
57
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.0
14.1
162
844
N03AE01
ATC
clonazepam; systemic
1.9
14.1
188
1029
S22.2
ICD-10 Finland
Fracture of sternum
4.3
14.1
36
85
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.9
14.0
41
107
NDG74
NOMESCO Finland
Fusion of first IP joint
6.7
14.0
22
33
RK250, ,
NOMESCO Finland
4.8
14.0
31
65
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
14.0
1920
16562
6BA02, ,
NOMESCO Finland
15.8
13.9
22
14
M01AB55
ATC
diclofenac, combinations; oral
1.7
13.9
272
1664
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
13.9
325
2080
A12AA04
ATC
calcium carbonate; oral
3.0
13.8
60
202
E86
ICD-10 Finland
Volume depletion
2.3
13.8
106
473
RK520, ,
NOMESCO Finland
5.6
13.8
26
47
T90
ICPC
Diabetes non-insulin dependent
1.3
13.8
1050
8375
M31.7
ICD-10 Finland
Microscopic polyangiitis
20.1
13.8
20
10
WX740
NOMESCO Finland
Nitrogen oxide therapy
20.1
13.8
20
10
TGA30
NOMESCO Finland
Thoracocentesis
3.9
13.8
40
104
M01AH01
ATC
celecoxib; oral
1.4
13.6
663
4927
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
75.4
13.6
15
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.1
13.6
24
20
I27.0
ICD-10 Finland
Primary pulmonary hypertension
12.1
13.6
24
20
4618A
ICD-9 Finland
Acute sinusitis, Other acute sinusitis
+∞
13.5
13
*
Z94.3
ICD-10 Finland
Heart and lungs transplant status
+∞
13.5
13
*
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
+∞
13.5
13
*
A11
ICPC
Chest pain NOS
1.6
13.5
353
2317
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.0
13.5
37
92
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
13.5
117
549
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
13.5
657
4882
B07.9
ICD-10 Finland
Verruca simplex
2.1
13.5
121
576
D07AD01
ATC
clobetasol; topical
1.4
13.5
592
4320
NDL52
NOMESCO Finland
Tenosynovectomy of hand
4.1
13.5
36
88
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.1
13.5
36
88
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
140.4
13.4
14
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
140.4
13.4
14
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.6
13.4
316
2024
R4180
NOMESCO Finland
Podiatric therapy
3.2
13.4
52
164
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
13.4
975
7721
SPAT1310
SPAT
Counselling related to known health issue
1.3
13.4
1171
9518
J01.4
ICD-10 Finland
Acute pansinusitis
18.3
13.3
20
11
WNF00
NOMESCO Finland
Infection source and contact determination
5.6
13.3
25
45
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.5
13.3
44
125
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
13.3
2511
22451
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
13.3
119
566
N30.2
ICD-10 Finland
Other chronic cystitis
3.6
13.2
43
121
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.5
13.2
383
2573
M33.1
ICD-10 Finland
Other dermatomyositis
13.8
13.2
22
16
R01AD01
ATC
beclometasone; nasal
1.5
13.2
475
3337
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
5.7
13.2
24
42
ZX197, ,
NOMESCO Finland
40.2
13.1
16
*
SPAT1097
SPAT
Recording of ECG
1.4
13.1
604
4443
R06AX13
ATC
loratadine; oral
1.5
13.1
396
2686
C07AB02
ATC
metoprolol; systemic
1.3
13.0
904
7108
J98.2
ICD-10 Finland
Interstitial emphysema
16.7
13.0
20
12
SFA10
NOMESCO Finland
One-surface restoration
1.3
12.9
1895
16423
M01AX17
ATC
nimesulide; oral
1.3
12.9
925
7304
Z71.8
ICD-10 Finland
Other specified counselling
1.3
12.9
1148
9345
132
Kela drug reimbursment
Sarcoidosis
4.0
12.9
36
91
OAB50, ,
SPAT
1.6
12.9
330
2157
G44.2
ICD-10 Finland
Tension-type headache
1.5
12.8
396
2696
M10
ICD-10 Finland
Gout
1.8
12.8
202
1163
R50.8
ICD-10 Finland
Other specified fever
4.9
12.8
28
58
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.5
12.8
77
308
A29
ICPC
General symptom/complaint other
1.4
12.8
537
3883
NDG76
NOMESCO Finland
Fusion of DIP joint
3.9
12.8
37
96
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
12.8
228
1361
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
12.7
594
4378
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.8
12.7
23
40
WW300
NOMESCO Finland
Transfer of autologic stem cells
10.5
12.7
24
23
N18.0
ICD-10 Finland
End-stage renal disease
3.4
12.7
45
134
C08CA02
ATC
felodipine; oral
1.5
12.7
438
3051
N30.0
ICD-10 Finland
Acute cystitis
1.4
12.7
565
4130
PAW37
NOMESCO Finland
Biopsy of temporal artery
3.6
12.7
41
115
R42
ICD-10 Finland
Dizziness and giddiness
1.3
12.7
933
7393
R09
ICPC
Sinus symptom/complaint
1.8
12.7
198
1138
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.8
12.6
62
224
J06.0
ICD-10 Finland
Acute laryngopharyngitis
4.9
12.6
27
55
J01XX08
ATC
linezolid; systemic
4.4
12.6
31
71
J20.8
ICD-10 Finland
Acute bronchitis due to other specified organisms
15.4
12.6
20
13
JN4CD
NOMESCO Finland
Very extensive body CT
1.9
12.6
153
813
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
3.3
12.6
46
140
J43.1
ICD-10 Finland
Panlobular emphysema
32.1
12.6
16
5
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
12.6
424
2941
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.7
12.5
252
1552
304
Kela drug reimbursment
Dornase alfa
+∞
12.5
12
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
12.5
12
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
12.5
12
*
K08.3
ICD-10 Finland
Retained dental root
1.6
12.5
305
1971
L01BB05
ATC
fludarabine; systemic
130.4
12.4
13
*
R83
ICPC
Respiratory infection other
1.4
12.4
601
4457
XX7LW, ,
NOMESCO Finland
13.2
12.4
21
16
I30.9
ICD-10 Finland
Acute pericarditis, unspecified
5.0
12.4
26
52
X58
ICD-10 Finland
Exposure to other specified factors
1.5
12.3
463
3279
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.1
12.3
111
530
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.4
12.3
24
45
A12BA01
ATC
potassium chloride; oral
1.8
12.3
187
1067
M01AE02
ATC
naproxen; oral, rectal
1.3
12.3
1964
17163
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
14.3
12.2
20
14
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
3.9
12.2
35
90
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.1
12.2
50
163
M10.0
ICD-10 Finland
Idiopathic gout
1.9
12.2
159
864
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.5
12.2
41
118
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
37.6
12.2
15
*
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
2.1
12.2
120
592
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
5.1
12.2
25
49
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
5.1
12.2
25
49
UJF92
NOMESCO Finland
Capsular endoscopy
2.5
12.2
75
304
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
3.8
12.2
36
95
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.6
12.1
39
109
XX4AW, ,
NOMESCO Finland
15.9
12.1
19
12
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
4.5
12.1
29
65
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
5.5
12.1
23
42
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.2
12.1
96
436
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.3
12.0
87
379
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
26.7
12.0
16
6
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
12.0
193
1118
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
4.1
12.0
32
78
KMAK, ,
NOMESCO Finland
1.3
12.0
1655
14201
SAA04
NOMESCO Finland
Special examination of mouth
1.8
12.0
163
898
R06AE09
ATC
levocetirizine; oral
1.5
12.0
389
2676
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
10.0
12.0
23
23
M70.2
ICD-10 Finland
Olecranon bursitis
1.9
11.9
145
771
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
4.0
11.9
33
83
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
1.8
11.8
179
1019
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
5.4
11.8
23
43
XJC00
NOMESCO Finland
Oesophageal manometry
5.4
11.8
23
43
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
11.8
494
3570
R55
ICD-10 Finland
Syncope and collapse
1.4
11.8
460
3281
B37.08
ICD-10 Finland
Other candidal stomatitis
3.5
11.8
40
116
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
2.4
11.8
78
327
L03
ICPC
Low back symptom/complaint
1.3
11.7
985
7938
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
11.7
171
963
M54
ICD-10 Finland
Dorsalgia
1.5
11.7
367
2506
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.9
11.7
138
726
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
4.3
11.7
29
67
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.8
11.7
56
200
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
4.7
11.6
26
55
M05BA01
ATC
etidronic acid; systemic
4.0
11.6
32
80
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
30.1
11.6
15
5
R03BC03
ATC
nedocromil; inhalant
1.7
11.6
217
1312
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
65.1
11.6
13
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
65.1
11.6
13
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.8
11.6
180
1033
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
11.6
218
1321
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
11.6
429
3031
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.3
11.5
89
399
J01CA08
ATC
pivmecillinam; oral
1.3
11.5
1191
9860
A07EC02
ATC
mesalazine; oral, rectal
1.8
11.5
172
976
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
3.2
11.5
44
138
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
+∞
11.5
11
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
+∞
11.5
11
*
E000006, ,
ATC
1.7
11.5
225
1378
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.2
11.5
99
465
49300
ICD-8 Finland
Asthma, bronchiale
2.4
11.4
74
307
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
120.3
11.4
12
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
4.4
11.4
28
64
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.7
11.4
26
56
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
11.4
156
863
SBA10
NOMESCO Finland
Measurement of salivary flow rate
3.2
11.3
44
139
SPAT1251
SPAT
Organisation of medication
1.9
11.3
134
706
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.7
11.3
221
1352
C01BD01
ATC
amiodarone; systemic
2.0
11.3
119
603
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
35.1
11.3
14
*
RK220, ,
NOMESCO Finland
5.1
11.2
23
45
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
2.0
11.2
126
652
SBA00
NOMESCO Finland
Microbiological examinations
2.1
11.2
99
469
L01CB
ATC
Podophyllotoxin derivatives
9.6
11.2
22
23
R49.01
ICD-10 Finland
Functional dysphonia
2.1
11.2
103
496
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
11.1
1058
8660
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
11.1
194
1151
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
25.1
11.1
15
6
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1.8
11.1
153
847
11
HP
Coronary artery bypass surgery
2.0
11.1
116
586
L04AA11
ATC
[U] etanercept
8.6
11.0
23
27
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
11.0
383
2672
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
5.0
11.0
23
46
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.4
11.0
73
307
K92.1
ICD-10 Finland
Melaena
1.6
11.0
236
1480
EB1WA, ,
NOMESCO Finland
4.4
11.0
27
62
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
10.9
382
2668
WX204
NOMESCO Finland
Axillary plexus blockaced
2.0
10.9
117
597
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.7
10.9
192
1144
J01EA01
ATC
trimethoprim; systemic
1.3
10.9
885
7096
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.7
10.8
213
1305
WPB10
NOMESCO Finland
Making a convalescent care decision
3.9
10.8
31
80
3006
Kela drug reimbursment
Baricitinib
11.9
10.8
19
16
L05
ICPC
Flank/axilla symptom/complaint
1.6
10.8
237
1493
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
3.4
10.8
38
113
A10AE05
ATC
insulin detemir; parenteral
1.7
10.8
177
1033
RS224, ,
NOMESCO Finland
5.1
10.8
22
43
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
10.7
97
464
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.1
10.7
95
451
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
28.1
10.7
14
5
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
10.7
662
5102
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.6
10.7
60
233
J03.0
ICD-10 Finland
Streptococcal tonsillitis
3.0
10.7
46
155
C02KX01
ATC
bosentan; oral
60.1
10.6
12
*
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
10.5
217
1346
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.6
10.5
218
1354
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.9
10.5
124
653
UKC02
NOMESCO Finland
Cystoscopy
1.3
10.5
740
5810
UGC02
NOMESCO Finland
Rigid bronchoscopy
8.5
10.5
22
26
E87.5
ICD-10 Finland
Hyperkalaemia
2.2
10.5
82
370
-69
ICPC
Other reason for encounter NEC
1.8
10.5
141
775
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
10.5
126
668
N03AX09
ATC
lamotrigine; oral
2.1
10.5
99
482
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
4.6
10.5
24
52
B48.5
ICD-10 Finland
Pneumocystosis
110.3
10.4
11
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
110.3
10.4
11
*
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
110.3
10.4
11
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
4.1
10.4
28
69
M81.8
ICD-10 Finland
Other osteoporosis
3.0
10.4
45
152
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.1
10.4
101
497
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2.6
10.4
56
213
293
Kela drug reimbursment
Baricitinib
12.0
10.3
18
15
SPAT1104
SPAT
Monitoring of emergency patient
1.6
10.3
230
1456
J01
ICD-10 Finland
Acute sinusitis
1.9
10.3
122
644
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
4.3
10.3
26
61
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
10.6
10.3
19
18
B03XA01
ATC
erythropoietin; parenteral
3.4
10.3
36
107
N07BB01
ATC
disulfiram; oral
2.0
10.2
114
589
S29
ICPC
Skin symptom/complaint other
1.3
10.2
774
6137
J01CF05
ATC
flucloxacillin; systemic
1.6
10.2
232
1474
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
3.7
10.2
32
88
K76.9
ICD-10 Finland
Liver disease, unspecified
2.7
10.2
52
192
SPAT1281
SPAT
Other administrative function
1.5
10.2
272
1795
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.1
10.2
89
421
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.8
10.2
136
747
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.3
10.2
72
312
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.8
10.2
143
798
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.0
10.1
104
522
A10BH05
ATC
linagliptin; oral
1.6
10.1
224
1415
N02BF01
ATC
gabapentin; oral
1.5
10.1
347
2414
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.9
10.1
118
620
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
2.4
10.1
68
288
280
Kela drug reimbursment
Clopidogrel
2.4
10.1
67
282
TK810
NOMESCO Finland
Hemofiltration
4.2
10.1
26
62
137
Kela drug reimbursment
Uraemia requiring dialysis
3.6
10.1
32
89
L04AA37
ATC
[U] baricitinib
11.3
10.0
18
16
L02
ICPC
Back symptom/complaint
1.5
10.0
297
2005
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
10.0
431
3128
X57
ICD-10 Finland
Unspecified privation
2.2
10.0
80
365
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
10.0
154
883
R06.4
ICD-10 Finland
Hyperventilation
2.9
10.0
46
161
J05AH02
ATC
oseltamivir; oral
4.6
10.0
23
50
J01MA01
ATC
ofloxacin; systemic
1.5
10.0
317
2171
A41.8
ICD-10 Finland
Other specified sepsis
2.3
10.0
70
302
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
3.2
10.0
38
119
EBA00
NOMESCO Finland
Extraction of tooth
1.3
10.0
1267
10719
J10.8
ICD-10 Finland
Influenza with other manifestations, seasonal influenza virus identified
40.1
10.0
12
*
WX727
NOMESCO Finland
Estimation of exercise oxygen therapy
40.1
10.0
12
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
40.1
10.0
12
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.7
10.0
31
85
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.6
10.0
55
212
S20.2
ICD-10 Finland
Contusion of thorax
1.7
10.0
188
1141
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
9.9
759
6024
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
9.9
166
974
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
4.0
9.9
27
67
D05AX52
ATC
calcipotriol, combinations; topical
1.7
9.9
189
1149
I95.9
ICD-10 Finland
Hypotension, unspecified
2.4
9.9
66
278
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.0
9.9
109
561
ZX120, ,
SPAT
2.5
9.9
62
254
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
9.9
560
7255
N05CF02
ATC
zolpidem; oral
1.4
9.9
535
4036
SPAT1252
SPAT
Overall medication plan or its review
1.5
9.8
271
1802
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
26.1
9.8
13
5
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
26.1
9.8
13
5
4040, ,
NOMESCO Finland
20.1
9.8
14
7
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
9.8
328
2272
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
9.8
208
1302
WVA20, ,
SPAT
1.8
9.8
133
735
RJ411, ,
NOMESCO Finland
4.0
9.8
27
68
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
4.7
9.8
22
47
ZX140
NOMESCO Finland
Intra articular
3.5
9.8
32
91
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.0
9.7
107
551
N05AH04
ATC
quetiapine; oral
1.4
9.7
487
3629
A07EA06
ATC
budesonide; oral, local oral
1.9
9.7
116
615
XX9XW, ,
NOMESCO Finland
3.9
9.7
28
73
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
13.4
9.7
16
12
RT271, ,
NOMESCO Finland
13.4
9.7
16
12
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
1.6
9.7
207
1298
K22.1
ICD-10 Finland
Ulcer of oesophagus
2.2
9.6
74
332
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
3.0
9.6
40
132
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.5
9.6
284
1916
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
7.8
9.6
21
27
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.8
9.6
128
703
I40.9
ICD-10 Finland
Acute myocarditis, unspecified
4.3
9.6
24
56
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
3.9
9.6
27
69
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
9.6
354
2499
WW409
NOMESCO Finland
Other aferesis
11.4
9.5
17
15
R84
ICPC
Malignant neoplasm bronchus/lung
4.4
9.5
23
52
R07.0
ICD-10 Finland
Pain in throat
1.7
9.5
180
1093
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.8
9.5
144
822
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
15.0
9.5
15
10
K22.7
ICD-10 Finland
Barrett oesophagus
2.5
9.5
58
235
SPAT1312
SPAT
General health counselling
1.3
9.5
1091
9114
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.1
9.5
39
128
D69.0
ICD-10 Finland
Allergic purpura
3.8
9.5
28
74
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.3
9.4
68
297
M79.1
ICD-10 Finland
Myalgia
1.4
9.4
442
3255
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.6
9.4
210
1329
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
2.8
9.4
47
172
J15.2
ICD-10 Finland
Pneumonia due to staphylococcus
100.3
9.4
10
*
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
100.3
9.4
10
*
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.8
9.4
45
161
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
9.4
183
1120
FXE00
NOMESCO Finland
Use of ECLA
30.1
9.4
12
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
30.1
9.4
12
*
-44
ICPC
Preventive immunization/medic
1.5
9.4
331
2315
YNB10
NOMESCO Finland
Collection of stem cells for transplant
17.5
9.4
14
8
R03DX07
ATC
roflumilast; oral
17.5
9.4
14
8
4829X
ICD-9 Finland
Other bacterial pneumonia, Bacterial pneumonia unspecified
+∞
9.4
9
*
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
+∞
9.4
9
*
M01AX01
ATC
nabumetone; oral
1.8
9.4
146
841
J01.8
ICD-10 Finland
Other acute sinusitis
5.2
9.3
19
37
D68.8
ICD-10 Finland
Other specified coagulation defects
3.1
9.3
38
124
SPAT1283
SPAT
Restricted health certificate
1.5
9.3
281
1904
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
9.3
620
4823
D10
ICPC
Vomiting
1.9
9.3
115
616
3A064, ,
NOMESCO Finland
4.4
9.3
23
53
RJ420, ,
NOMESCO Finland
4.4
9.3
23
53
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.1
9.3
89
436
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.8
9.3
28
75
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.8
9.3
132
739
NXL00
NOMESCO Finland
Biopsy of muscle
4.9
9.3
20
41
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
9.3
221
1421
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
2.1
9.3
81
383
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.7
9.3
173
1047
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.7
9.3
149
866
NDF10
NOMESCO Finland
Synovectomy of wrist
9.5
9.2
18
19
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.8
9.2
143
822
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.6
9.2
214
1369
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.3
9.2
69
307
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.4
9.2
60
251
S76
ICPC
Skin infection other
1.6
9.2
193
1205
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.4
9.2
32
95
K78
ICPC
Atrial fibrillation/flutter
1.4
9.2
363
2596
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
9.1
399
2903
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
9.1
266
1790
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
2.3
9.1
66
289
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.8
9.1
45
164
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
2.7
9.1
48
181
V03AE01
ATC
polystyrene sulfonate; oral
2.5
9.1
57
234
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.0
9.1
89
440
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.0
9.1
19
38
3005
Kela drug reimbursment
Tofacitinib
8.3
9.0
19
23
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
15.6
9.0
14
9
I47.2
ICD-10 Finland
Ventricular tachycardia
2.1
9.0
85
415
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.0
9.0
96
490
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.6
9.0
50
194
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
4.1
9.0
24
59
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
2.1
8.9
84
409
Z94.1
ICD-10 Finland
Heart transplant status
18.6
8.9
13
7
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
18.6
8.9
13
7
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
18.6
8.9
13
7
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
8.9
918
7563
WX320
NOMESCO Finland
Spinalanesthesy
1.3
8.9
950
7859
U02
ICPC
Urinary frequency/urgency
1.4
8.9
505
3836
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
2.6
8.9
50
195
J81
ICD-10 Finland
Pulmonary oedema
3.7
8.9
27
73
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
4.3
8.9
22
51
I73.0
ICD-10 Finland
Raynaud syndrome
2.5
8.9
55
225
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
8.9
109
584
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
4.5
8.8
21
47
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
6.8
8.8
21
31
OAA67, ,
SPAT
0.6
8.8
142
2356
GD1CQ
NOMESCO Finland
Lung circulation SPECT with low dose CT
8.6
8.8
18
21
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.8
8.8
130
738
L12
ICPC
Hand/finger symptom/complaint
1.3
8.8
555
4286
SFA20
NOMESCO Finland
Two-surface restoration
1.2
8.8
1925
17182
J21.99
ICD-10 Finland
Acute bronchiolitis, unspecified
9.5
8.8
17
18
-34
ICPC
Blood test
2.0
8.7
96
495
RF220, ,
NOMESCO Finland
2.6
8.7
48
185
N05BA06
ATC
lorazepam; systemic, sublingual
1.6
8.7
177
1096
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.0
8.7
93
475
R01AD11
ATC
triamcinolone; nasal
1.5
8.7
242
1613
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.9
8.7
104
552
348
Kela drug reimbursment
Roflumilast
14.0
8.7
14
10
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
3.9
8.7
25
65
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
50.1
8.7
10
*
A91
ICPC
Abnormal result investigation NOS
1.6
8.7
198
1262
B01AE07
ATC
dabigatran etexilate; oral
1.7
8.7
165
1005
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
3.6
8.7
28
79
M54.8
ICD-10 Finland
Other dorsalgia
1.7
8.7
139
808
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
3.1
8.7
35
114
349
Kela drug reimbursment
Febuxostat
4.2
8.6
22
52
A05
ICPC
Feeling ill
1.7
8.6
146
861
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.9
8.6
38
130
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.1
8.6
34
109
WX780
NOMESCO Finland
Remote monitoring CPAP
1.7
8.6
139
809
R07.1
ICD-10 Finland
Chest pain on breathing
2.5
8.6
51
204
C10AC01
ATC
colestyramine; oral
2.0
8.6
93
477
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
8.6
240
1601
M17.5
ICD-10 Finland
Other secondary gonarthrosis
2.4
8.6
58
247
L01BB01, ,
ATC
11.6
8.6
15
13
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.6
723
5809
N30
ICD-10 Finland
Cystitis
1.5
8.5
227
1499
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
9.0
8.5
17
19
C10AA05
ATC
atorvastatin; oral
1.2
8.5
1852
16499
D02AX
ATC
Other emollients and protectives
2.0
8.5
91
465
M04AA03
ATC
febuxostat; oral
4.1
8.5
23
57
D01
ICPC
Abdominal pain/cramps general
1.4
8.5
362
2622
L03AA13
ATC
pegfilgrastim; parenteral
1.8
8.5
127
723
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
27.6
8.5
11
*
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
8.5
239
1598
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.8
8.5
41
148
M32
ICD-10 Finland
Systemic lupus erythematosus
20.0
8.5
12
6
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
20.0
8.5
12
6
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
20.0
8.5
12
6
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.6
8.5
219
1437
PD4AD
NOMESCO Finland
CT of lower extremity arteries
2.7
8.5
44
165
I20.00
ICD-10 Finland
Unstable angina
1.8
8.5
126
717
K29.7
ICD-10 Finland
Gastritis, unspecified
1.7
8.4
135
784
H01
ICPC
Ear pain/earache
1.4
8.4
324
2304
GBB00
NOMESCO Finland
Tracheostomy
2.7
8.4
42
154
L29
ICPC
Musculoskeletal sympt/complt other
1.4
8.4
312
2204
R21
ICPC
Throat symptom/complaint
1.4
8.4
486
3701
K51.5
ICD-10 Finland
Left sided colitis
2.1
8.4
76
365
J02AC05
ATC
isavuconazole; systemic
90.2
8.4
9
*
B01AC06
ATC
acetylsalicylic acid; oral
1.7
8.4
165
1013
288
Kela drug reimbursment
Febuxostat
3.9
8.4
24
62
J34.2
ICD-10 Finland
Deviated nasal septum
1.7
8.4
157
952
E000007, ,
ATC
1.7
8.4
147
876
R75
ICPC
Sinusitis acute/chronic
1.8
8.4
112
617
N05BB01
ATC
hydroxyzine; systemic
1.6
8.4
182
1147
Z01.2
ICD-10 Finland
Dental examination
1.2
8.4
1482
12938
NA2AD
NOMESCO Finland
Thoracic spine CT examination
3.4
8.3
29
86
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
+∞
8.3
8
*
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
+∞
8.3
8
*
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
3.0
8.3
36
122
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.7
8.3
42
155
D06
ICPC
Abdominal pain localized other
1.5
8.3
270
1859
AN3
HP
Balloon angioplasty and metallic stent
1.8
8.3
118
662
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
8.3
249
1687
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.7
8.3
41
150
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
8.3
118
663
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
8.3
465
3527
J04.0
ICD-10 Finland
Acute laryngitis
2.2
8.3
70
328
H57.1
ICD-10 Finland
Ocular pain
1.9
8.3
105
569
GD1LA
NOMESCO Finland
GD
2.2
8.2
63
283
D05BB02
ATC
acitretin; oral
2.0
8.2
87
443
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
8.2
64
290
K94
ICPC
Phlebitis/thrombophlebitis
2.3
8.2
58
252
WZA00
NOMESCO Finland
Concise certificate
1.6
8.2
183
1161
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
8.2
524
4052
I45.9
ICD-10 Finland
Conduction disorder, unspecified
3.0
8.2
35
118
S21
ICPC
Skin texture symptom/complaint
1.3
8.2
571
4471
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
3.7
8.2
25
68
L50.0
ICD-10 Finland
Allergic urticaria
2.1
8.2
72
343
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.9
8.2
37
129
U71
ICPC
Cystitis/urinary infection other
1.6
8.1
205
1337
B02.8
ICD-10 Finland
Zoster with other complications
3.0
8.1
34
113
A01AB10
ATC
natamycin; local oral
2.0
8.1
89
459
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
2.8
8.1
40
146
TEA00
NOMESCO Finland
Biopsy of lip
2.8
8.1
40
146
AN4
HP
Balloon angioplasty and drug eluding stent
1.7
8.1
143
854
C08DA01
ATC
verapamil; systemic
1.7
8.1
147
885
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
3.8
8.1
24
64
H05BX01
ATC
cinacalcet; oral
3.8
8.1
24
64
WX704
NOMESCO Finland
Intubation
1.5
8.1
266
1838
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.5
8.0
224
1494
S20
ICPC
Corn/callosity
2.0
8.0
84
426
RK290, ,
NOMESCO Finland
6.8
8.0
19
28
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.5
8.0
48
193
Z02.7
ICD-10 Finland
Issue of medical certificate
1.5
8.0
253
1732
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
10.0
8.0
15
15
602
Kela drug reimbursment
Children's severe malnutrition
22.0
8.0
11
5
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
22.0
8.0
11
5
N04BC05
ATC
pramipexole; oral
1.5
8.0
268
1857
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.4
8.0
53
224
D06BB04
ATC
podophyllotoxin; topical
1.9
8.0
93
490
WX202
NOMESCO Finland
Supraclavicular plexus blockade
2.4
8.0
50
206
C08DB01
ATC
diltiazem; oral
1.5
8.0
227
1522
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
3.8
8.0
23
60
R10.0
ICD-10 Finland
Acute abdomen
1.9
7.9
96
512
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
7.2
7.9
18
25
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
7.9
165
1029
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.0
7.9
77
381
61
HP
Catheterization and pressure measurement of the left side of the heart
2.0
7.9
77
381
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.6
7.9
180
1148
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.8
7.9
108
600
N02AJ13
ATC
tramadol and paracetamol; systemic
2.0
7.9
77
382
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
3.1
7.8
32
105
FL1AC
NOMESCO Finland
Left cardioangiography
2.1
7.8
71
342
Z00.0
ICD-10 Finland
General medical examination
1.3
7.8
687
5543
E87.6
ICD-10 Finland
Hypokalaemia
1.8
7.8
119
682
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
7.8
312
2235
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.1
7.8
72
349
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
2.5
7.8
45
178
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.5
7.8
46
184
A08
ICPC
Swelling
1.5
7.8
217
1448
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.7
7.8
41
155
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
3.4
7.8
27
80
4224
FHL
Endonasal anthrostomy
3.2
7.8
29
90
RK310, ,
NOMESCO Finland
9.4
7.8
15
16
SPAT1240
SPAT
Therapeutic discussion
1.5
7.8
224
1506
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.0
7.8
76
377
R52.2
ICD-10 Finland
Other chronic pain
1.8
7.7
108
603
A34
ICPC
General and Unspecified, Blood test
2.4
7.7
51
215
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
1.8
7.7
112
633
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
45.1
7.7
9
*
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
45.1
7.7
9
*
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
15.0
7.7
12
8
Z57.3
ICD-10 Finland
Occupational exposure to other air contaminants
6.4
7.7
19
30
R03BB05
ATC
aclidinium bromide; inhalant
6.4
7.7
19
30
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
1.9
7.7
93
497
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
5.9
7.7
20
34
R79
ICPC
Chronic bronchitis
7.4
7.7
17
23
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
3.4
7.7
26
76
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
3.2
7.7
29
91
5CM18, ,
NOMESCO Finland
4.5
7.6
18
40
N05AA02
ATC
levomepromazine; systemic
1.8
7.6
105
584
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
7.6
646
5188
N06AB03
ATC
fluoxetine; oral
1.4
7.6
346
2535
PD5BD
NOMESCO Finland
Extensive CT of aorta
2.0
7.6
80
407
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
2.2
7.6
61
280
K83.0
ICD-10 Finland
Cholangitis
2.2
7.6
61
280
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.1
7.6
71
346
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
4.0
7.6
21
53
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
7.6
540
4237
GX1P5
NOMESCO Finland
Nocturnal CO2 monitoring
18.4
7.6
11
6
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
2.1
7.6
72
353
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.5
7.6
217
1457
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.7
7.6
141
855
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
6.7
7.6
18
27
L04AC14
ATC
sarilumab; systemic
11.8
7.6
13
11
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
25.0
7.6
10
*
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
25.0
7.6
10
*
I95.1
ICD-10 Finland
Orthostatic hypotension
1.6
7.6
178
1144
L20
ICPC
Joint symptom/complaint NOS
1.7
7.6
121
704
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.6
7.6
190
1240
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.3
7.5
27
82
H92.0
ICD-10 Finland
Otalgia
1.6
7.5
163
1028
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.3
7.5
54
237
K93
ICPC
Pulmonary embolism
2.7
7.5
38
141
OAB43, ,
SPAT
0.7
7.5
275
3827
ECB20
NOMESCO Finland
Oral alveoplasty
2.5
7.5
45
182
J32.1
ICD-10 Finland
Chronic frontal sinusitis
7.1
7.5
17
24
J11.0
ICD-10 Finland
Influenza with pneumonia, virus not identified
7.1
7.5
17
24
RF210, ,
NOMESCO Finland
1.9
7.5
84
438
N01
ICPC
Headache
1.5
7.5
251
1742
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.3
7.5
55
244
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
3.7
7.4
23
63
I20.91
ICD-10 Finland
Angina pectoris, unspecified
2.1
7.4
65
309
A10BA02
ATC
metformin; oral
1.2
7.4
1174
10109
WX290
NOMESCO Finland
Other blockage of nerve
1.2
7.4
1370
11977
K85.8
ICD-10 Finland
Other acute pancreatitis
2.9
7.4
33
114
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
7.4
155
969
SPAT1058
SPAT
PEF monitoring instruction
1.5
7.4
255
1778
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
3.1
7.4
29
93
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.1
7.4
29
93
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.1
7.4
29
93
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.2
7.4
60
277
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
6.0
7.4
19
32
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
7.3
249
1731
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.0
7.3
79
406
J01CF02
ATC
cloxacillin; systemic
1.9
7.3
83
434
M01AB01
ATC
indometacin; systemic, rectal
1.4
7.3
310
2245
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
2.8
7.3
35
126
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
8.4
7.3
15
18
M19.2
ICD-10 Finland
Other secondary arthrosis
2.3
7.3
51
221
J15.6
ICD-10 Finland
Pneumonia due to other Gram-negative bacteria
+∞
7.3
7
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
7.3
7
*
6BB16, ,
NOMESCO Finland
+∞
7.3
7
*
46209
ICD-8 Finland
Acute pharyngitis, Unspecified
+∞
7.3
7
*
A48.1
ICD-10 Finland
Legionnaires disease
+∞
7.3
7
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.6
7.3
23
64
RT274, ,
NOMESCO Finland
10.9
7.3
13
12
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
10.9
7.3
13
12
AN2
HP
Balloon angioplasty, including several vessels
1.7
7.3
117
682
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
2.6
7.3
39
149
M01CC01
ATC
penicillamine; oral
9.4
7.3
14
15
R01AD05
ATC
budesonide; nasal
1.5
7.3
201
1340
R51
ICD-10 Finland
Headache
1.7
7.3
124
735
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
4.1
7.3
19
46
M01AH05
ATC
etoricoxib; oral
1.2
7.3
2143
19527
ZXD20
NOMESCO Finland
Day surgery
1.4
7.3
407
3086
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
2.0
7.2
75
380
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
1.8
7.2
108
616
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
3.4
7.2
25
74
S19
ICPC
Skin injury other
1.6
7.2
141
866
P03
ICPC
Feeling depressed
1.5
7.2
193
1277
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
7.2
200
1334
K11.2
ICD-10 Finland
Sialoadenitis
1.8
7.2
100
558
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
3.0
7.2
31
105
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
5.8
7.2
19
33
R35
ICD-10 Finland
Polyuria
1.4
7.2
284
2031
C09CA01
ATC
losartan; oral
1.2
7.2
1035
8825
B02
ICD-10 Finland
Zoster [herpes zoster]
1.6
7.2
152
953
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
4.5
7.2
17
38
NA3BM
NOMESCO Finland
Lumbar spine MRI examination with 3 Tesla magnet
4.5
7.2
17
38
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.5
7.2
184
1207
ZXC50
NOMESCO Finland
Cryotherapy
1.6
7.2
145
899
L30.3
ICD-10 Finland
Infective dermatitis
1.7
7.2
114
663
R48
ICPC
Respiratory, Clarification/discussion RFE/demand
3.9
7.2
20
51
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.6
7.1
140
861
S02
ICPC
Pruritus
1.8
7.1
111
641
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
20.0
7.1
10
5
TPH04, ,
SPAT
2.4
7.1
45
187
JEA00
NOMESCO Finland
Appendectomy
1.6
7.1
167
1075
RS310, ,
NOMESCO Finland
12.0
7.1
12
10
J15
ICD-10 Finland
Bacterial pneumonia, not elsewhere classified
12.0
7.1
12
10
R04.8
ICD-10 Finland
Haemorrhage from other sites in respiratory passages
12.0
7.1
12
10
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.3
7.1
53
237
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.4
7.1
334
2465
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.7
7.1
136
833
F2682, ,
NOMESCO Finland
8.8
7.0
14
16
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
8.8
7.0
14
16
NHG22
NOMESCO Finland
Fusion of subtalar joint
3.0
7.0
29
96
R50
ICPC
Respiratory, Medication/prescr/renewal
10.0
7.0
13
13
K05.31
ICD-10 Finland
Periodontitis pronounced
1.3
7.0
396
3005
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.6
7.0
168
1085
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
7.0
414
3163
WX610
NOMESCO Finland
Patient controlled analgesia
3.6
7.0
22
61
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
7.0
801
6663
B80
ICPC
Iron deficiency anaemia
1.9
7.0
84
448
RK323, ,
NOMESCO Finland
4.2
7.0
18
43
K51.8
ICD-10 Finland
Other ulcerative colitis
2.4
7.0
45
188
H65.2
ICD-10 Finland
Chronic serous otitis media
2.5
7.0
40
158
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
7.0
7.0
16
23
SCA02
NOMESCO Finland
Preventive oral health care
1.4
7.0
268
1908
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.5
7.0
213
1451
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.2
7.0
56
258
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.6
7.0
141
875
M60.9
ICD-10 Finland
Myositis, unspecified
3.3
7.0
25
76
WX212
NOMESCO Finland
Femoral plexus blockade
1.8
7.0
94
521
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.0
6.9
68
338
R06.5
ICD-10 Finland
Mouth breathing
1.4
6.9
267
1901
PJA10
NOMESCO Finland
Exploration of lymph nodes
2.4
6.9
46
195
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
6.9
138
853
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.3
6.9
49
214
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
5.4
6.9
19
35
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
2.8
6.9
33
119
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.7
6.9
120
716
M05.0
ICD-10 Finland
Felty syndrome
13.8
6.9
11
8
XQ855, ,
SPAT
2.3
6.9
47
202
SGC10
NOMESCO Finland
Pulp capping
1.5
6.9
194
1300
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.5
6.9
179
1179
N06AB10
ATC
escitalopram; oral
1.3
6.9
496
3900
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
6.8
315
2314
HA1AA
NOMESCO Finland
X-ray mammography
1.5
6.8
227
1572
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
2.9
6.8
30
103
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
3.4
6.8
23
67
NGQ20
NOMESCO Finland
Amputation of lower leg
3.3
6.8
24
72
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
2.0
6.8
66
327
C01CA24
ATC
epinephrine; parenteral
1.6
6.8
133
818
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.6
6.8
133
818
DMB10
NOMESCO Finland
Radical maxillary antrotomy
4.1
6.8
18
44
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
6.7
6.8
16
24
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
6.7
6.8
16
24
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.3
6.8
50
222
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
2.1
6.8
60
287
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
10.9
6.8
12
11
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
2.2
6.8
52
235
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
2.9
6.8
31
109
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
9.3
6.8
13
14
R50.0
ICD-10 Finland
Fever with chills
9.3
6.8
13
14
D01AE15
ATC
terbinafine; topical
1.4
6.8
253
1792
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.8
6.8
92
511
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
6.8
599
4835
L16
ICPC
Ankle symptom/complaint
1.4
6.8
367
2769
L95.8
ICD-10 Finland
Other vasculitis limited to skin
6.1
6.8
17
28
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
6.8
152
968
D84.8
ICD-10 Finland
Other specified immunodeficiencies
40.1
6.8
8
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
40.1
6.8
8
*
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
40.1
6.8
8
*
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
40.1
6.8
8
*
S79.9
ICD-10 Finland
Unspecified injury of hip and thigh
2.7
6.7
34
126
XG430
NOMESCO Finland
Spiroegometry
16.7
6.7
10
6
GX1R5
NOMESCO Finland
Peak expiratory flow (PEF) measurement
16.7
6.7
10
6
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.2
6.7
55
255
TQW80
NOMESCO Finland
Local dermatologic skincare
1.8
6.7
96
541
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.3
6.7
50
223
J01MA06
ATC
norfloxacin; oral
1.3
6.7
424
3271
NH2AA
NOMESCO Finland
Heel X-ray examination
3.5
6.7
22
63
SXC03
NOMESCO Finland
Other oral or dental procedure
2.6
6.7
36
138
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
1.9
6.7
84
455
RJ511, ,
NOMESCO Finland
7.2
6.7
15
21
A03FA02
ATC
cisapride; oral, rectal
1.4
6.7
264
1889
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.7
6.7
33
121
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.7
37
144
S01AD03
ATC
aciclovir; ophthalmic
1.7
6.7
118
707
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
2.8
6.7
31
110
J01DC04
ATC
cefaclor; oral
2.8
6.7
31
110
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
6.7
97
550
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
22.5
6.7
9
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.5
6.7
39
156
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.1
6.7
58
276
A10AB01
ATC
insulin (human); parenteral
1.8
6.6
87
478
D01AC02
ATC
miconazole; topical
1.4
6.6
268
1926
RJ412, ,
NOMESCO Finland
6.4
6.6
16
25
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.1
6.6
60
290
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.4
6.6
44
187
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.6
6.6
36
139
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
6.6
122
740
R76.0
ICD-10 Finland
Raised antibody titre
5.5
6.6
18
33
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
5.5
6.6
18
33
PE1AT
NOMESCO Finland
Femoral artery PTA
2.2
6.6
50
225
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
6.6
429
3325
R27
ICPC
Fear of respiratory disease other
2.5
6.6
40
163
GAC00
NOMESCO Finland
Biopsy of pleura
3.6
6.6
21
59
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
12.2
6.6
11
9
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.7
6.6
117
703
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
8.7
6.5
13
15
NDB60
NOMESCO Finland
Prosthetic replacement of MCP joint of finger
8.7
6.5
13
15
J15.7
ICD-10 Finland
Pneumonia due to Mycoplasma pneumoniae
10.0
6.5
12
12
I20.0
ICD-10 Finland
Unstable angina
2.4
6.5
41
170
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.4
6.5
41
170
T92
ICPC
Gout
1.8
6.5
95
540
TQW99
NOMESCO Finland
Other minor procedure on skin
1.5
6.5
196
1333
SPF30
NOMESCO Finland
Relining of denture
1.9
6.5
75
396
F05.9
ICD-10 Finland
Delirium, unspecified
1.9
6.5
82
446
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
3.6
6.5
20
55
153
Kela drug reimbursment
Lenalidomid
3.6
6.5
20
55
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.1
6.5
54
253
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
1.8
6.4
85
468
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
5.3
6.4
18
34
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
3.9
6.4
18
46
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
70.0
6.4
7
*
WPB11
NOMESCO Finland
Palliative sedation
70.0
6.4
7
*
4038, ,
NOMESCO Finland
70.0
6.4
7
*
B44.9
ICD-10 Finland
Aspergillosis, unspecified
70.0
6.4
7
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.3
6.4
23
70
D06BX01
ATC
metronidazole; topical
1.4
6.4
320
2384
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.4
2721
25437
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.7
6.4
117
708
NC2AA
NOMESCO Finland
Forearm X-ray examination
2.3
6.4
44
190
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
14.3
6.4
10
7
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
6.4
357
2706
K10.3
ICD-10 Finland
Alveolitis of jaws
1.7
6.4
111
663
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.0
6.4
62
308
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
6.4
177
1183
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
2.3
6.4
46
203
R06.6
ICD-10 Finland
Hiccough
4.1
6.3
17
42
J94.2
ICD-10 Finland
Haemothorax
4.1
6.3
17
42
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
6.3
215
1496
M45
ICD-10 Finland
Ankylosing spondylitis
2.1
6.3
54
255
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.7
6.3
111
664
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.5
6.3
37
148
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
1.6
6.3
149
960
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
6.5
6.3
15
23
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
6.5
6.3
15
23
SPAT1360
SPAT
Extensive global examination
1.4
6.3
245
1748
NCF10
NOMESCO Finland
Synovectomy of elbow joint, open
8.1
6.3
13
16
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.1
6.3
58
282
SPAT1291
SPAT
Other function in accordance with NCSP classification
2.2
6.3
49
223
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
2.7
6.3
33
125
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.3
59
289
196
Kela drug reimbursment
Paricalcitol and cinacalcet
5.5
6.3
17
31
J06
ICD-10 Finland
Acute upper respiratory infections of multiple and unspecified sites
1.9
6.3
72
379
-43
ICPC
Other diagnostic procedure
2.1
6.3
57
276
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
9.3
6.3
12
13
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
9.3
6.3
12
13
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
2.4
6.3
41
173
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
6.3
226
1591
R03
ICPC
Wheezing
2.5
6.3
36
143
J62.0
ICD-10 Finland
Pneumoconiosis due to talc dust
18.0
6.3
9
5
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
18.0
6.3
9
5
XKC03
NOMESCO Finland
Water cystometry
1.7
6.3
99
576
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
6.3
207
1434
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
6.3
178
1196
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
3.8
6.3
18
47
G04BE08
ATC
tadalafil; oral
3.8
6.3
18
47
RJ421, ,
NOMESCO Finland
3.8
6.3
18
47
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
6.3
250
1794
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
1.6
6.2
137
868
J01.3
ICD-10 Finland
Acute sphenoidal sinusitis
+∞
6.2
6
*
J20.1
ICD-10 Finland
Acute bronchitis due to Haemophilus influenzae
+∞
6.2
6
*
J15.0
ICD-10 Finland
Pneumonia due to Klebsiella pneumoniae
+∞
6.2
6
*
B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
6.2
6
*
46101
ICD-8 Finland
Acute sinusitis, Frontalis
+∞
6.2
6
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.2
6.2
49
224
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.7
6.2
104
614
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.8
6.2
30
109
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.9
6.2
28
98
L14
ICPC
Leg/thigh symptom/complaint
1.4
6.2
277
2027
R5110, ,
SPAT
1.4
6.2
331
2493
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
5.0
6.2
18
36
A05AA02
ATC
ursodeoxycholic acid; oral
2.3
6.2
43
187
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.6
6.2
139
887
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
6.2
3387
32297
XF612
NOMESCO Finland
Measurement of central venous pressure
6.3
6.2
15
24
N06AB06
ATC
sertraline; oral
1.4
6.2
275
2012
L04AX04
ATC
lenalidomide; oral
3.5
6.1
20
57
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
1.9
6.1
71
375
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
5.7
6.1
16
28
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.1
1390
12336
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
2.6
6.1
33
127
RS222, ,
NOMESCO Finland
2.5
6.1
35
139
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.1
91
521
N05BE01
ATC
buspirone; oral
1.9
6.1
77
419
ZXD35
NOMESCO Finland
Usual procedure
1.7
6.1
99
581
GD1FN
NOMESCO Finland
Lung ventilation isotope imaging
12.5
6.1
10
8
G04CA02
ATC
tamsulosin; oral
1.2
6.1
1192
10446
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
6.1
25
83
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.0
6.1
64
328
51709
ICD-8 Finland
Other chronic interstitial pneumonia, Unspecified
8.6
6.0
12
14
SFA30
NOMESCO Finland
Three-surface restoration
1.2
6.0
1408
12521
L40.9
ICD-10 Finland
Psoriasis, unspecified
2.1
6.0
52
247
L57.0
ICD-10 Finland
Actinic keratosis
1.3
6.0
499
3993
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
6.0
415
3242
ZXX09
NOMESCO Finland
Extent of procedure, more than 8 units
10.0
6.0
11
11
K08.80
ICD-10 Finland
Toothache NOS
1.4
6.0
218
1537
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.6
6.0
144
932
B05DA
ATC
Isotonic solutions
3.2
6.0
23
73
K01.0
ICD-10 Finland
Embedded teeth
2.7
6.0
30
111
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pulmonary Disease
29 [38004472]
29 [38004472]
1.5e+00
2.7e+00
3.7e+00
9.8e+00
4.8e+00
5.0e+00
3.7e+00
cases:26.00%
controls:7.61%
cases:36.54%
controls:3.82%
cases:24.04%
controls:0.75%
cases:79.77%
controls:0.02%
cases:44.34%
controls:0.65%
cases:85.20%
controls:3.80%
cases:78.95%
controls:8.39%
1146
3352
3262
40692
1611
1685
2798
42369
1060
332
3349
43722
3517
10
892
44044
1925
285
2416
43667
3401
1614
591
40877
2322
2897
619
31648
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
3.3e+00
4.8e+00
6.6e+00
1.0e+50
5.7e+00
4.4e+00
3.8e+00
cases:13.20%
controls:0.57%
cases:18.51%
controls:0.19%
cases:13.68%
controls:0.02%
cases:11.07%
controls:0.00%
cases:6.61%
controls:0.02%
cases:15.96%
controls:0.23%
cases:29.28%
controls:0.95%
582
252
3826
43792
816
84
3593
43970
603
9
3806
44045
488
0
3921
44054
287
10
4054
43942
637
96
3355
42395
861
327
2080
34218
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
2.1e+00
3.6e+00
5.0e+00
—
6.4e+00
3.6e+00
2.9e+00
cases:3.90%
controls:0.51%
cases:6.06%
controls:0.18%
cases:3.74%
controls:0.02%
—
—
cases:9.01%
controls:0.02%
cases:5.91%
controls:0.18%
cases:8.70%
controls:0.54%
172
226
4236
43818
267
78
4142
43976
165
11
4244
44043
—
391
7
3950
43945
236
75
3756
42416
256
188
2685
34357
Interstitial pulmonary disease, unspecified
J84.9 [45543277]
J84.9 [45543277]
-1.0e+50
1.4e+00
3.4e+00
1.0e+50
7.0e+00
6.3e+00
5.2e+00
cases:0.00%
controls:0.16%
cases:0.36%
controls:0.09%
cases:0.84%
controls:0.03%
cases:42.75%
controls:0.00%
cases:20.09%
controls:0.02%
cases:36.30%
controls:0.11%
cases:30.64%
controls:0.23%
0
70
4408
43974
16
39
4393
44015
37
12
4372
44042
1885
0
2524
44054
872
10
3469
43942
1449
45
2543
42446
901
81
2040
34464
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
1.1e+00
2.2e+00
3.5e+00
6.8e+00
3.3e+00
3.0e+00
2.4e+00
cases:22.84%
controls:8.96%
cases:22.70%
controls:3.19%
cases:10.05%
controls:0.35%
cases:15.79%
controls:0.02%
cases:7.76%
controls:0.30%
cases:38.05%
controls:3.03%
cases:53.59%
controls:9.68%
1007
3947
3401
40097
1001
1404
3408
42650
443
155
3966
43899
696
9
3713
44045
337
133
4004
43819
1519
1287
2473
41204
1576
3344
1365
31201
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
2.0e+00
3.4e+00
5.3e+00
—
5.3e+00
3.4e+00
2.9e+00
cases:2.65%
controls:0.38%
cases:4.83%
controls:0.16%
cases:3.06%
controls:0.02%
—
—
cases:7.12%
controls:0.04%
cases:4.43%
controls:0.16%
cases:8.09%
controls:0.50%
117
169
4291
43875
213
72
4196
43982
135
7
4274
44047
—
309
16
4032
43936
177
69
3815
42422
238
174
2703
34371
moxifloxacin; oral, parenteral
J01MA14 [21603021]
J01MA14 [21603021]
2.4e+00
3.7e+00
4.5e+00
—
4.7e+00
3.5e+00
3.1e+00
cases:4.02%
controls:0.39%
cases:3.63%
controls:0.10%
cases:1.79%
controls:0.02%
—
—
cases:1.27%
controls:0.01%
cases:3.18%
controls:0.10%
cases:7.48%
controls:0.36%
177
173
4231
43871
160
42
4249
44012
79
9
4330
44045
—
55
5
4286
43947
127
41
3865
42450
220
123
2721
34422
Other interstitial pulmonary diseases with fibrosis
J84.1 [45557630]
J84.1 [45557630]
-3.8e-01
1.5e+00
2.8e+00
—
6.5e+00
5.7e+00
5.5e+00
cases:0.11%
controls:0.17%
cases:0.59%
controls:0.14%
cases:0.59%
controls:0.04%
—
—
cases:13.87%
controls:0.03%
cases:30.54%
controls:0.15%
cases:34.92%
controls:0.23%
5
73
4403
43971
26
61
4383
43993
26
16
4383
44038
—
602
11
3739
43941
1219
63
2773
42428
1027
78
1914
34467
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
1.4e+00
2.3e+00
2.8e+00
5.2e+00
4.0e+00
3.2e+00
2.5e+00
cases:29.42%
controls:9.12%
cases:28.94%
controls:3.83%
cases:10.52%
controls:0.72%
cases:4.38%
controls:0.02%
cases:28.96%
controls:0.73%
cases:50.15%
controls:3.98%
cases:56.75%
controls:9.92%
1297
4017
3111
40027
1276
1689
3133
42365
464
318
3945
43736
193
11
4216
44043
1257
322
3084
43630
2002
1692
1990
40799
1669
3426
1272
31119
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
1.4e+00
2.3e+00
2.8e+00
5.2e+00
4.0e+00
3.2e+00
2.5e+00
cases:29.42%
controls:9.16%
cases:28.96%
controls:3.86%
cases:10.52%
controls:0.72%
cases:4.38%
controls:0.02%
cases:28.96%
controls:0.73%
cases:50.20%
controls:4.00%
cases:56.75%
controls:10.02%
1297
4036
3111
40008
1277
1701
3132
42353
464
318
3945
43736
193
11
4216
44043
1257
322
3084
43630
2004
1699
1988
40792
1669
3461
1272
31084
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
2.1e+00
2.4e+00
2.8e+00
5.7e+00
3.1e+00
2.5e+00
2.3e+00
cases:7.15%
controls:0.90%
cases:6.53%
controls:0.65%
cases:2.65%
controls:0.17%
cases:3.40%
controls:0.01%
cases:3.13%
controls:0.14%
cases:7.79%
controls:0.66%
cases:9.38%
controls:1.03%
315
396
4093
43648
288
285
4121
43769
117
73
4292
43981
150
5
4259
44049
136
62
4205
43890
311
279
3681
42212
276
356
2665
34189
High resolution CT examination of lungs
GD1DD [2001303632]
GD1DD [2001303632]
2.2e+00
4.0e+00
5.1e+00
1.0e+50
—
5.2e+00
4.4e+00
cases:3.15%
controls:0.36%
cases:6.46%
controls:0.12%
cases:3.40%
controls:0.02%
cases:11.25%
controls:0.00%
—
—
cases:15.31%
controls:0.10%
cases:21.08%
controls:0.34%
139
158
4269
43886
285
54
4124
44000
150
9
4259
44045
496
0
3913
44054
—
611
44
3381
42447
620
116
2321
34429
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
1.9e+00
3.6e+00
5.0e+00
—
4.7e+00
3.3e+00
2.0e+00
cases:6.03%
controls:0.91%
cases:13.29%
controls:0.40%
cases:9.28%
controls:0.07%
—
—
cases:5.87%
controls:0.06%
cases:9.77%
controls:0.38%
cases:8.47%
controls:1.23%
266
400
4142
43644
586
175
3823
43879
409
30
4000
44024
—
255
25
4086
43927
390
161
3602
42330
249
425
2692
34120
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
2.0e+00
3.1e+00
4.0e+00
1.0e+50
4.9e+00
3.3e+00
2.9e+00
cases:1.47%
controls:0.21%
cases:1.81%
controls:0.08%
cases:1.13%
controls:0.02%
cases:0.34%
controls:0.00%
cases:2.56%
controls:0.02%
cases:2.35%
controls:0.09%
cases:5.13%
controls:0.30%
65
91
4343
43953
80
37
4329
44017
50
9
4359
44045
15
0
4394
44054
111
9
4230
43943
94
37
3898
42454
151
103
2790
34442
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
1.2e+00
2.1e+00
3.6e+00
6.4e+00
3.1e+00
1.9e+00
1.6e+00
cases:10.98%
controls:3.73%
cases:13.11%
controls:1.75%
cases:8.30%
controls:0.25%
cases:6.51%
controls:0.01%
cases:5.55%
controls:0.26%
cases:11.90%
controls:1.89%
cases:26.18%
controls:6.70%
484
1642
3924
42402
578
769
3831
43285
366
108
4043
43946
287
5
4122
44049
241
116
4100
43836
475
805
3517
41686
770
2315
2171
32230
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
1.2e+00
2.6e+00
3.9e+00
5.8e+00
3.0e+00
2.0e+00
1.5e+00
cases:10.23%
controls:3.45%
cases:13.63%
controls:1.16%
cases:5.51%
controls:0.12%
cases:4.15%
controls:0.01%
cases:2.46%
controls:0.13%
cases:9.32%
controls:1.39%
cases:18.09%
controls:4.65%
451
1520
3957
42524
601
513
3808
43541
243
52
4166
44002
183
6
4226
44048
107
58
4234
43894
372
589
3620
41902
532
1606
2409
32939
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.8e-01
5.7e-01
2.1e+00
5.3e+00
4.0e+00
4.1e+00
4.0e+00
cases:20.37%
controls:23.51%
cases:11.88%
controls:7.10%
cases:5.85%
controls:0.73%
cases:3.79%
controls:0.02%
cases:2.95%
controls:0.06%
cases:21.54%
controls:0.43%
cases:34.48%
controls:0.99%
898
10355
3510
33689
524
3128
3885
40926
258
320
4151
43734
167
9
4242
44045
128
25
4213
43927
860
184
3132
42307
1014
341
1927
34204
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
4.2e+00
5.7e+00
1.0e+50
1.0e+50
—
5.2e+00
4.5e+00
cases:4.11%
controls:0.06%
cases:4.51%
controls:0.02%
cases:2.74%
controls:0.00%
cases:2.49%
controls:0.00%
—
—
cases:3.38%
controls:0.02%
cases:7.82%
controls:0.09%
181
27
4227
44017
199
7
4210
44047
121
0
4288
44054
110
0
4299
44054
—
135
8
3857
42483
230
32
2711
34513
Thorax CT examination
GD1AD [2001303618]
GD1AD [2001303618]
1.8e+00
2.9e+00
4.5e+00
1.0e+50
4.0e+00
3.4e+00
2.8e+00
cases:1.66%
controls:0.27%
cases:3.49%
controls:0.20%
cases:1.86%
controls:0.02%
cases:3.56%
controls:0.00%
cases:0.88%
controls:0.02%
cases:5.94%
controls:0.21%
cases:9.35%
controls:0.65%
73
120
4335
43924
154
87
4255
43967
82
9
4327
44045
157
0
4252
44054
38
7
4303
43945
237
88
3755
42403
275
225
2666
34320
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
1.4e+00
2.0e+00
2.8e+00
6.2e+00
3.0e+00
2.2e+00
1.7e+00
cases:8.82%
controls:2.30%
cases:7.60%
controls:1.07%
cases:2.81%
controls:0.18%
cases:5.53%
controls:0.01%
cases:3.34%
controls:0.18%
cases:9.87%
controls:1.15%
cases:14.14%
controls:3.02%
389
1012
4019
43032
335
473
4074
43581
124
79
4285
43975
244
5
4165
44049
145
77
4196
43875
394
490
3598
42001
416
1042
2525
33503
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
1.6e+00
2.6e+00
4.4e+00
—
3.4e+00
3.7e+00
3.3e+00
cases:7.71%
controls:1.71%
cases:7.05%
controls:0.54%
cases:4.88%
controls:0.06%
—
—
cases:1.45%
controls:0.05%
cases:15.43%
controls:0.43%
cases:22.03%
controls:0.99%
340
755
4068
43289
311
238
4098
43816
215
27
4194
44027
—
63
21
4278
43931
616
184
3376
42307
648
341
2293
34204
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
1.6e+00
2.6e+00
4.4e+00
—
3.4e+00
3.7e+00
3.3e+00
cases:7.71%
controls:1.71%
cases:7.05%
controls:0.54%
cases:4.88%
controls:0.06%
—
—
cases:1.45%
controls:0.05%
cases:15.43%
controls:0.43%
cases:22.03%
controls:0.99%
340
755
4068
43289
311
238
4098
43816
215
27
4194
44027
—
63
21
4278
43931
616
184
3376
42307
648
341
2293
34204
FEV1
20150-9 [3024653]
20150-9 [3024653]
1.6e+00
2.6e+00
4.4e+00
—
3.4e+00
3.7e+00
3.3e+00
cases:7.71%
controls:1.71%
cases:7.05%
controls:0.54%
cases:4.88%
controls:0.06%
—
—
cases:1.45%
controls:0.05%
cases:15.43%
controls:0.43%
cases:22.03%
controls:0.99%
340
755
4068
43289
311
238
4098
43816
215
27
4194
44027
—
63
21
4278
43931
616
184
3376
42307
648
341
2293
34204
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.6e+00
2.6e+00
4.7e+00
—
3.4e+00
3.5e+00
3.2e+00
cases:6.78%
controls:1.48%
cases:5.85%
controls:0.44%
cases:4.35%
controls:0.04%
—
—
cases:1.20%
controls:0.04%
cases:10.72%
controls:0.35%
cases:16.80%
controls:0.80%
299
650
4109
43394
258
195
4151
43859
192
18
4217
44036
—
52
17
4289
43935
428
149
3564
42342
494
275
2447
34270
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.6e+00
2.6e+00
4.7e+00
—
3.4e+00
3.5e+00
3.2e+00
cases:6.78%
controls:1.48%
cases:5.85%
controls:0.44%
cases:4.35%
controls:0.04%
—
—
cases:1.20%
controls:0.04%
cases:10.72%
controls:0.35%
cases:16.80%
controls:0.80%
299
650
4109
43394
258
195
4151
43859
192
18
4217
44036
—
52
17
4289
43935
428
149
3564
42342
494
275
2447
34270
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.6e+00
2.6e+00
4.7e+00
—
3.4e+00
3.5e+00
3.2e+00
cases:6.78%
controls:1.48%
cases:5.85%
controls:0.44%
cases:4.35%
controls:0.04%
—
—
cases:1.20%
controls:0.04%
cases:10.72%
controls:0.35%
cases:16.80%
controls:0.80%
299
650
4109
43394
258
195
4151
43859
192
18
4217
44036
—
52
17
4289
43935
428
149
3564
42342
494
275
2447
34270
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.6e+00
2.6e+00
4.7e+00
—
3.4e+00
3.5e+00
3.2e+00
cases:6.78%
controls:1.48%
cases:5.85%
controls:0.44%
cases:4.35%
controls:0.04%
—
—
cases:1.20%
controls:0.04%
cases:10.72%
controls:0.35%
cases:16.80%
controls:0.80%
299
650
4109
43394
258
195
4151
43859
192
18
4217
44036
—
52
17
4289
43935
428
149
3564
42342
494
275
2447
34270
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.6e+00
2.6e+00
4.7e+00
—
3.4e+00
3.5e+00
3.2e+00
cases:6.78%
controls:1.48%
cases:5.85%
controls:0.44%
cases:4.35%
controls:0.04%
—
—
cases:1.20%
controls:0.04%
cases:10.72%
controls:0.35%
cases:16.80%
controls:0.80%
299
650
4109
43394
258
195
4151
43859
192
18
4217
44036
—
52
17
4289
43935
428
149
3564
42342
494
275
2447
34270
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.4e+00
2.9e+00
4.4e+00
1.0e+50
5.0e+00
2.8e+00
2.2e+00
cases:1.57%
controls:0.37%
cases:2.52%
controls:0.15%
cases:1.43%
controls:0.02%
cases:0.59%
controls:0.00%
cases:3.09%
controls:0.02%
cases:2.58%
controls:0.16%
cases:5.88%
controls:0.72%
69
164
4339
43880
111
65
4298
43989
63
8
4346
44046
26
0
4383
44054
134
9
4207
43943
103
67
3889
42424
173
248
2768
34297
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
1.4e+00
2.7e+00
4.6e+00
—
4.7e+00
3.2e+00
2.1e+00
cases:1.97%
controls:0.52%
cases:2.79%
controls:0.19%
cases:2.22%
controls:0.02%
—
—
cases:2.65%
controls:0.03%
cases:4.41%
controls:0.18%
cases:5.20%
controls:0.69%
87
228
4321
43816
123
84
4286
43970
98
10
4311
44044
—
115
11
4226
43941
176
78
3816
42413
153
239
2788
34306
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.8e+00
2.7e+00
3.1e+00
1.0e+50
4.3e+00
3.8e+00
2.8e+00
cases:2.34%
controls:0.40%
cases:2.54%
controls:0.17%
cases:1.18%
controls:0.05%
cases:0.16%
controls:0.00%
cases:3.78%
controls:0.05%
cases:6.74%
controls:0.16%
cases:8.67%
controls:0.55%
103
174
4305
43870
112
75
4297
43979
52
23
4357
44031
7
0
4402
44054
164
23
4177
43929
269
69
3723
42422
255
189
2686
34356
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
543-9 [3005702]
2.0e+00
3.9e+00
—
—
6.0e+00
3.7e+00
2.8e+00
cases:1.86%
controls:0.25%
cases:3.33%
controls:0.07%
—
—
—
—
cases:5.46%
controls:0.01%
cases:3.46%
controls:0.09%
cases:5.71%
controls:0.37%
82
108
4326
43936
147
30
4262
44024
—
—
237
6
4104
43946
138
38
3854
42453
168
128
2773
34417
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
1.1e+00
1.8e+00
3.3e+00
5.1e+00
3.2e+00
2.2e+00
1.8e+00
cases:16.92%
controls:6.63%
cases:19.44%
controls:3.85%
cases:16.15%
controls:0.71%
cases:2.88%
controls:0.02%
cases:14.17%
controls:0.68%
cases:26.93%
controls:4.01%
cases:37.74%
controls:9.14%
746
2918
3662
41126
857
1695
3552
42359
712
311
3697
43743
127
8
4282
44046
615
299
3726
43653
1075
1705
2917
40786
1110
3159
1831
31386
Chronic respiratory failure
J96.1 [45557632]
J96.1 [45557632]
2.1e+00
2.3e+00
3.5e+00
—
3.6e+00
3.3e+00
3.4e+00
cases:0.64%
controls:0.08%
cases:0.77%
controls:0.07%
cases:0.39%
controls:0.01%
—
—
cases:0.69%
controls:0.02%
cases:2.63%
controls:0.10%
cases:4.69%
controls:0.16%
28
35
4380
44009
34
33
4375
44021
17
5
4392
44049
—
30
8
4311
43944
105
41
3887
42450
138
54
2803
34491
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
9.7e-01
2.8e+00
4.3e+00
1.0e+50
5.2e+00
3.1e+00
1.9e+00
cases:1.38%
controls:0.53%
cases:2.29%
controls:0.14%
cases:1.86%
controls:0.02%
cases:0.32%
controls:0.00%
cases:2.88%
controls:0.02%
cases:3.28%
controls:0.16%
cases:4.05%
controls:0.63%
61
233
4347
43811
101
60
4308
43994
82
11
4327
44043
14
0
4395
44054
125
7
4216
43945
131
66
3861
42425
119
217
2822
34328
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2469-5 [3024980]
1.8e+00
2.9e+00
3.6e+00
—
4.2e+00
3.3e+00
2.5e+00
cases:0.98%
controls:0.17%
cases:1.34%
controls:0.07%
cases:0.66%
controls:0.02%
—
—
cases:0.76%
controls:0.01%
cases:1.78%
controls:0.06%
cases:2.35%
controls:0.19%
43
75
4365
43969
59
33
4350
44021
29
8
4380
44046
—
33
5
4308
43947
71
27
3921
42464
69
66
2872
34479
Rheumatology
66 [38004491]
66 [38004491]
1.7e+00
2.2e+00
2.5e+00
4.1e+00
2.9e+00
2.7e+00
2.2e+00
cases:11.98%
controls:2.50%
cases:11.43%
controls:1.41%
cases:3.36%
controls:0.29%
cases:0.82%
controls:0.01%
cases:4.49%
controls:0.26%
cases:16.73%
controls:1.38%
cases:20.23%
controls:2.67%
528
1103
3880
42941
504
623
3905
43431
148
126
4261
43928
36
6
4373
44048
195
113
4146
43839
668
585
3324
41906
595
921
2346
33624
Sicca syndrome [Sjögren]
M35.0 [45562711]
M35.0 [45562711]
2.2e+00
2.8e+00
3.3e+00
1.0e+50
3.9e+00
3.3e+00
2.4e+00
cases:1.47%
controls:0.17%
cases:1.25%
controls:0.07%
cases:0.36%
controls:0.01%
cases:0.66%
controls:0.00%
cases:0.58%
controls:0.01%
cases:1.95%
controls:0.07%
cases:2.18%
controls:0.19%
65
74
4343
43970
55
33
4354
44021
16
6
4393
44048
29
0
4380
44054
25
5
4316
43947
78
30
3914
42461
64
67
2877
34478
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
9.2e-01
1.8e+00
3.3e+00
4.8e+00
3.1e+00
2.2e+00
1.7e+00
cases:21.19%
controls:9.65%
cases:25.81%
controls:5.57%
cases:22.14%
controls:0.99%
cases:3.72%
controls:0.03%
cases:18.80%
controls:0.99%
cases:35.80%
controls:5.75%
cases:47.57%
controls:13.79%
934
4250
3474
39794
1138
2453
3271
41601
976
437
3433
43617
164
14
4245
44040
816
433
3525
43519
1429
2443
2563
40048
1399
4763
1542
29782
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
9.3e-01
1.8e+00
3.3e+00
4.8e+00
3.1e+00
2.2e+00
1.7e+00
cases:21.32%
controls:9.69%
cases:25.88%
controls:5.57%
cases:22.23%
controls:1.00%
cases:3.72%
controls:0.03%
cases:18.77%
controls:0.99%
cases:35.85%
controls:5.77%
cases:47.70%
controls:13.83%
940
4266
3468
39778
1141
2456
3268
41598
980
439
3429
43615
164
14
4245
44040
815
436
3526
43516
1431
2450
2561
40041
1403
4779
1538
29766
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
9.2e-01
1.8e+00
3.4e+00
4.8e+00
3.1e+00
2.2e+00
1.7e+00
cases:21.08%
controls:9.61%
cases:25.74%
controls:5.57%
cases:22.23%
controls:0.99%
cases:3.70%
controls:0.03%
cases:18.71%
controls:0.98%
cases:35.75%
controls:5.75%
cases:47.53%
controls:13.83%
929
4234
3479
39810
1135
2456
3274
41598
980
437
3429
43617
163
14
4246
44040
812
431
3529
43521
1427
2444
2565
40047
1398
4779
1543
29766
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
1.7e+00
2.4e+00
3.7e+00
—
4.3e+00
3.5e+00
2.3e+00
cases:2.79%
controls:0.53%
cases:1.43%
controls:0.14%
cases:0.45%
controls:0.01%
—
—
cases:0.83%
controls:0.01%
cases:3.96%
controls:0.12%
cases:4.66%
controls:0.48%
123
232
4285
43812
63
60
4346
43994
20
5
4389
44049
—
36
5
4305
43947
158
51
3834
42440
137
167
2804
34378
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
8.9e-01
1.7e+00
3.4e+00
4.7e+00
3.2e+00
2.2e+00
1.7e+00
cases:21.53%
controls:10.12%
cases:26.81%
controls:6.00%
cases:23.02%
controls:1.03%
cases:3.83%
controls:0.04%
cases:19.56%
controls:1.03%
cases:37.63%
controls:6.20%
cases:49.74%
controls:15.23%
949
4459
3459
39585
1182
2644
3227
41410
1015
455
3394
43599
169
16
4240
44038
849
453
3492
43499
1502
2636
2490
39855
1463
5260
1478
29285
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
8.8e-01
1.7e+00
3.3e+00
4.7e+00
3.1e+00
2.2e+00
1.7e+00
cases:21.55%
controls:10.19%
cases:26.79%
controls:6.03%
cases:23.02%
controls:1.04%
cases:3.83%
controls:0.04%
cases:19.56%
controls:1.04%
cases:37.60%
controls:6.23%
cases:49.74%
controls:15.31%
950
4486
3458
39558
1181
2657
3228
41397
1015
459
3394
43595
169
16
4240
44038
849
456
3492
43496
1501
2647
2491
39844
1463
5288
1478
29257
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
8.8e-01
1.7e+00
3.3e+00
4.8e+00
3.1e+00
2.2e+00
1.7e+00
cases:21.03%
controls:9.93%
cases:25.86%
controls:5.77%
cases:22.32%
controls:1.03%
cases:3.74%
controls:0.03%
cases:18.75%
controls:1.03%
cases:35.92%
controls:5.99%
cases:47.77%
controls:14.42%
927
4374
3481
39670
1140
2541
3269
41513
984
455
3425
43599
165
14
4244
44040
814
451
3527
43501
1434
2544
2558
39947
1405
4981
1536
29564
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
8.8e-01
1.7e+00
3.3e+00
4.7e+00
3.1e+00
2.2e+00
1.7e+00
cases:22.57%
controls:10.74%
cases:27.60%
controls:6.23%
cases:23.72%
controls:1.11%
cases:3.99%
controls:0.04%
cases:20.23%
controls:1.09%
cases:38.58%
controls:6.43%
cases:50.39%
controls:15.81%
995
4732
3413
39312
1217
2745
3192
41309
1046
490
3363
43564
176
17
4233
44037
878
479
3463
43473
1540
2732
2452
39759
1482
5461
1459
29084
Spirometry
127783003 [4133840]
127783003 [4133840]
1.5e+00
2.5e+00
2.9e+00
1.0e+50
3.2e+00
4.0e+00
3.5e+00
cases:1.63%
controls:0.37%
cases:1.38%
controls:0.11%
cases:0.43%
controls:0.02%
cases:1.61%
controls:0.00%
cases:0.48%
controls:0.02%
cases:6.76%
controls:0.13%
cases:9.42%
controls:0.32%
72
162
4336
43882
61
49
4348
44005
19
10
4390
44044
71
0
4338
44054
21
9
4320
43943
270
55
3722
42436
277
111
2664
34434
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
8.6e-01
1.7e+00
3.3e+00
4.8e+00
3.1e+00
2.2e+00
1.7e+00
cases:20.30%
controls:9.77%
cases:24.74%
controls:5.63%
cases:21.30%
controls:1.00%
cases:3.56%
controls:0.03%
cases:18.11%
controls:1.00%
cases:34.67%
controls:5.82%
cases:46.72%
controls:14.03%
895
4304
3513
39740
1091
2481
3318
41573
939
442
3470
43612
157
13
4252
44041
786
438
3555
43514
1384
2471
2608
40020
1374
4846
1567
29699
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
1.7e+00
2.3e+00
4.1e+00
—
3.8e+00
2.8e+00
2.9e+00
cases:1.72%
controls:0.32%
cases:1.11%
controls:0.12%
cases:0.66%
controls:0.01%
—
—
cases:0.53%
controls:0.01%
cases:1.38%
controls:0.08%
cases:2.99%
controls:0.18%
76
141
4332
43903
49
51
4360
44003
29
5
4380
44049
—
23
5
4318
43947
55
35
3937
42456
88
61
2853
34484
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
8.5e-01
1.7e+00
3.3e+00
4.7e+00
3.1e+00
2.2e+00
1.7e+00
cases:21.96%
controls:10.69%
cases:27.06%
controls:6.29%
cases:23.07%
controls:1.10%
cases:3.90%
controls:0.04%
cases:19.67%
controls:1.09%
cases:37.78%
controls:6.51%
cases:49.81%
controls:15.85%
968
4709
3440
39335
1193
2773
3216
41281
1017
486
3392
43568
172
16
4237
44038
854
478
3487
43474
1508
2765
2484
39726
1465
5475
1476
29070
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 [45601131]
J44.0 [45601131]
2.3e+00
3.0e+00
3.7e+00
—
3.1e+00
2.8e+00
2.5e+00
cases:1.72%
controls:0.17%
cases:1.66%
controls:0.08%
cases:0.57%
controls:0.01%
—
—
cases:0.41%
controls:0.02%
cases:1.78%
controls:0.12%
cases:4.11%
controls:0.35%
76
75
4332
43969
73
37
4336
44017
25
6
4384
44048
—
18
8
4323
43944
71
49
3921
42442
121
121
2820
34424
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
1.7e+00
2.7e+00
4.2e+00
—
4.4e+00
2.4e+00
2.0e+00
cases:4.31%
controls:0.81%
cases:6.74%
controls:0.47%
cases:4.24%
controls:0.07%
—
—
cases:5.00%
controls:0.07%
cases:6.86%
controls:0.63%
cases:15.50%
controls:2.53%
190
357
4218
43687
297
207
4112
43847
187
30
4222
44024
—
217
29
4124
43923
274
269
3718
42222
456
873
2485
33672
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
1.0e+00
2.4e+00
4.6e+00
1.0e+50
4.9e+00
2.7e+00
1.7e+00
cases:5.44%
controls:2.00%
cases:7.05%
controls:0.69%
cases:6.89%
controls:0.07%
cases:0.91%
controls:0.00%
cases:7.35%
controls:0.06%
cases:8.84%
controls:0.62%
cases:11.87%
controls:2.38%
240
879
4168
43165
311
305
4098
43749
304
32
4105
44022
40
0
4369
44054
319
27
4022
43925
353
264
3639
42227
349
822
2592
33723
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
1.7e+00
2.7e+00
4.2e+00
—
4.3e+00
2.5e+00
1.9e+00
cases:4.13%
controls:0.79%
cases:6.87%
controls:0.50%
cases:4.29%
controls:0.07%
—
—
cases:4.75%
controls:0.07%
cases:7.24%
controls:0.67%
cases:16.08%
controls:2.72%
182
347
4226
43697
303
219
4106
43835
189
30
4220
44024
—
206
29
4135
43923
289
284
3703
42207
473
941
2468
33604
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
1.5e+00
2.4e+00
3.3e+00
1.0e+50
5.2e+00
2.6e+00
2.2e+00
cases:1.07%
controls:0.24%
cases:1.72%
controls:0.16%
cases:0.79%
controls:0.03%
cases:0.45%
controls:0.00%
cases:2.10%
controls:0.01%
cases:2.03%
controls:0.16%
cases:4.22%
controls:0.47%
47
106
4361
43938
76
71
4333
43983
35
13
4374
44041
20
0
4389
44054
91
5
4250
43947
81
67
3911
42424
124
163
2817
34382
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
9.3e-01
1.7e+00
3.2e+00
4.7e+00
3.3e+00
2.0e+00
1.4e+00
cases:8.87%
controls:3.70%
cases:10.02%
controls:2.01%
cases:7.92%
controls:0.34%
cases:1.41%
controls:0.01%
cases:7.44%
controls:0.31%
cases:14.00%
controls:2.14%
cases:19.96%
controls:5.82%
391
1628
4017
42416
442
885
3967
43169
349
148
4060
43906
62
6
4347
44048
323
136
4018
43816
559
908
3433
41583
587
2012
2354
32533
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
30352-9 [3006184]
1.4e+00
2.3e+00
4.0e+00
—
4.5e+00
2.8e+00
2.2e+00
cases:1.09%
controls:0.28%
cases:1.41%
controls:0.15%
cases:0.77%
controls:0.01%
—
—
cases:0.97%
controls:0.01%
cases:2.51%
controls:0.15%
cases:5.95%
controls:0.70%
48
122
4360
43922
62
66
4347
43988
34
6
4375
44048
—
42
5
4299
43947
100
64
3892
42427
175
241
2766
34304
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
1.2e+00
2.4e+00
4.4e+00
1.0e+50
4.2e+00
2.8e+00
1.9e+00
cases:2.65%
controls:0.79%
cases:2.77%
controls:0.26%
cases:1.77%
controls:0.02%
cases:0.29%
controls:0.00%
cases:1.82%
controls:0.03%
cases:3.36%
controls:0.22%
cases:5.27%
controls:0.86%
117
346
4291
43698
122
116
4287
43938
78
10
4331
44044
13
0
4396
44054
79
12
4262
43940
134
93
3858
42398
155
298
2786
34247
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
1.6e+00
2.4e+00
3.2e+00
1.0e+50
4.2e+00
2.9e+00
2.4e+00
cases:4.97%
controls:1.00%
cases:5.60%
controls:0.52%
cases:2.06%
controls:0.08%
cases:0.32%
controls:0.00%
cases:3.16%
controls:0.05%
cases:7.79%
controls:0.48%
cases:12.78%
controls:1.30%
219
442
4189
43602
247
229
4162
43825
91
37
4318
44017
14
0
4395
44054
137
21
4204
43931
311
204
3681
42287
376
450
2565
34095
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
1.7e+00
2.3e+00
3.7e+00
—
3.6e+00
2.7e+00
2.7e+00
cases:1.91%
controls:0.37%
cases:1.20%
controls:0.12%
cases:0.75%
controls:0.02%
—
—
cases:0.60%
controls:0.02%
cases:1.50%
controls:0.10%
cases:3.09%
controls:0.22%
84
162
4324
43882
53
54
4356
44000
33
8
4376
44046
—
26
7
4315
43945
60
44
3932
42447
91
76
2850
34469
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
1.6e+00
2.5e+00
4.2e+00
—
4.2e+00
2.3e+00
1.9e+00
cases:5.94%
controls:1.29%
cases:8.94%
controls:0.77%
cases:5.69%
controls:0.09%
—
—
cases:5.78%
controls:0.10%
cases:8.72%
controls:0.92%
cases:20.03%
controls:3.63%
262
569
4146
43475
394
338
4015
43716
251
41
4158
44013
—
251
42
4090
43910
348
391
3644
42100
589
1255
2352
33290
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
64799-0 [40767503]
1.5e+00
2.5e+00
3.9e+00
—
4.2e+00
2.5e+00
2.1e+00
cases:1.04%
controls:0.23%
cases:1.56%
controls:0.13%
cases:0.86%
controls:0.02%
—
—
cases:1.08%
controls:0.02%
cases:1.33%
controls:0.11%
cases:3.54%
controls:0.46%
46
101
4362
43943
69
59
4340
43995
38
8
4371
44046
—
47
7
4294
43945
53
48
3939
42443
104
158
2837
34387
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
1.6e+00
2.2e+00
3.4e+00
1.0e+50
4.4e+00
2.7e+00
2.3e+00
cases:3.63%
controls:0.75%
cases:3.15%
controls:0.35%
cases:1.09%
controls:0.04%
cases:0.16%
controls:0.00%
cases:1.80%
controls:0.02%
cases:4.48%
controls:0.32%
cases:8.36%
controls:0.95%
160
329
4248
43715
139
155
4270
43899
48
17
4361
44037
7
0
4402
44054
78
10
4263
43942
179
135
3813
42356
246
329
2695
34216
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
2589-0 [3012110]
1.1e+00
2.7e+00
4.2e+00
—
4.0e+00
2.6e+00
1.9e+00
cases:1.29%
controls:0.43%
cases:2.13%
controls:0.15%
cases:1.56%
controls:0.02%
—
—
cases:1.22%
controls:0.02%
cases:1.80%
controls:0.14%
cases:2.86%
controls:0.46%
57
190
4351
43854
94
65
4315
43989
69
10
4340
44044
—
53
10
4288
43942
72
59
3920
42432
84
158
2857
34387
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
2742-5 [3034780]
1.0e+00
2.4e+00
4.5e+00
1.0e+50
4.4e+00
2.5e+00
1.6e+00
cases:1.81%
controls:0.67%
cases:2.93%
controls:0.26%
cases:2.70%
controls:0.03%
cases:0.20%
controls:0.00%
cases:2.00%
controls:0.03%
cases:2.61%
controls:0.22%
cases:3.47%
controls:0.74%
80
293
4328
43751
129
116
4280
43938
119
14
4290
44040
9
0
4400
44054
87
11
4254
43941
104
92
3888
42399
102
256
2839
34289
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
41001-9 [3042596]
3.1e+00
5.1e+00
—
1.0e+50
—
4.2e+00
3.9e+00
cases:0.91%
controls:0.04%
cases:2.29%
controls:0.01%
—
—
cases:0.88%
controls:0.00%
—
—
cases:1.80%
controls:0.03%
cases:5.07%
controls:0.11%
40
19
4368
44025
101
6
4308
44048
—
39
0
4370
44054
—
72
12
3920
42479
149
38
2792
34507
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
50548-7 [3030692]
3.1e+00
5.0e+00
—
1.0e+50
—
4.1e+00
4.0e+00
cases:1.16%
controls:0.05%
cases:2.06%
controls:0.01%
—
—
cases:0.86%
controls:0.00%
—
—
cases:2.00%
controls:0.04%
cases:4.52%
controls:0.09%
51
23
4357
44021
91
6
4318
44048
—
38
0
4371
44054
—
80
15
3912
42476
133
31
2808
34514
Bronchial lavation
TGC00 [2001303585]
TGC00 [2001303585]
2.5e+00
5.5e+00
1.0e+50
1.0e+50
—
4.4e+00
3.8e+00
cases:1.59%
controls:0.13%
cases:4.74%
controls:0.02%
cases:2.56%
controls:0.00%
cases:4.11%
controls:0.00%
—
—
cases:3.33%
controls:0.04%
cases:4.93%
controls:0.12%
70
57
4338
43987
209
9
4200
44045
113
0
4296
44054
181
0
4228
44054
—
133
18
3859
42473
145
42
2796
34503
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
8.4e-01
2.2e+00
3.8e+00
1.0e+50
4.3e+00
2.8e+00
2.2e+00
cases:2.47%
controls:1.08%
cases:3.04%
controls:0.35%
cases:1.79%
controls:0.04%
cases:2.11%
controls:0.00%
cases:3.06%
controls:0.04%
cases:5.49%
controls:0.36%
cases:10.34%
controls:1.32%
109
477
4299
43567
134
155
4275
43899
79
18
4330
44036
93
0
4316
44054
133
19
4208
43933
219
154
3773
42337
304
456
2637
34089
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
1.5e+00
3.1e+00
—
1.0e+50
6.0e+00
3.3e+00
2.2e+00
cases:2.61%
controls:0.59%
cases:4.83%
controls:0.23%
—
—
cases:0.77%
controls:0.00%
cases:6.73%
controls:0.02%
cases:4.26%
controls:0.17%
cases:6.15%
controls:0.74%
115
260
4293
43784
213
100
4196
43954
—
34
0
4375
44054
292
8
4049
43944
170
73
3822
42418
181
254
2760
34291
Other specified interstitial pulmonary diseases
J84.8 [45548126]
J84.8 [45548126]
-1.0e+50
—
3.2e+00
1.0e+50
—
6.7e+00
6.1e+00
cases:0.00%
controls:0.05%
—
—
cases:0.27%
controls:0.01%
cases:23.43%
controls:0.00%
—
—
cases:23.97%
controls:0.04%
cases:21.90%
controls:0.06%
0
22
4408
44022
—
12
5
4397
44049
1033
0
3376
44054
—
957
17
3035
42474
644
21
2297
34524
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
2.1e+00
2.1e+00
2.2e+00
—
2.8e+00
3.2e+00
3.6e+00
cases:1.04%
controls:0.13%
cases:1.11%
controls:0.13%
cases:0.45%
controls:0.05%
—
—
cases:0.78%
controls:0.05%
cases:3.28%
controls:0.14%
cases:6.70%
controls:0.20%
46
58
4362
43986
49
58
4360
43996
20
22
4389
44032
—
34
21
4307
43931
131
61
3861
42430
197
70
2744
34475
Pneumonia
R81 [2002000949]
R81 [2002000949]
2.2e+00
3.7e+00
4.7e+00
1.0e+50
1.0e+50
2.9e+00
2.5e+00
cases:1.34%
controls:0.16%
cases:1.54%
controls:0.04%
cases:1.18%
controls:0.01%
cases:0.29%
controls:0.00%
cases:0.16%
controls:0.00%
cases:1.00%
controls:0.05%
cases:2.14%
controls:0.18%
59
69
4349
43975
68
17
4341
44037
52
5
4357
44049
13
0
4396
44054
7
0
4334
43952
40
23
3952
42468
63
61
2878
34484
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
6.5e-01
1.6e+00
2.7e+00
6.5e+00
2.3e+00
1.3e+00
9.2e-01
cases:8.64%
controls:4.72%
cases:11.57%
controls:2.70%
cases:5.47%
controls:0.38%
cases:8.48%
controls:0.01%
cases:3.62%
controls:0.39%
cases:11.47%
controls:3.39%
cases:25.26%
controls:11.82%
381
2079
4027
41965
510
1189
3899
42865
241
166
4168
43888
374
6
4035
44048
157
173
4184
43779
458
1441
3534
41050
743
4084
2198
30461
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
1.2e+00
1.7e+00
2.5e+00
5.3e+00
2.2e+00
1.8e+00
1.2e+00
cases:5.24%
controls:1.72%
cases:5.87%
controls:1.10%
cases:2.22%
controls:0.19%
cases:2.74%
controls:0.01%
cases:2.00%
controls:0.23%
cases:7.19%
controls:1.29%
cases:11.05%
controls:3.46%
231
757
4177
43287
259
484
4150
43570
98
84
4311
43970
121
6
4288
44048
87
103
4254
43849
287
549
3705
41942
325
1194
2616
33351
Pleural plaque with presence of asbestos
J92.0 [45567277]
J92.0 [45567277]
1.6e+00
1.8e+00
3.0e+00
1.0e+50
3.7e+00
3.1e+00
2.6e+00
cases:1.54%
controls:0.31%
cases:0.93%
controls:0.15%
cases:0.45%
controls:0.02%
cases:2.09%
controls:0.00%
cases:1.04%
controls:0.03%
cases:3.18%
controls:0.15%
cases:4.28%
controls:0.34%
68
136
4340
43908
41
68
4368
43986
20
10
4389
44044
92
0
4317
44054
45
11
4296
43941
127
62
3865
42429
126
118
2815
34427
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
GD1ED [2001303637]
2.0e+00
4.0e+00
—
1.0e+50
—
5.2e+00
4.6e+00
cases:1.77%
controls:0.24%
cases:2.47%
controls:0.05%
—
—
cases:3.27%
controls:0.00%
—
—
cases:4.41%
controls:0.03%
cases:7.11%
controls:0.08%
78
107
4330
43937
109
20
4300
44034
—
144
0
4265
44054
—
176
11
3816
42480
209
27
2732
34518
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
1.7e+00
2.4e+00
3.4e+00
1.0e+50
3.4e+00
2.7e+00
2.2e+00
cases:2.72%
controls:0.49%
cases:1.95%
controls:0.19%
cases:0.82%
controls:0.03%
cases:1.32%
controls:0.00%
cases:0.83%
controls:0.03%
cases:2.68%
controls:0.19%
cases:3.94%
controls:0.47%
120
214
4288
43830
86
82
4323
43972
36
12
4373
44042
58
0
4351
44054
36
12
4305
43940
107
82
3885
42409
116
162
2825
34383
Oxygen saturation in Capillary blood
2709-4 [3021901]
2709-4 [3021901]
1.3e+00
2.3e+00
3.4e+00
—
4.1e+00
2.6e+00
2.0e+00
cases:0.68%
controls:0.19%
cases:1.27%
controls:0.12%
cases:0.68%
controls:0.02%
—
—
cases:1.41%
controls:0.02%
cases:1.63%
controls:0.12%
cases:3.77%
controls:0.54%
30
84
4378
43960
56
55
4353
43999
30
10
4379
44044
—
61
10
4280
43942
65
52
3927
42439
111
187
2830
34358
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
61365-3 [40764126]
3.4e+00
4.7e+00
—
1.0e+50
—
4.0e+00
3.6e+00
cases:0.73%
controls:0.02%
cases:1.52%
controls:0.01%
—
—
cases:0.66%
controls:0.00%
—
—
cases:1.28%
controls:0.02%
cases:2.62%
controls:0.07%
32
11
4376
44033
67
6
4342
44048
—
29
0
4380
44054
—
51
10
3941
42481
77
25
2864
34520
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
7.5e-01
1.4e+00
2.3e+00
4.6e+00
3.2e+00
2.0e+00
1.5e+00
cases:15.06%
controls:7.73%
cases:7.55%
controls:1.99%
cases:2.54%
controls:0.27%
cases:1.84%
controls:0.02%
cases:5.67%
controls:0.25%
cases:12.53%
controls:1.86%
cases:19.89%
controls:5.36%
664
3406
3744
40638
333
877
4076
43177
112
119
4297
43935
81
8
4328
44046
246
110
4095
43842
500
791
3492
41700
585
1850
2356
32695
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
7.4e-01
1.5e+00
3.0e+00
4.2e+00
2.7e+00
2.0e+00
1.6e+00
cases:23.28%
controls:12.60%
cases:27.94%
controls:7.62%
cases:24.00%
controls:1.61%
cases:4.83%
controls:0.07%
cases:19.79%
controls:1.65%
cases:38.38%
controls:7.85%
cases:51.00%
controls:17.83%
1026
5549
3382
38495
1232
3358
3177
40696
1058
711
3351
43343
213
33
4196
44021
859
725
3482
43227
1532
3336
2460
39155
1500
6159
1441
28386
Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.2 [45586127]
D86.2 [45586127]
1.7e+00
2.3e+00
2.6e+00
1.0e+50
3.5e+00
2.9e+00
2.6e+00
cases:0.29%
controls:0.05%
cases:0.32%
controls:0.03%
cases:0.16%
controls:0.01%
cases:0.18%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.68%
controls:0.04%
cases:0.95%
controls:0.07%
13
23
4395
44021
14
14
4395
44040
7
5
4402
44049
8
0
4401
44054
16
5
4325
43947
27
16
3965
42475
28
24
2913
34521
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
113016006 [4010399]
1.1e+00
2.3e+00
4.0e+00
—
3.1e+00
3.1e+00
2.1e+00
cases:5.42%
controls:1.83%
cases:5.60%
controls:0.58%
cases:3.67%
controls:0.07%
—
—
cases:1.36%
controls:0.06%
cases:10.65%
controls:0.56%
cases:15.06%
controls:2.10%
239
806
4169
43238
247
257
4162
43797
162
32
4247
44022
—
59
27
4282
43925
425
237
3567
42254
443
726
2498
33819
Inpatient Hospital
21 [8717]
21 [8717]
6.8e-01
1.4e+00
2.4e+00
6.2e+00
2.4e+00
1.5e+00
1.2e+00
cases:45.83%
controls:30.00%
cases:29.14%
controls:9.54%
cases:12.50%
controls:1.28%
cases:20.19%
controls:0.05%
cases:11.84%
controls:1.23%
cases:29.56%
controls:8.68%
cases:46.31%
controls:21.45%
2020
13215
2388
30829
1285
4201
3124
39853
551
562
3858
43492
890
23
3519
44031
514
539
3827
43413
1180
3690
2812
38801
1362
7410
1579
27135
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
34645-2 [3031478]
3.0e+00
4.8e+00
—
1.0e+50
—
3.9e+00
3.8e+00
cases:1.07%
controls:0.05%
cases:3.31%
controls:0.03%
—
—
cases:1.18%
controls:0.00%
—
—
cases:2.53%
controls:0.05%
cases:6.32%
controls:0.14%
47
23
4361
44021
146
12
4263
44042
—
52
0
4357
44054
—
101
22
3891
42469
186
50
2755
34495
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
21363-7 [3020565]
2.9e+00
4.7e+00
—
1.0e+50
1.0e+50
4.0e+00
4.0e+00
cases:1.00%
controls:0.06%
cases:2.90%
controls:0.03%
—
—
cases:1.11%
controls:0.00%
cases:2.99%
controls:0.00%
cases:2.08%
controls:0.04%
cases:4.56%
controls:0.09%
44
25
4364
44019
128
12
4281
44042
—
49
0
4360
44054
130
0
4211
43952
83
16
3909
42475
134
31
2807
34514
Bronchiectasis
J47 [45605889]
J47 [45605889]
3.0e+00
4.3e+00
1.0e+50
1.0e+50
—
4.5e+00
3.7e+00
cases:1.45%
controls:0.07%
cases:1.38%
controls:0.02%
cases:0.82%
controls:0.00%
cases:1.75%
controls:0.00%
—
—
cases:2.56%
controls:0.03%
cases:3.57%
controls:0.10%
64
32
4344
44012
61
8
4348
44046
36
0
4373
44054
77
0
4332
44054
—
102
12
3890
42479
105
33
2836
34512
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
1.3e+00
2.3e+00
3.4e+00
—
4.1e+00
2.4e+00
1.9e+00
cases:0.86%
controls:0.23%
cases:1.45%
controls:0.14%
cases:0.73%
controls:0.02%
—
—
cases:1.45%
controls:0.03%
cases:1.78%
controls:0.16%
cases:4.08%
controls:0.62%
38
101
4370
43943
64
63
4345
43991
32
11
4377
44043
—
63
11
4278
43941
71
68
3921
42423
120
214
2821
34331
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
1.2e+00
2.2e+00
3.7e+00
1.0e+50
4.2e+00
2.2e+00
1.9e+00
cases:1.18%
controls:0.36%
cases:1.22%
controls:0.14%
cases:0.57%
controls:0.01%
cases:0.20%
controls:0.00%
cases:1.38%
controls:0.02%
cases:1.45%
controls:0.17%
cases:3.30%
controls:0.52%
52
160
4356
43884
54
62
4355
43992
25
6
4384
44048
9
0
4400
44054
60
9
4281
43943
58
71
3934
42420
97
180
2844
34365
Seropositive rheumatoid arthritis, unspecified
M05.9 [45553050]
M05.9 [45553050]
2.2e+00
2.3e+00
2.4e+00
1.0e+50
3.4e+00
2.8e+00
2.2e+00
cases:1.29%
controls:0.15%
cases:0.84%
controls:0.08%
cases:0.25%
controls:0.02%
cases:0.43%
controls:0.00%
cases:0.39%
controls:0.01%
cases:1.15%
controls:0.07%
cases:1.70%
controls:0.18%
57
64
4351
43980
37
37
4372
44017
11
10
4398
44044
19
0
4390
44054
17
6
4324
43946
46
30
3946
42461
50
63
2891
34482
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
1.5e+00
3.0e+00
—
1.0e+50
5.8e+00
3.0e+00
2.0e+00
cases:2.59%
controls:0.60%
cases:3.81%
controls:0.20%
—
—
cases:0.52%
controls:0.00%
cases:4.31%
controls:0.01%
cases:3.01%
controls:0.15%
cases:4.35%
controls:0.61%
114
265
4294
43779
168
87
4241
43967
—
23
0
4386
44054
187
6
4154
43946
120
64
3872
42427
128
212
2813
34333
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
29257-3 [3002482]
2.9e+00
4.7e+00
—
1.0e+50
—
3.8e+00
3.8e+00
cases:1.29%
controls:0.07%
cases:3.65%
controls:0.03%
—
—
cases:1.36%
controls:0.00%
—
—
cases:2.78%
controls:0.06%
cases:6.97%
controls:0.17%
57
31
4351
44013
161
15
4248
44039
—
60
0
4349
44054
—
111
27
3881
42464
205
58
2736
34487
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
35333-4 [3036086]
1.2e+00
3.0e+00
—
1.0e+50
5.2e+00
3.4e+00
2.2e+00
cases:1.02%
controls:0.30%
cases:2.36%
controls:0.12%
—
—
cases:0.36%
controls:0.00%
cases:3.27%
controls:0.02%
cases:3.96%
controls:0.14%
cases:4.39%
controls:0.50%
45
132
4363
43912
104
51
4305
44003
—
16
0
4393
44054
142
8
4199
43944
158
58
3834
42433
129
171
2812
34374
Emergency Room Visit
ER [9203]
ER [9203]
7.0e-01
1.5e+00
2.6e+00
5.9e+00
1.8e+00
1.4e+00
1.2e+00
cases:47.84%
controls:31.36%
cases:33.73%
controls:10.43%
cases:13.81%
controls:1.20%
cases:15.33%
controls:0.05%
cases:7.35%
controls:1.25%
cases:30.51%
controls:9.97%
cases:55.56%
controls:27.84%
2109
13812
2299
30232
1487
4595
2922
39459
609
529
3800
43525
676
21
3733
44033
319
550
4022
43402
1218
4235
2774
38256
1634
9618
1307
24927
Internal Medicine
11 [38004456]
11 [38004456]
8.1e-01
1.5e+00
2.5e+00
5.3e+00
2.1e+00
1.5e+00
1.3e+00
cases:38.38%
controls:21.62%
cases:28.71%
controls:8.18%
cases:13.38%
controls:1.29%
cases:11.86%
controls:0.07%
cases:8.96%
controls:1.22%
cases:28.81%
controls:8.13%
cases:47.53%
controls:19.99%
1692
9524
2716
34520
1266
3604
3143
40450
590
570
3819
43484
523
29
3886
44025
389
535
3952
43417
1150
3454
2842
39037
1398
6906
1543
27639
Infectious Disease
44 [38004484]
44 [38004484]
1.4e+00
2.4e+00
3.4e+00
1.0e+50
3.2e+00
2.6e+00
2.0e+00
cases:4.42%
controls:1.09%
cases:4.22%
controls:0.42%
cases:1.93%
controls:0.07%
cases:1.88%
controls:0.00%
cases:1.34%
controls:0.05%
cases:4.18%
controls:0.31%
cases:7.89%
controls:1.17%
195
479
4213
43565
186
183
4223
43871
85
30
4324
44024
83
0
4326
44054
58
24
4283
43928
167
131
3825
42360
232
405
2709
34140
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
2.1e+00
2.3e+00
2.3e+00
—
2.3e+00
2.8e+00
3.2e+00
cases:1.27%
controls:0.16%
cases:1.07%
controls:0.10%
cases:0.43%
controls:0.05%
—
—
cases:0.46%
controls:0.05%
cases:1.73%
controls:0.10%
cases:3.33%
controls:0.14%
56
70
4352
43974
47
46
4362
44008
19
20
4390
44034
—
20
21
4321
43931
69
44
3923
42447
98
49
2843
34496
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
1.8e+00
2.3e+00
3.0e+00
—
2.5e+00
2.9e+00
2.4e+00
cases:3.77%
controls:0.62%
cases:2.00%
controls:0.20%
cases:0.36%
controls:0.02%
—
—
cases:0.28%
controls:0.02%
cases:2.83%
controls:0.16%
cases:5.41%
controls:0.50%
166
274
4242
43770
88
90
4321
43964
16
8
4393
44046
—
12
10
4329
43942
113
67
3879
42424
159
174
2782
34371
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 [3020073]
20607-8 [3020073]
3.1e+00
3.8e+00
—
—
1.0e+50
4.0e+00
4.0e+00
cases:0.45%
controls:0.02%
cases:0.52%
controls:0.01%
—
—
—
—
cases:0.41%
controls:0.00%
cases:0.80%
controls:0.01%
cases:1.36%
controls:0.03%
20
9
4388
44035
23
5
4386
44049
—
—
18
0
4323
43952
32
6
3960
42485
40
9
2901
34536
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1961-2 [3015235]
1.3e+00
2.2e+00
3.3e+00
—
4.1e+00
2.3e+00
1.7e+00
cases:0.86%
controls:0.23%
cases:1.63%
controls:0.18%
cases:1.04%
controls:0.04%
—
—
cases:1.68%
controls:0.03%
cases:2.35%
controls:0.23%
cases:4.35%
controls:0.86%
38
101
4370
43943
72
79
4337
43975
46
17
4363
44037
—
73
13
4268
43939
94
98
3898
42393
128
298
2813
34247
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
2.9e+00
4.5e+00
—
1.0e+50
—
3.6e+00
3.8e+00
cases:1.47%
controls:0.08%
cases:2.97%
controls:0.03%
—
—
cases:0.98%
controls:0.00%
—
—
cases:2.08%
controls:0.06%
cases:5.58%
controls:0.14%
65
35
4343
44009
131
15
4278
44039
—
43
0
4366
44054
—
83
24
3909
42467
164
47
2777
34498
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
6.9e-01
1.4e+00
2.6e+00
5.2e+00
2.5e+00
1.4e+00
9.9e-01
cases:11.91%
controls:6.34%
cases:13.63%
controls:3.60%
cases:6.28%
controls:0.52%
cases:2.11%
controls:0.01%
cases:5.83%
controls:0.51%
cases:14.25%
controls:3.99%
cases:27.24%
controls:12.22%
525
2793
3883
41251
601
1588
3808
42466
277
228
4132
43826
93
5
4316
44049
253
224
4088
43728
569
1694
3423
40797
801
4220
2140
30325
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
26508-2 [3004809]
1.5e+00
2.5e+00
3.0e+00
—
3.6e+00
2.4e+00
1.7e+00
cases:0.98%
controls:0.22%
cases:0.93%
controls:0.07%
cases:0.45%
controls:0.02%
—
—
cases:0.67%
controls:0.02%
cases:1.13%
controls:0.11%
cases:1.73%
controls:0.33%
43
96
4365
43948
41
33
4368
44021
20
10
4389
44044
—
29
8
4312
43944
45
45
3947
42446
51
114
2890
34431
Bacteria identified in Sputum by Culture
6460-0 [3023419]
6460-0 [3023419]
2.6e+00
4.0e+00
1.0e+50
1.0e+50
—
4.5e+00
3.6e+00
cases:1.18%
controls:0.09%
cases:1.77%
controls:0.03%
cases:0.84%
controls:0.00%
cases:0.20%
controls:0.00%
—
—
cases:2.73%
controls:0.03%
cases:5.44%
controls:0.15%
52
41
4356
44003
78
15
4331
44039
37
0
4372
44054
9
0
4400
44054
—
109
13
3883
42478
160
52
2781
34493
Pleural effusion, not elsewhere classified
J90 [45605897]
J90 [45605897]
2.2e+00
2.5e+00
2.8e+00
—
3.4e+00
2.2e+00
1.6e+00
cases:1.34%
controls:0.16%
cases:1.16%
controls:0.10%
cases:0.54%
controls:0.03%
—
—
cases:0.69%
controls:0.02%
cases:1.13%
controls:0.13%
cases:1.60%
controls:0.32%
59
69
4349
43975
51
43
4358
44011
24
15
4385
44039
—
30
10
4311
43942
45
55
3947
42436
47
109
2894
34436
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
5.2e-01
1.3e+00
3.1e+00
4.1e+00
2.7e+00
1.8e+00
1.2e+00
cases:30.17%
controls:20.50%
cases:29.08%
controls:10.40%
cases:22.61%
controls:1.32%
cases:2.38%
controls:0.04%
cases:16.15%
controls:1.29%
cases:40.31%
controls:10.33%
cases:54.78%
controls:27.69%
1330
9027
3078
35017
1282
4580
3127
39474
997
583
3412
43471
105
17
4304
44037
701
565
3640
43387
1609
4389
2383
38102
1611
9565
1330
24980
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
222351000000102 [44790048]
2.5e+00
4.3e+00
—
1.0e+50
—
3.9e+00
3.8e+00
cases:0.61%
controls:0.05%
cases:1.50%
controls:0.02%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.43%
controls:0.03%
cases:3.81%
controls:0.09%
27
22
4381
44022
66
9
4343
44045
—
22
0
4387
44054
—
57
12
3935
42479
112
32
2829
34513
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
222341000000100 [44790047]
2.5e+00
4.3e+00
—
1.0e+50
—
3.9e+00
3.8e+00
cases:0.61%
controls:0.05%
cases:1.50%
controls:0.02%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.43%
controls:0.03%
cases:3.81%
controls:0.09%
27
22
4381
44022
66
9
4343
44045
—
22
0
4387
44054
—
57
12
3935
42479
112
32
2829
34513
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
222361000000104 [44790049]
2.5e+00
4.3e+00
—
1.0e+50
—
3.9e+00
3.8e+00
cases:0.61%
controls:0.05%
cases:1.50%
controls:0.02%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.43%
controls:0.03%
cases:3.81%
controls:0.09%
27
22
4381
44022
66
9
4343
44045
—
22
0
4387
44054
—
57
12
3935
42479
112
32
2829
34513
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
810871000000102 [44806118]
2.5e+00
4.3e+00
—
1.0e+50
—
3.9e+00
3.8e+00
cases:0.61%
controls:0.05%
cases:1.50%
controls:0.02%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.43%
controls:0.03%
cases:3.81%
controls:0.09%
27
22
4381
44022
66
9
4343
44045
—
22
0
4387
44054
—
57
12
3935
42479
112
32
2829
34513
Streptococcus pneumoniae Ag [Presence] in Urine
24027-5 [3011363]
24027-5 [3011363]
3.4e+00
3.7e+00
—
1.0e+50
1.0e+50
3.9e+00
3.6e+00
cases:0.52%
controls:0.02%
cases:1.02%
controls:0.02%
—
—
cases:0.36%
controls:0.00%
cases:0.92%
controls:0.00%
cases:0.78%
controls:0.02%
cases:1.50%
controls:0.04%
23
8
4385
44036
45
11
4364
44043
—
16
0
4393
44054
40
0
4301
43952
31
7
3961
42484
44
15
2897
34530
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
23826-1 [3012477]
2.8e+00
4.4e+00
—
1.0e+50
1.0e+50
3.7e+00
3.6e+00
cases:1.04%
controls:0.07%
cases:2.99%
controls:0.04%
—
—
cases:1.20%
controls:0.00%
cases:3.18%
controls:0.00%
cases:2.30%
controls:0.06%
cases:5.17%
controls:0.15%
46
29
4362
44015
132
16
4277
44038
—
53
0
4356
44054
138
0
4203
43952
92
25
3900
42466
152
52
2789
34493
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
2.8e+00
4.4e+00
—
1.0e+50
—
3.6e+00
3.7e+00
cases:1.86%
controls:0.11%
cases:3.86%
controls:0.05%
—
—
cases:1.32%
controls:0.00%
—
—
cases:2.88%
controls:0.08%
cases:7.48%
controls:0.21%
82
49
4326
43995
170
22
4239
44032
—
58
0
4351
44054
—
115
34
3877
42457
220
72
2721
34473
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
7.4e-01
2.0e+00
4.3e+00
—
4.4e+00
2.0e+00
1.0e+00
cases:5.31%
controls:2.59%
cases:5.99%
controls:0.88%
cases:5.42%
controls:0.08%
—
—
cases:5.76%
controls:0.07%
cases:5.71%
controls:0.85%
cases:8.84%
controls:3.42%
234
1142
4174
42902
264
387
4145
43667
239
34
4170
44020
—
250
32
4091
43920
228
363
3764
42128
260
1180
2681
33365
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
11572-5 [3021614]
6.3e-01
1.9e+00
4.4e+00
—
4.5e+00
2.0e+00
1.0e+00
cases:5.35%
controls:2.92%
cases:6.21%
controls:1.00%
cases:5.74%
controls:0.07%
—
—
cases:5.85%
controls:0.07%
cases:6.36%
controls:0.93%
cases:9.55%
controls:3.71%
236
1287
4172
42757
274
440
4135
43614
253
32
4156
44022
—
254
31
4087
43921
254
394
3738
42097
281
1283
2660
33262
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
NK4XE [2001308469]
1.7e+00
2.2e+00
2.5e+00
—
2.9e+00
2.8e+00
2.3e+00
cases:3.45%
controls:0.68%
cases:2.36%
controls:0.26%
cases:0.43%
controls:0.03%
—
—
cases:0.48%
controls:0.03%
cases:3.76%
controls:0.25%
cases:6.19%
controls:0.64%
152
298
4256
43746
104
115
4305
43939
19
15
4390
44039
—
21
12
4320
43940
150
105
3842
42386
182
221
2759
34324
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
1.6e+00
2.6e+00
3.9e+00
1.0e+50
—
3.3e+00
3.0e+00
cases:2.09%
controls:0.44%
cases:2.27%
controls:0.17%
cases:1.11%
controls:0.02%
cases:2.45%
controls:0.00%
—
—
cases:2.25%
controls:0.08%
cases:4.25%
controls:0.23%
92
192
4316
43852
100
74
4309
43980
49
10
4360
44044
108
0
4301
44054
—
90
36
3902
42455
125
79
2816
34466
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
1.4e+00
2.3e+00
4.1e+00
1.0e+50
2.8e+00
2.2e+00
1.6e+00
cases:3.97%
controls:1.06%
cases:3.36%
controls:0.35%
cases:2.06%
controls:0.04%
cases:1.00%
controls:0.00%
cases:0.58%
controls:0.03%
cases:3.43%
controls:0.40%
cases:7.07%
controls:1.48%
175
467
4233
43577
148
155
4261
43899
91
16
4318
44038
44
0
4365
44054
25
15
4316
43937
137
169
3855
42322
208
512
2733
34033
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
1.5e+00
1.8e+00
1.8e+00
3.5e+00
1.9e+00
1.9e+00
1.9e+00
cases:6.72%
controls:1.63%
cases:6.87%
controls:1.19%
cases:2.49%
controls:0.43%
cases:0.50%
controls:0.02%
cases:2.74%
controls:0.41%
cases:8.07%
controls:1.24%
cases:12.27%
controls:1.96%
296
717
4112
43327
303
524
4106
43530
110
191
4299
43863
22
7
4387
44047
119
179
4222
43773
322
527
3670
41964
361
676
2580
33869
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
2.9e+00
4.3e+00
—
1.0e+50
—
3.5e+00
3.6e+00
cases:1.75%
controls:0.10%
cases:3.86%
controls:0.05%
—
—
cases:1.25%
controls:0.00%
—
—
cases:3.03%
controls:0.09%
cases:7.38%
controls:0.22%
77
45
4331
43999
170
23
4239
44031
—
55
0
4354
44054
—
121
39
3871
42452
217
76
2724
34469
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
1.0e+00
1.8e+00
3.1e+00
—
4.0e+00
2.4e+00
2.0e+00
cases:1.16%
controls:0.42%
cases:0.95%
controls:0.15%
cases:0.34%
controls:0.02%
—
—
cases:0.62%
controls:0.01%
cases:1.58%
controls:0.15%
cases:3.20%
controls:0.46%
51
186
4357
43858
42
67
4367
43987
15
7
4394
44047
—
27
5
4314
43947
63
62
3929
42429
94
158
2847
34387
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
1.5e+00
2.2e+00
2.5e+00
1.0e+50
3.0e+00
2.8e+00
2.4e+00
cases:2.38%
controls:0.55%
cases:2.31%
controls:0.26%
cases:0.59%
controls:0.05%
cases:1.91%
controls:0.00%
cases:0.74%
controls:0.04%
cases:3.68%
controls:0.24%
cases:6.26%
controls:0.59%
105
241
4303
43803
102
116
4307
43938
26
22
4383
44032
84
0
4325
44054
32
17
4309
43935
147
103
3845
42388
184
203
2757
34342
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
1.3e+00
1.9e+00
3.6e+00
1.0e+50
3.1e+00
2.5e+00
1.9e+00
cases:1.45%
controls:0.41%
cases:1.56%
controls:0.23%
cases:0.88%
controls:0.02%
cases:1.34%
controls:0.00%
cases:1.13%
controls:0.05%
cases:2.51%
controls:0.22%
cases:3.81%
controls:0.56%
64
179
4344
43865
69
102
4340
43952
39
11
4370
44043
59
0
4350
44054
49
23
4292
43929
100
94
3892
42397
112
195
2829
34350
salbutamol and ipratropium bromide
R03AL02 [43534844]
R03AL02 [43534844]
2.3e+00
2.8e+00
2.6e+00
—
2.3e+00
3.3e+00
3.2e+00
cases:0.45%
controls:0.05%
cases:0.50%
controls:0.03%
cases:0.16%
controls:0.01%
—
—
cases:0.12%
controls:0.01%
cases:0.75%
controls:0.03%
cases:1.94%
controls:0.08%
20
21
4388
44023
22
13
4387
44041
7
5
4402
44049
—
5
5
4336
43947
30
12
3962
42479
57
27
2884
34518
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
1.3e+00
2.1e+00
3.5e+00
1.0e+50
3.4e+00
2.3e+00
1.7e+00
cases:3.24%
controls:0.90%
cases:4.99%
controls:0.67%
cases:3.81%
controls:0.12%
cases:0.36%
controls:0.00%
cases:3.64%
controls:0.13%
cases:7.09%
controls:0.76%
cases:11.46%
controls:2.21%
143
395
4265
43649
220
294
4189
43760
168
54
4241
44000
16
0
4393
44054
158
58
4183
43894
283
323
3709
42168
337
763
2604
33782
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
1.3e+00
2.1e+00
3.5e+00
—
3.3e+00
2.3e+00
1.7e+00
cases:3.77%
controls:1.01%
cases:5.49%
controls:0.72%
cases:4.13%
controls:0.13%
—
—
cases:3.89%
controls:0.15%
cases:7.57%
controls:0.84%
cases:12.14%
controls:2.35%
166
444
4242
43600
242
318
4167
43736
182
59
4227
43995
—
169
65
4172
43887
302
358
3690
42133
357
812
2584
33733
Outpatient Hospital
22 [8756]
22 [8756]
5.0e-01
1.1e+00
2.0e+00
6.0e+00
2.3e+00
1.4e+00
9.9e-01
cases:35.89%
controls:25.40%
cases:18.89%
controls:7.12%
cases:5.83%
controls:0.86%
cases:11.20%
controls:0.03%
cases:7.30%
controls:0.82%
cases:20.72%
controls:6.15%
cases:34.75%
controls:16.46%
1582
11189
2826
32855
833
3135
3576
40919
257
380
4152
43674
494
14
3915
44040
317
359
4024
43593
827
2614
3165
39877
1022
5687
1919
28858
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.6e+00
1.9e+00
1.9e+00
—
2.5e+00
3.1e+00
3.2e+00
cases:2.04%
controls:0.43%
cases:1.79%
controls:0.28%
cases:0.66%
controls:0.10%
—
—
cases:0.92%
controls:0.08%
cases:5.79%
controls:0.26%
cases:7.99%
controls:0.35%
90
190
4318
43854
79
125
4330
43929
29
43
4380
44011
—
40
34
4301
43918
231
112
3761
42379
235
120
2706
34425
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
9.0e-01
1.9e+00
3.6e+00
1.0e+50
3.7e+00
2.3e+00
1.8e+00
cases:4.11%
controls:1.71%
cases:4.65%
controls:0.71%
cases:2.59%
controls:0.07%
cases:3.38%
controls:0.00%
cases:3.69%
controls:0.10%
cases:7.19%
controls:0.74%
cases:14.25%
controls:2.79%
181
751
4227
43293
205
311
4204
43743
114
33
4295
44021
149
0
4260
44054
160
42
4181
43910
287
314
3705
42177
419
963
2522
33582
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
9.0e-01
1.9e+00
3.6e+00
1.0e+50
3.7e+00
2.3e+00
1.8e+00
cases:4.11%
controls:1.71%
cases:4.65%
controls:0.71%
cases:2.59%
controls:0.07%
cases:3.36%
controls:0.00%
cases:3.69%
controls:0.10%
cases:7.19%
controls:0.74%
cases:14.25%
controls:2.79%
181
752
4227
43292
205
313
4204
43741
114
33
4295
44021
148
0
4261
44054
160
42
4181
43910
287
314
3705
42177
419
963
2522
33582
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
C34.32 [2000500619]
C34.32 [2000500619]
2.5e+00
2.2e+00
2.4e+00
1.0e+50
3.1e+00
2.0e+00
2.0e+00
cases:0.32%
controls:0.03%
cases:0.32%
controls:0.04%
cases:0.23%
controls:0.02%
cases:0.32%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.40%
controls:0.06%
cases:0.75%
controls:0.10%
14
12
4394
44032
14
16
4395
44038
10
9
4399
44045
14
0
4395
44054
15
7
4326
43945
16
24
3976
42467
22
34
2919
34511
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
1.3e+00
2.1e+00
3.5e+00
—
3.3e+00
2.2e+00
1.7e+00
cases:3.58%
controls:0.97%
cases:5.28%
controls:0.70%
cases:3.99%
controls:0.13%
—
—
cases:3.69%
controls:0.14%
cases:7.24%
controls:0.82%
cases:11.29%
controls:2.29%
158
428
4250
43616
233
307
4176
43747
176
57
4233
43997
—
160
62
4181
43890
289
348
3703
42143
332
792
2609
33753
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
1.1e+00
1.8e+00
2.1e+00
4.2e+00
2.0e+00
1.6e+00
1.3e+00
cases:27.43%
controls:11.46%
cases:25.31%
controls:5.40%
cases:6.99%
controls:0.90%
cases:1.63%
controls:0.02%
cases:6.40%
controls:0.90%
cases:22.34%
controls:5.64%
cases:35.16%
controls:12.40%
1209
5046
3199
38998
1116
2380
3293
41674
308
396
4101
43658
72
11
4337
44043
278
394
4063
43558
892
2396
3100
40095
1034
4283
1907
30262
CD8 cells/Lymphocytes in Specimen
80222-3 [21494814]
80222-3 [21494814]
2.9e+00
3.6e+00
1.0e+50
—
1.0e+50
4.0e+00
3.7e+00
cases:0.48%
controls:0.03%
cases:0.48%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
cases:0.39%
controls:0.00%
cases:0.88%
controls:0.02%
cases:1.60%
controls:0.04%
21
12
4387
44032
21
6
4388
44048
5
0
4404
44054
—
17
0
4324
43952
35
7
3957
42484
47
14
2894
34531
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
1.0e+00
1.9e+00
3.2e+00
—
4.4e+00
2.0e+00
1.4e+00
cases:4.42%
controls:1.68%
cases:4.51%
controls:0.68%
cases:1.93%
controls:0.08%
—
—
cases:3.89%
controls:0.05%
cases:4.31%
controls:0.59%
cases:8.13%
controls:2.08%
195
739
4213
43305
199
299
4210
43755
85
34
4324
44020
—
169
21
4172
43931
172
251
3820
42240
239
719
2702
33826
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
9.0e-01
1.9e+00
3.5e+00
1.0e+50
3.6e+00
2.3e+00
1.7e+00
cases:4.11%
controls:1.72%
cases:4.63%
controls:0.70%
cases:2.54%
controls:0.08%
cases:3.33%
controls:0.00%
cases:3.64%
controls:0.10%
cases:6.99%
controls:0.73%
cases:13.97%
controls:2.78%
181
757
4227
43287
204
310
4205
43744
112
34
4297
44020
147
0
4262
44054
158
44
4183
43908
279
311
3713
42180
411
962
2530
33583
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
1.3e+00
2.0e+00
3.5e+00
1.0e+50
3.3e+00
2.2e+00
1.7e+00
cases:3.29%
controls:0.90%
cases:5.13%
controls:0.70%
cases:4.06%
controls:0.13%
cases:0.41%
controls:0.00%
cases:3.82%
controls:0.15%
cases:7.24%
controls:0.83%
cases:11.25%
controls:2.32%
145
395
4263
43649
226
309
4183
43745
179
59
4230
43995
18
0
4391
44054
166
65
4175
43887
289
351
3703
42140
331
801
2610
33744
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
8.0e-01
2.0e+00
3.7e+00
1.0e+50
3.7e+00
2.3e+00
1.5e+00
cases:2.20%
controls:1.00%
cases:2.77%
controls:0.38%
cases:1.59%
controls:0.04%
cases:2.29%
controls:0.00%
cases:2.21%
controls:0.05%
cases:4.11%
controls:0.42%
cases:6.94%
controls:1.66%
97
440
4311
43604
122
168
4287
43886
70
18
4339
44036
101
0
4308
44054
96
24
4245
43928
164
179
3828
42312
204
575
2737
33970
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
3520-4 [3010375]
1.6e+00
1.8e+00
2.3e+00
—
2.9e+00
2.2e+00
3.1e+00
cases:0.41%
controls:0.08%
cases:0.39%
controls:0.06%
cases:0.23%
controls:0.02%
—
—
cases:0.30%
controls:0.02%
cases:0.50%
controls:0.06%
cases:1.80%
controls:0.08%
18
36
4390
44008
17
27
4392
44027
10
10
4399
44044
—
13
7
4328
43945
20
24
3972
42467
53
28
2888
34517
Clinical & Laboratory Immunology (Internal Medicine) Physician
207RI0001X [38003875]
207RI0001X [38003875]
2.4e+00
3.4e+00
—
1.0e+50
1.0e+50
4.2e+00
4.0e+00
cases:0.36%
controls:0.03%
cases:0.34%
controls:0.01%
—
—
cases:0.61%
controls:0.00%
cases:0.35%
controls:0.00%
cases:0.93%
controls:0.01%
cases:1.12%
controls:0.02%
16
15
4392
44029
15
5
4394
44049
—
27
0
4382
44054
15
0
4326
43952
37
6
3955
42485
33
7
2908
34538
CD19 cells/cells in Blood
8117-4 [3016228]
8117-4 [3016228]
2.9e+00
3.6e+00
—
—
1.0e+50
3.9e+00
3.7e+00
cases:0.48%
controls:0.03%
cases:0.48%
controls:0.01%
—
—
—
—
cases:0.41%
controls:0.00%
cases:0.80%
controls:0.02%
cases:1.56%
controls:0.04%
21
12
4387
44032
21
6
4388
44048
—
—
18
0
4323
43952
32
7
3960
42484
46
14
2895
34531
Mantle cell lymphoma
C83.1 [45542646]
C83.1 [45542646]
2.6e+00
3.2e+00
3.4e+00
—
—
2.9e+00
1.8e+00
cases:0.41%
controls:0.03%
cases:0.45%
controls:0.02%
cases:0.34%
controls:0.01%
—
—
—
—
cases:0.40%
controls:0.02%
cases:0.27%
controls:0.05%
18
13
4390
44031
20
8
4389
44046
15
5
4394
44049
—
—
16
9
3976
42482
8
16
2933
34529
Seronegative rheumatoid arthritis
M06.0 [45577103]
M06.0 [45577103]
1.2e+00
1.4e+00
2.4e+00
3.5e+00
2.3e+00
1.7e+00
1.5e+00
cases:1.16%
controls:0.34%
cases:0.77%
controls:0.18%
cases:0.32%
controls:0.03%
cases:0.36%
controls:0.01%
cases:0.48%
controls:0.05%
cases:0.98%
controls:0.18%
cases:1.36%
controls:0.32%
51
148
4357
43896
34
81
4375
43973
14
13
4395
44041
16
5
4393
44049
21
22
4320
43930
39
78
3953
42413
40
110
2901
34435
Lactate [Moles/volume] in Blood
32693-4 [3047181]
32693-4 [3047181]
6.2e-01
2.0e+00
3.9e+00
—
3.4e+00
2.3e+00
1.8e+00
cases:0.88%
controls:0.48%
cases:1.18%
controls:0.17%
cases:0.77%
controls:0.02%
—
—
cases:0.76%
controls:0.03%
cases:1.80%
controls:0.19%
cases:3.60%
controls:0.62%
39
210
4369
43834
52
74
4357
43980
34
7
4375
44047
—
33
11
4308
43941
72
82
3920
42409
106
214
2835
34331
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
6.8e-01
1.1e+00
2.6e+00
4.3e+00
2.5e+00
1.5e+00
1.2e+00
cases:16.31%
controls:9.00%
cases:20.14%
controls:7.41%
cases:17.87%
controls:1.56%
cases:5.44%
controls:0.08%
cases:15.76%
controls:1.49%
cases:27.18%
controls:8.04%
cases:38.56%
controls:16.23%
719
3963
3689
40081
888
3263
3521
40791
788
686
3621
43368
240
36
4169
44018
684
657
3657
43295
1085
3416
2907
39075
1134
5605
1807
28940
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
8.7e-01
1.9e+00
3.5e+00
1.0e+50
3.6e+00
2.3e+00
1.7e+00
cases:4.02%
controls:1.73%
cases:4.58%
controls:0.71%
cases:2.47%
controls:0.08%
cases:3.27%
controls:0.00%
cases:3.48%
controls:0.10%
cases:6.84%
controls:0.74%
cases:14.28%
controls:2.82%
177
762
4231
43282
202
314
4207
43740
109
35
4300
44019
144
0
4265
44054
151
45
4190
43907
273
315
3719
42176
420
973
2521
33572
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
1.1e+00
2.0e+00
3.2e+00
—
3.7e+00
2.0e+00
1.8e+00
cases:2.52%
controls:0.86%
cases:3.08%
controls:0.42%
cases:1.66%
controls:0.07%
—
—
cases:2.42%
controls:0.06%
cases:3.43%
controls:0.46%
cases:7.04%
controls:1.29%
111
377
4297
43667
136
184
4273
43870
73
30
4336
44024
—
105
27
4236
43925
137
196
3855
42295
207
446
2734
34099
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
M35.9 [45553174]
3.0e+00
3.6e+00
—
1.0e+50
—
4.0e+00
3.1e+00
cases:0.59%
controls:0.03%
cases:0.68%
controls:0.02%
—
—
cases:0.25%
controls:0.00%
—
—
cases:1.18%
controls:0.02%
cases:1.46%
controls:0.06%
26
13
4382
44031
30
8
4379
44046
—
11
0
4398
44054
—
47
9
3945
42482
43
22
2898
34523
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
6521-9 [3009595]
4.2e+00
—
1.0e+50
1.0e+50
—
5.0e+00
4.6e+00
cases:0.88%
controls:0.01%
—
—
cases:1.75%
controls:0.00%
cases:0.39%
controls:0.00%
—
—
cases:2.43%
controls:0.02%
cases:5.27%
controls:0.06%
39
6
4369
44038
—
77
0
4332
44054
17
0
4392
44054
—
97
7
3895
42484
155
20
2786
34525
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
80721-4 [21493690]
2.8e+00
3.6e+00
—
—
—
3.8e+00
3.5e+00
cases:0.66%
controls:0.04%
cases:0.75%
controls:0.02%
—
—
—
—
—
—
cases:1.30%
controls:0.03%
cases:2.28%
controls:0.07%
29
18
4379
44026
33
9
4376
44045
—
—
—
52
12
3940
42479
67
24
2874
34521
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
1.0e+00
1.8e+00
3.3e+00
1.0e+50
3.4e+00
2.3e+00
1.9e+00
cases:1.93%
controls:0.72%
cases:2.02%
controls:0.34%
cases:0.95%
controls:0.03%
cases:1.25%
controls:0.00%
cases:1.50%
controls:0.05%
cases:3.18%
controls:0.34%
cases:7.92%
controls:1.29%
85
316
4323
43728
89
149
4320
43905
42
15
4367
44039
55
0
4354
44054
65
22
4276
43930
127
146
3865
42345
233
446
2708
34099
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
J44.1 [45601132]
J44.1 [45601132]
1.6e+00
2.5e+00
2.8e+00
1.0e+50
2.3e+00
2.4e+00
2.1e+00
cases:0.75%
controls:0.15%
cases:0.79%
controls:0.06%
cases:0.25%
controls:0.02%
cases:0.25%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.93%
controls:0.09%
cases:2.11%
controls:0.25%
33
68
4375
43976
35
28
4374
44026
11
7
4398
44047
11
0
4398
44054
9
9
4332
43943
37
37
3955
42454
62
88
2879
34457
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.1e+00
2.0e+00
3.2e+00
—
3.7e+00
2.0e+00
1.7e+00
cases:2.61%
controls:0.88%
cases:3.38%
controls:0.48%
cases:2.06%
controls:0.09%
—
—
cases:3.04%
controls:0.08%
cases:4.16%
controls:0.57%
cases:7.89%
controls:1.60%
115
387
4293
43657
149
212
4260
43842
91
38
4318
44016
—
132
33
4209
43919
166
242
3826
42249
232
554
2709
33991
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.1e+00
2.0e+00
3.2e+00
—
3.7e+00
2.0e+00
1.7e+00
cases:2.59%
controls:0.88%
cases:3.38%
controls:0.47%
cases:2.00%
controls:0.08%
—
—
cases:2.97%
controls:0.08%
cases:4.11%
controls:0.56%
cases:7.72%
controls:1.54%
114
386
4294
43658
149
209
4260
43845
88
37
4321
44017
—
129
33
4212
43919
164
239
3828
42252
227
531
2714
34014
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
11156-7 [3008757]
1.3e+00
2.5e+00
2.6e+00
—
3.2e+00
2.2e+00
1.8e+00
cases:0.66%
controls:0.17%
cases:0.75%
controls:0.06%
cases:0.20%
controls:0.02%
—
—
cases:0.32%
controls:0.01%
cases:0.73%
controls:0.08%
cases:1.02%
controls:0.17%
29
76
4379
43968
33
26
4376
44028
9
7
4400
44047
—
14
6
4327
43946
29
33
3963
42458
30
57
2911
34488
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
1.6e+00
2.5e+00
3.1e+00
1.0e+50
2.3e+00
2.2e+00
2.0e+00
cases:6.85%
controls:1.46%
cases:4.42%
controls:0.37%
cases:0.86%
controls:0.04%
cases:0.34%
controls:0.00%
cases:0.35%
controls:0.04%
cases:3.58%
controls:0.40%
cases:10.34%
controls:1.50%
302
643
4106
43401
195
165
4214
43889
38
18
4371
44036
15
0
4394
44054
15
16
4326
43936
143
171
3849
42320
304
517
2637
34028
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
1.1e+00
2.1e+00
3.7e+00
1.0e+50
3.4e+00
2.1e+00
1.3e+00
cases:1.04%
controls:0.36%
cases:2.29%
controls:0.29%
cases:1.56%
controls:0.04%
cases:1.25%
controls:0.00%
cases:1.08%
controls:0.04%
cases:2.58%
controls:0.34%
cases:5.92%
controls:1.68%
46
159
4362
43885
101
128
4308
43926
69
17
4340
44037
55
0
4354
44054
47
16
4294
43936
103
143
3889
42348
174
582
2767
33963
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
1.7e+00
2.5e+00
3.7e+00
—
—
3.3e+00
2.3e+00
cases:1.72%
controls:0.33%
cases:1.77%
controls:0.15%
cases:0.84%
controls:0.02%
—
—
—
—
cases:3.01%
controls:0.11%
cases:4.18%
controls:0.42%
76
146
4332
43898
78
64
4331
43990
37
9
4372
44045
—
—
120
47
3872
42444
123
144
2818
34401
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
26975-3 [3025245]
1.1e+00
2.8e+00
—
1.0e+50
4.9e+00
2.9e+00
1.9e+00
cases:0.73%
controls:0.25%
cases:1.59%
controls:0.10%
—
—
cases:0.14%
controls:0.00%
cases:1.82%
controls:0.01%
cases:2.45%
controls:0.13%
cases:2.96%
controls:0.45%
32
111
4376
43933
70
45
4339
44009
—
6
0
4403
44054
79
6
4262
43946
98
57
3894
42434
87
156
2854
34389
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
90304-7 [1175426]
2.6e+00
3.7e+00
1.0e+50
—
—
3.8e+00
3.4e+00
cases:0.61%
controls:0.05%
cases:0.75%
controls:0.02%
cases:0.23%
controls:0.00%
—
—
—
—
cases:1.30%
controls:0.03%
cases:2.28%
controls:0.08%
27
21
4381
44023
33
8
4376
44046
10
0
4399
44054
—
—
52
12
3940
42479
67
26
2874
34519
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
5.0e-01
1.4e+00
2.6e+00
4.6e+00
2.3e+00
1.2e+00
9.6e-01
cases:6.42%
controls:4.01%
cases:6.94%
controls:1.85%
cases:3.15%
controls:0.25%
cases:1.81%
controls:0.02%
cases:2.46%
controls:0.25%
cases:6.56%
controls:2.05%
cases:14.62%
controls:6.18%
283
1767
4125
42277
306
816
4103
43238
139
108
4270
43946
80
8
4329
44046
107
110
4234
43842
262
871
3730
41620
430
2135
2511
32410
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
11090-8 [3016921]
1.1e+00
2.7e+00
—
1.0e+50
5.0e+00
2.9e+00
1.8e+00
cases:0.93%
controls:0.31%
cases:1.77%
controls:0.12%
—
—
cases:0.20%
controls:0.00%
cases:1.96%
controls:0.01%
cases:2.66%
controls:0.15%
cases:3.13%
controls:0.52%
41
135
4367
43909
78
53
4331
44001
—
9
0
4400
44054
85
6
4256
43946
106
63
3886
42428
92
179
2849
34366
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
6.1e-01
1.1e+00
2.3e+00
4.8e+00
2.3e+00
1.3e+00
1.1e+00
cases:10.14%
controls:5.79%
cases:9.32%
controls:3.19%
cases:4.24%
controls:0.45%
cases:1.95%
controls:0.02%
cases:4.38%
controls:0.44%
cases:10.95%
controls:3.34%
cases:23.77%
controls:9.70%
447
2550
3961
41494
411
1404
3998
42650
187
200
4222
43854
86
7
4323
44047
190
194
4151
43758
437
1421
3555
41070
699
3350
2242
31195
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
6.6e-01
1.2e+00
2.3e+00
4.6e+00
2.3e+00
1.3e+00
1.1e+00
cases:10.16%
controls:5.52%
cases:9.07%
controls:3.03%
cases:3.97%
controls:0.40%
cases:1.75%
controls:0.02%
cases:4.12%
controls:0.41%
cases:10.42%
controls:3.09%
cases:23.22%
controls:8.99%
448
2431
3960
41613
400
1335
4009
42719
175
177
4234
43877
77
8
4332
44046
179
181
4162
43771
416
1313
3576
41178
683
3106
2258
31439
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
4.2e-01
1.1e+00
2.2e+00
5.5e+00
2.2e+00
1.3e+00
8.0e-01
cases:19.67%
controls:13.82%
cases:17.80%
controls:6.70%
cases:7.64%
controls:0.90%
cases:5.08%
controls:0.02%
cases:7.16%
controls:0.85%
cases:21.22%
controls:6.87%
cases:36.72%
controls:20.68%
867
6085
3541
37959
785
2953
3624
41101
337
397
4072
43657
224
10
4185
44044
311
375
4030
43577
847
2918
3145
39573
1080
7145
1861
27400
pirfenidone; oral
L04AX05 [40254039]
L04AX05 [40254039]
—
—
—
—
3.3e+00
4.9e+00
5.2e+00
—
—
—
—
—
—
—
—
cases:0.32%
controls:0.01%
cases:3.21%
controls:0.02%
cases:4.90%
controls:0.03%
—
—
—
—
14
5
4327
43947
128
10
3864
42481
144
10
2797
34535
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 [3030558]
34720-3 [3030558]
2.2e+00
4.0e+00
1.0e+50
—
1.0e+50
3.9e+00
3.4e+00
cases:0.29%
controls:0.03%
cases:0.70%
controls:0.01%
cases:0.29%
controls:0.00%
—
—
cases:0.88%
controls:0.00%
cases:0.60%
controls:0.01%
cases:1.22%
controls:0.04%
13
14
4395
44030
31
6
4378
44048
13
0
4396
44054
—
38
0
4303
43952
24
5
3968
42486
36
15
2905
34530
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
6.0e-01
1.2e+00
2.3e+00
4.6e+00
2.4e+00
1.3e+00
1.1e+00
cases:8.42%
controls:4.78%
cases:6.51%
controls:2.03%
cases:2.59%
controls:0.27%
cases:1.29%
controls:0.01%
cases:2.70%
controls:0.26%
cases:7.24%
controls:1.99%
cases:15.30%
controls:5.68%
371
2105
4037
41939
287
894
4122
43160
114
121
4295
43933
57
6
4352
44048
117
113
4224
43839
289
847
3703
41644
450
1962
2491
32583
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
8112-5 [3027831]
2.6e+00
3.7e+00
1.0e+50
—
—
3.8e+00
3.4e+00
cases:0.61%
controls:0.05%
cases:0.73%
controls:0.02%
cases:0.18%
controls:0.00%
—
—
—
—
cases:1.23%
controls:0.03%
cases:2.24%
controls:0.08%
27
21
4381
44023
32
8
4377
44046
8
0
4401
44054
—
—
49
12
3943
42479
66
26
2875
34519
Fungus identified in Specimen by Culture
580-1 [3000494]
580-1 [3000494]
6.7e-01
1.9e+00
3.2e+00
—
4.4e+00
2.0e+00
1.4e+00
cases:3.95%
controls:2.05%
cases:4.26%
controls:0.68%
cases:1.81%
controls:0.08%
—
—
cases:4.31%
controls:0.06%
cases:4.51%
controls:0.65%
cases:9.42%
controls:2.54%
174
904
4234
43140
188
301
4221
43753
80
34
4329
44020
—
187
25
4154
43927
180
276
3812
42215
277
879
2664
33666
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
29374-6 [3006999]
1.1e+00
2.7e+00
—
1.0e+50
5.0e+00
2.9e+00
1.8e+00
cases:0.91%
controls:0.31%
cases:1.70%
controls:0.12%
—
—
cases:0.20%
controls:0.00%
cases:1.91%
controls:0.01%
cases:2.63%
controls:0.15%
cases:3.06%
controls:0.52%
40
135
4368
43909
75
52
4334
44002
—
9
0
4400
44054
83
6
4258
43946
105
63
3887
42428
90
179
2851
34366
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
8.7e-01
1.9e+00
3.5e+00
1.0e+50
3.4e+00
2.2e+00
1.6e+00
cases:3.56%
controls:1.52%
cases:4.01%
controls:0.64%
cases:2.09%
controls:0.07%
cases:2.81%
controls:0.00%
cases:2.76%
controls:0.10%
cases:5.76%
controls:0.66%
cases:11.46%
controls:2.61%
157
671
4251
43373
177
280
4232
43774
92
29
4317
44025
124
0
4285
44054
120
42
4221
43910
230
282
3762
42209
337
903
2604
33642
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
76080-1 [46235759]
1.1e+00
2.0e+00
3.7e+00
1.0e+50
3.5e+00
1.7e+00
1.4e+00
cases:1.29%
controls:0.42%
cases:1.70%
controls:0.24%
cases:0.84%
controls:0.02%
cases:0.52%
controls:0.00%
cases:0.67%
controls:0.02%
cases:1.03%
controls:0.20%
cases:3.16%
controls:0.79%
57
186
4351
43858
75
104
4334
43950
37
9
4372
44045
23
0
4386
44054
29
9
4312
43943
41
84
3951
42407
93
274
2848
34271
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
1.6e+00
2.5e+00
3.7e+00
—
—
3.3e+00
2.3e+00
cases:1.75%
controls:0.35%
cases:1.79%
controls:0.15%
cases:0.84%
controls:0.02%
—
—
—
—
cases:2.96%
controls:0.12%
cases:4.15%
controls:0.43%
77
156
4331
43888
79
67
4330
43987
37
9
4372
44045
—
—
118
50
3874
42441
122
148
2819
34397
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
6.4e-01
1.1e+00
2.2e+00
4.5e+00
2.4e+00
1.3e+00
1.1e+00
cases:8.30%
controls:4.55%
cases:6.31%
controls:2.15%
cases:2.77%
controls:0.30%
cases:1.27%
controls:0.01%
cases:2.95%
controls:0.27%
cases:7.64%
controls:2.26%
cases:17.14%
controls:6.46%
366
2004
4042
42040
278
946
4131
43108
122
132
4287
43922
56
6
4353
44048
128
120
4213
43832
305
959
3687
41532
504
2231
2437
32314
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
6.2e-01
1.2e+00
2.3e+00
4.5e+00
2.3e+00
1.4e+00
1.1e+00
cases:17.20%
controls:10.09%
cases:15.88%
controls:5.55%
cases:7.76%
controls:0.87%
cases:3.31%
controls:0.04%
cases:7.95%
controls:0.87%
cases:20.09%
controls:5.64%
cases:34.89%
controls:15.48%
758
4445
3650
39599
700
2444
3709
41610
342
382
4067
43672
146
17
4263
44037
345
383
3996
43569
802
2397
3190
40094
1026
5347
1915
29198
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
94500-6 [706163]
3.3e-01
1.2e+00
2.4e+00
5.6e+00
2.1e+00
1.0e+00
7.0e-01
cases:9.94%
controls:7.32%
cases:11.07%
controls:3.78%
cases:5.42%
controls:0.50%
cases:3.47%
controls:0.01%
cases:3.75%
controls:0.48%
cases:9.94%
controls:3.77%
cases:23.70%
controls:13.35%
438
3222
3970
40822
488
1667
3921
42387
239
221
4170
43833
153
6
4256
44048
163
211
4178
43741
397
1604
3595
40887
697
4612
2244
29933
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
1.4e+00
1.9e+00
2.7e+00
—
3.1e+00
2.4e+00
1.8e+00
cases:5.85%
controls:1.47%
cases:5.33%
controls:0.81%
cases:2.06%
controls:0.14%
—
—
cases:3.02%
controls:0.14%
cases:8.64%
controls:0.85%
cases:11.05%
controls:2.08%
258
647
4150
43397
235
356
4174
43698
91
63
4318
43991
—
131
62
4210
43890
345
360
3647
42131
325
717
2616
33828
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
17791-5 [3027450]
1.1e+00
2.7e+00
—
1.0e+50
5.0e+00
2.8e+00
1.8e+00
cases:0.95%
controls:0.33%
cases:1.72%
controls:0.12%
—
—
cases:0.20%
controls:0.00%
cases:1.94%
controls:0.01%
cases:2.66%
controls:0.16%
cases:3.20%
controls:0.55%
42
147
4366
43897
76
53
4333
44001
—
9
0
4400
44054
84
6
4257
43946
106
69
3886
42422
94
190
2847
34355
Chronic maxillary sinusitis
J32.0 [45586667]
J32.0 [45586667]
1.5e+00
1.9e+00
2.8e+00
1.0e+50
2.5e+00
2.8e+00
1.8e+00
cases:1.68%
controls:0.38%
cases:0.98%
controls:0.14%
cases:0.23%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.37%
controls:0.03%
cases:1.18%
controls:0.08%
cases:2.31%
controls:0.37%
74
169
4334
43875
43
62
4366
43992
10
6
4399
44048
6
0
4403
44054
16
14
4325
43938
47
32
3945
42459
68
129
2873
34416
adalimumab; parenteral
L04AB04 [21603911]
L04AB04 [21603911]
2.4e+00
2.2e+00
2.4e+00
—
1.9e+00
2.2e+00
2.2e+00
cases:1.04%
controls:0.10%
cases:0.91%
controls:0.10%
cases:0.34%
controls:0.03%
—
—
cases:0.32%
controls:0.05%
cases:0.88%
controls:0.10%
cases:1.19%
controls:0.13%
46
44
4362
44000
40
43
4369
44011
15
14
4394
44040
—
14
22
4327
43930
35
41
3957
42450
35
44
2906
34501
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
1.0e+00
1.8e+00
3.3e+00
1.0e+50
3.5e+00
1.9e+00
1.7e+00
cases:1.97%
controls:0.70%
cases:2.13%
controls:0.36%
cases:1.43%
controls:0.05%
cases:0.54%
controls:0.00%
cases:1.73%
controls:0.05%
cases:2.88%
controls:0.42%
cases:5.20%
controls:1.01%
87
309
4321
43735
94
157
4315
43897
63
23
4346
44031
24
0
4385
44054
75
24
4266
43928
115
179
3877
42312
153
350
2788
34195
Segmented neutrophils/Leukocytes in Blood
26505-8 [3017354]
26505-8 [3017354]
1.3e+00
2.2e+00
2.9e+00
—
3.2e+00
2.4e+00
1.3e+00
cases:0.48%
controls:0.13%
cases:0.57%
controls:0.06%
cases:0.29%
controls:0.02%
—
—
cases:0.32%
controls:0.01%
cases:0.73%
controls:0.07%
cases:0.75%
controls:0.21%
21
59
4387
43985
25
27
4384
44027
13
7
4396
44047
—
14
6
4327
43946
29
28
3963
42463
22
73
2919
34472
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
5.0e-01
1.2e+00
2.5e+00
5.2e+00
2.2e+00
1.1e+00
6.5e-01
cases:13.59%
controls:8.70%
cases:12.38%
controls:4.13%
cases:5.58%
controls:0.49%
cases:4.15%
controls:0.02%
cases:4.42%
controls:0.52%
cases:12.02%
controls:4.38%
cases:23.84%
controls:14.06%
599
3831
3809
40213
546
1820
3863
42234
246
217
4163
43837
183
11
4226
44043
192
230
4149
43722
480
1860
3512
40631
701
4858
2240
29687
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.9e-01
1.2e+00
2.7e+00
4.5e+00
2.3e+00
1.4e+00
7.8e-01
cases:40.63%
controls:31.68%
cases:44.61%
controls:19.94%
cases:35.61%
controls:3.70%
cases:16.22%
controls:0.22%
cases:27.92%
controls:3.63%
cases:51.28%
controls:21.04%
cases:64.03%
controls:44.89%
1791
13955
2617
30089
1967
8784
2442
35270
1570
1629
2839
42425
715
95
3694
43959
1212
1596
3129
42356
2047
8938
1945
33553
1883
15507
1058
19038
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
1.1e+00
1.7e+00
2.9e+00
1.0e+50
3.8e+00
2.0e+00
1.7e+00
cases:2.18%
controls:0.77%
cases:2.20%
controls:0.39%
cases:1.04%
controls:0.06%
cases:0.68%
controls:0.00%
cases:1.84%
controls:0.04%
cases:2.81%
controls:0.40%
cases:6.90%
controls:1.35%
96
340
4312
43704
97
173
4312
43881
46
25
4363
44029
30
0
4379
44054
80
18
4261
43934
112
168
3880
42323
203
468
2738
34077
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
8.6e-01
1.4e+00
2.2e+00
2.9e+00
2.6e+00
1.7e+00
1.4e+00
cases:5.65%
controls:2.47%
cases:4.47%
controls:1.15%
cases:1.63%
controls:0.18%
cases:0.29%
controls:0.02%
cases:2.30%
controls:0.18%
cases:6.69%
controls:1.26%
cases:13.57%
controls:3.67%
249
1086
4159
42958
197
505
4212
43549
72
80
4337
43974
13
7
4396
44047
100
77
4241
43875
267
534
3725
41957
399
1268
2542
33277
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
7.7e-01
1.8e+00
3.6e+00
1.0e+50
3.3e+00
2.0e+00
1.6e+00
cases:1.70%
controls:0.79%
cases:2.15%
controls:0.36%
cases:1.02%
controls:0.03%
cases:1.36%
controls:0.00%
cases:1.34%
controls:0.05%
cases:2.68%
controls:0.38%
cases:6.19%
controls:1.29%
75
350
4333
43694
95
158
4314
43896
45
12
4364
44042
60
0
4349
44054
58
22
4283
43930
107
160
3885
42331
182
446
2759
34099
CD19 cells [#/volume] in Blood
8116-6 [3010503]
8116-6 [3010503]
2.6e+00
3.4e+00
1.0e+50
—
—
3.5e+00
3.7e+00
cases:0.79%
controls:0.06%
cases:0.77%
controls:0.03%
cases:0.18%
controls:0.00%
—
—
—
—
cases:1.00%
controls:0.03%
cases:1.87%
controls:0.05%
35
27
4373
44017
34
12
4375
44042
8
0
4401
44054
—
—
40
13
3952
42478
55
17
2886
34528
Emergency Medicine
93 [38004510]
93 [38004510]
5.4e-01
1.1e+00
2.4e+00
5.5e+00
1.6e+00
1.1e+00
7.6e-01
cases:21.48%
controls:13.77%
cases:19.98%
controls:7.41%
cases:9.55%
controls:0.97%
cases:8.05%
controls:0.03%
cases:4.58%
controls:0.93%
cases:20.57%
controls:8.13%
cases:40.33%
controls:24.10%
947
6065
3461
37979
881
3266
3528
40788
421
429
3988
43625
355
15
4054
44039
199
407
4142
43545
821
3455
3171
39036
1186
8324
1755
26221
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
5.9e-01
1.1e+00
2.2e+00
4.7e+00
2.3e+00
1.2e+00
9.8e-01
cases:11.59%
controls:6.75%
cases:10.57%
controls:3.72%
cases:4.79%
controls:0.53%
cases:2.18%
controls:0.02%
cases:4.86%
controls:0.53%
cases:12.12%
controls:4.05%
cases:25.98%
controls:11.68%
511
2972
3897
41072
466
1640
3943
42414
211
235
4198
43819
96
9
4313
44045
211
233
4130
43719
484
1719
3508
40772
764
4034
2177
30511
CR(E)ST syndrome
M34.1 [45582129]
M34.1 [45582129]
2.2e+00
2.5e+00
2.6e+00
—
—
2.8e+00
3.0e+00
cases:0.36%
controls:0.04%
cases:0.43%
controls:0.04%
cases:0.18%
controls:0.01%
—
—
—
—
cases:0.55%
controls:0.04%
cases:0.85%
controls:0.04%
16
17
4392
44027
19
16
4390
44038
8
6
4401
44048
—
—
22
15
3970
42476
25
15
2916
34530
Inpatient Visit
IP [9201]
IP [9201]
5.0e-01
9.5e-01
1.6e+00
5.8e+00
2.3e+00
1.1e+00
7.8e-01
cases:10.57%
controls:6.69%
cases:7.82%
controls:3.17%
cases:2.11%
controls:0.42%
cases:4.26%
controls:0.01%
cases:3.55%
controls:0.38%
cases:8.94%
controls:3.27%
cases:21.08%
controls:10.94%
466
2947
3942
41097
345
1396
4064
42658
93
183
4316
43871
188
6
4221
44048
154
168
4187
43784
357
1390
3635
41101
620
3778
2321
30767
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
8.5e-01
1.9e+00
3.2e+00
—
3.1e+00
2.2e+00
1.7e+00
cases:4.49%
controls:1.97%
cases:3.90%
controls:0.58%
cases:1.79%
controls:0.07%
—
—
cases:1.47%
controls:0.07%
cases:5.34%
controls:0.64%
cases:10.13%
controls:1.99%
198
866
4210
43178
172
255
4237
43799
79
33
4330
44021
—
64
29
4277
43923
213
270
3779
42221
298
688
2643
33857
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 [40764127]
61366-1 [40764127]
3.5e+00
—
—
1.0e+50
1.0e+50
4.7e+00
4.8e+00
cases:0.52%
controls:0.02%
—
—
—
—
cases:0.66%
controls:0.00%
cases:1.80%
controls:0.00%
cases:1.28%
controls:0.01%
cases:2.38%
controls:0.02%
23
7
4385
44037
—
—
29
0
4380
44054
78
0
4263
43952
51
5
3941
42486
70
7
2871
34538
erdosteine; oral
R05CB15 [21603394]
R05CB15 [21603394]
1.2e+00
2.1e+00
3.0e+00
1.0e+50
3.0e+00
1.9e+00
1.7e+00
cases:7.06%
controls:2.17%
cases:6.03%
controls:0.79%
cases:1.63%
controls:0.08%
cases:0.32%
controls:0.00%
cases:1.98%
controls:0.10%
cases:5.79%
controls:0.87%
cases:15.27%
controls:3.05%
311
957
4097
43087
266
347
4143
43707
72
37
4337
44017
14
0
4395
44054
86
45
4255
43907
231
370
3761
42121
449
1053
2492
33492
Rheumatoid arthritis, unspecified
M06.9 [45533705]
M06.9 [45533705]
1.6e+00
2.1e+00
2.6e+00
—
2.7e+00
2.1e+00
1.8e+00
cases:1.38%
controls:0.27%
cases:0.88%
controls:0.11%
cases:0.18%
controls:0.01%
—
—
cases:0.41%
controls:0.03%
cases:0.98%
controls:0.12%
cases:1.87%
controls:0.31%
61
119
4347
43925
39
48
4370
44006
8
6
4401
44048
—
18
12
4323
43940
39
53
3953
42438
55
106
2886
34439
roxithromycin; oral
J01FA06 [21602974]
J01FA06 [21602974]
1.2e+00
2.5e+00
3.7e+00
—
2.5e+00
1.6e+00
1.4e+00
cases:7.60%
controls:2.51%
cases:5.19%
controls:0.47%
cases:1.61%
controls:0.04%
—
—
cases:0.65%
controls:0.05%
cases:2.40%
controls:0.48%
cases:6.32%
controls:1.61%
335
1106
4073
42938
229
206
4180
43848
71
17
4338
44037
—
28
23
4313
43929
96
203
3896
42288
186
555
2755
33990
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
1.5e+00
1.5e+00
1.8e+00
2.3e+00
1.9e+00
2.0e+00
2.1e+00
cases:0.57%
controls:0.12%
cases:0.41%
controls:0.10%
cases:0.32%
controls:0.05%
cases:0.27%
controls:0.03%
cases:0.37%
controls:0.06%
cases:0.58%
controls:0.08%
cases:1.05%
controls:0.14%
25
55
4383
43989
18
42
4391
44012
14
24
4395
44030
12
12
4397
44042
16
25
4325
43927
23
35
3969
42456
31
47
2910
34498
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.8e-01
1.2e+00
2.3e+00
3.6e+00
2.4e+00
1.6e+00
1.2e+00
cases:18.28%
controls:11.13%
cases:17.60%
controls:5.93%
cases:10.73%
controls:1.20%
cases:2.27%
controls:0.06%
cases:10.83%
controls:1.14%
cases:25.00%
controls:6.22%
cases:40.05%
controls:16.51%
806
4904
3602
39140
776
2611
3633
41443
473
528
3936
43526
100
27
4309
44027
470
501
3871
43451
998
2641
2994
39850
1178
5705
1763
28840
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
7.6e-01
1.4e+00
2.6e+00
—
3.6e+00
2.5e+00
2.1e+00
cases:0.93%
controls:0.44%
cases:0.66%
controls:0.17%
cases:0.16%
controls:0.01%
—
—
cases:0.55%
controls:0.02%
cases:1.60%
controls:0.14%
cases:3.30%
controls:0.42%
41
193
4367
43851
29
73
4380
43981
7
5
4402
44049
—
24
7
4317
43945
64
58
3928
42433
97
145
2844
34400
CD3 cells [#/volume] in Blood
8122-4 [3011412]
8122-4 [3011412]
2.4e+00
3.5e+00
1.0e+50
—
—
3.5e+00
3.4e+00
cases:0.93%
controls:0.08%
cases:1.02%
controls:0.03%
cases:0.29%
controls:0.00%
—
—
—
—
cases:1.43%
controls:0.04%
cases:2.55%
controls:0.08%
41
36
4367
44008
45
14
4364
44040
13
0
4396
44054
—
—
57
18
3935
42473
75
29
2866
34516
Mycobacterium tuberculosis genotype [Identifier] in Isolate
35352-4 [3036432]
35352-4 [3036432]
1.8e+00
3.4e+00
1.0e+50
1.0e+50
—
4.2e+00
3.4e+00
cases:0.34%
controls:0.05%
cases:0.86%
controls:0.03%
cases:0.50%
controls:0.00%
cases:0.20%
controls:0.00%
—
—
cases:0.80%
controls:0.01%
cases:2.04%
controls:0.07%
15
24
4393
44020
38
13
4371
44041
22
0
4387
44054
9
0
4400
44054
—
32
5
3960
42486
60
23
2881
34522
Sarcoidosis of lung
D86.0 [45576422]
D86.0 [45576422]
1.7e+00
2.4e+00
2.9e+00
1.0e+50
—
3.0e+00
2.9e+00
cases:0.52%
controls:0.09%
cases:0.54%
controls:0.05%
cases:0.25%
controls:0.01%
cases:0.16%
controls:0.00%
—
—
cases:1.08%
controls:0.05%
cases:1.53%
controls:0.09%
23
41
4385
44003
24
22
4385
44032
11
6
4398
44048
7
0
4402
44054
—
43
23
3949
42468
45
31
2896
34514
Myosin Ab [Presence] in Serum or Plasma by Immunoblot
72458-3 [43055089]
72458-3 [43055089]
1.9e+00
3.7e+00
1.0e+50
1.0e+50
—
4.3e+00
3.0e+00
cases:0.32%
controls:0.05%
cases:0.91%
controls:0.02%
cases:1.18%
controls:0.00%
cases:0.23%
controls:0.00%
—
—
cases:2.10%
controls:0.03%
cases:2.14%
controls:0.11%
14
21
4394
44023
40
10
4369
44044
52
0
4357
44054
10
0
4399
44054
—
84
13
3908
42478
63
37
2878
34508
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.4e+00
2.0e+00
3.3e+00
—
2.8e+00
1.8e+00
1.5e+00
cases:3.11%
controls:0.77%
cases:2.31%
controls:0.32%
cases:0.98%
controls:0.04%
—
—
cases:0.62%
controls:0.04%
cases:2.18%
controls:0.37%
cases:6.15%
controls:1.43%
137
341
4271
43703
102
141
4307
43913
43
16
4366
44038
—
27
16
4314
43936
87
156
3905
42335
181
495
2760
34050
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
59026-5 [40762119]
1.1e+00
2.7e+00
—
—
4.2e+00
2.9e+00
2.0e+00
cases:0.54%
controls:0.18%
cases:1.11%
controls:0.08%
—
—
—
—
cases:0.88%
controls:0.01%
cases:1.35%
controls:0.08%
cases:1.73%
controls:0.23%
24
79
4384
43965
49
34
4360
44020
—
—
38
6
4303
43946
54
33
3938
42458
51
81
2890
34464
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
7.7e-01
1.8e+00
3.4e+00
1.0e+50
3.4e+00
2.0e+00
1.4e+00
cases:3.02%
controls:1.42%
cases:3.56%
controls:0.59%
cases:1.81%
controls:0.06%
cases:2.27%
controls:0.00%
cases:2.33%
controls:0.08%
cases:4.58%
controls:0.62%
cases:9.32%
controls:2.45%
133
626
4275
43418
157
262
4252
43792
80
27
4329
44027
100
0
4309
44054
101
35
4240
43917
183
263
3809
42228
274
845
2667
33700
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
5.6e-01
1.1e+00
2.2e+00
4.6e+00
2.2e+00
1.2e+00
9.4e-01
cases:12.32%
controls:7.45%
cases:11.91%
controls:4.26%
cases:5.42%
controls:0.63%
cases:2.40%
controls:0.02%
cases:5.53%
controls:0.62%
cases:13.88%
controls:4.64%
cases:28.12%
controls:13.28%
543
3281
3865
40763
525
1875
3884
42179
239
276
4170
43778
106
11
4303
44043
240
272
4101
43680
554
1970
3438
40521
827
4588
2114
29957
Occupatioal Medicine
901 [44777713]
901 [44777713]
1.2e+00
1.6e+00
2.3e+00
1.0e+50
3.3e+00
3.0e+00
1.4e+00
cases:0.84%
controls:0.25%
cases:0.54%
controls:0.11%
cases:0.14%
controls:0.01%
cases:0.84%
controls:0.00%
cases:0.32%
controls:0.01%
cases:1.58%
controls:0.08%
cases:1.26%
controls:0.32%
37
112
4371
43932
24
47
4385
44007
6
6
4403
44048
37
0
4372
44054
14
5
4327
43947
63
35
3929
42456
37
110
2904
34435
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
6.9e-01
1.1e+00
2.5e+00
3.9e+00
2.1e+00
1.4e+00
1.1e+00
cases:9.85%
controls:5.22%
cases:8.03%
controls:2.76%
cases:6.10%
controls:0.53%
cases:1.47%
controls:0.03%
cases:4.54%
controls:0.56%
cases:11.15%
controls:2.97%
cases:20.27%
controls:7.57%
434
2298
3974
41746
354
1214
4055
42840
269
234
4140
43820
65
14
4344
44040
197
247
4144
43705
445
1263
3547
41228
596
2615
2345
31930
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]
7993-9 [3025023]
2.4e+00
3.7e+00
—
1.0e+50
1.0e+50
3.1e+00
3.6e+00
cases:0.75%
controls:0.07%
cases:1.22%
controls:0.03%
—
—
cases:0.20%
controls:0.00%
cases:1.04%
controls:0.00%
cases:0.80%
controls:0.04%
cases:2.07%
controls:0.06%
33
29
4375
44015
54
14
4355
44040
—
9
0
4400
44054
45
0
4296
43952
32
15
3960
42476
61
20
2880
34525
Mycobacterium sp identified in Sputum by Organism specific culture
539-7 [3027544]
539-7 [3027544]
2.3e+00
3.6e+00
—
1.0e+50
1.0e+50
3.8e+00
3.1e+00
cases:0.73%
controls:0.07%
cases:1.32%
controls:0.04%
—
—
cases:0.39%
controls:0.00%
cases:1.68%
controls:0.00%
cases:0.93%
controls:0.02%
cases:2.92%
controls:0.13%
32
33
4376
44011
58
16
4351
44038
—
17
0
4392
44054
73
0
4268
43952
37
9
3955
42482
86
46
2855
34499
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
1.4e+00
1.7e+00
1.7e+00
3.0e+00
1.7e+00
1.7e+00
1.5e+00
cases:8.17%
controls:2.17%
cases:7.55%
controls:1.48%
cases:2.54%
controls:0.45%
cases:0.32%
controls:0.02%
cases:2.42%
controls:0.44%
cases:7.21%
controls:1.43%
cases:9.49%
controls:2.21%
360
957
4048
43087
333
650
4076
43404
112
199
4297
43855
14
7
4395
44047
105
193
4236
43759
288
606
3704
41885
279
763
2662
33782
Mycobacterium sp identified in Specimen
40699-1 [3042631]
40699-1 [3042631]
2.2e+00
3.7e+00
—
1.0e+50
—
3.7e+00
3.2e+00
cases:1.38%
controls:0.15%
cases:2.20%
controls:0.06%
—
—
cases:0.54%
controls:0.00%
—
—
cases:2.38%
controls:0.06%
cases:3.98%
controls:0.17%
61
66
4347
43978
97
25
4312
44029
—
24
0
4385
44054
—
95
26
3897
42465
117
60
2824
34485
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 [3037875]
29723-4 [3037875]
3.4e+00
—
—
1.0e+50
1.0e+50
4.7e+00
4.7e+00
cases:0.52%
controls:0.02%
—
—
—
—
cases:0.64%
controls:0.00%
cases:1.82%
controls:0.00%
cases:1.28%
controls:0.01%
cases:2.38%
controls:0.02%
23
8
4385
44036
—
—
28
0
4381
44054
79
0
4262
43952
51
5
3941
42486
70
8
2871
34537
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
6.5e-01
1.6e+00
3.2e+00
—
3.5e+00
2.0e+00
1.7e+00
cases:1.00%
controls:0.52%
cases:1.07%
controls:0.21%
cases:0.39%
controls:0.02%
—
—
cases:0.90%
controls:0.03%
cases:1.35%
controls:0.18%
cases:3.40%
controls:0.63%
44
230
4364
43814
47
93
4362
43961
17
7
4392
44047
—
39
12
4302
43940
54
78
3938
42413
100
216
2841
34329
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
19231-0 [3004490]
1.0e+00
1.8e+00
3.1e+00
1.0e+50
3.5e+00
1.7e+00
1.6e+00
cases:1.75%
controls:0.63%
cases:1.70%
controls:0.29%
cases:0.98%
controls:0.04%
cases:0.48%
controls:0.00%
cases:1.20%
controls:0.04%
cases:1.70%
controls:0.32%
cases:3.50%
controls:0.76%
77
278
4331
43766
75
127
4334
43927
43
19
4366
44035
21
0
4388
44054
52
16
4289
43936
68
138
3924
42353
103
261
2838
34284
Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41005-0 [3040359]
41005-0 [3040359]
2.7e+00
3.9e+00
—
1.0e+50
1.0e+50
2.6e+00
3.5e+00
cases:0.75%
controls:0.05%
cases:0.95%
controls:0.02%
—
—
cases:0.27%
controls:0.00%
cases:0.74%
controls:0.00%
cases:0.53%
controls:0.04%
cases:1.56%
controls:0.05%
33
22
4375
44022
42
9
4367
44045
—
12
0
4397
44054
32
0
4309
43952
21
16
3971
42475
46
17
2895
34528
Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41003-5 [3041642]
41003-5 [3041642]
2.7e+00
3.9e+00
—
1.0e+50
1.0e+50
2.6e+00
3.5e+00
cases:0.75%
controls:0.05%
cases:0.95%
controls:0.02%
—
—
cases:0.27%
controls:0.00%
cases:0.74%
controls:0.00%
cases:0.53%
controls:0.04%
cases:1.56%
controls:0.05%
33
22
4375
44022
42
9
4367
44045
—
12
0
4397
44054
32
0
4309
43952
21
16
3971
42475
46
17
2895
34528
Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41009-2 [3038546]
41009-2 [3038546]
2.7e+00
3.9e+00
—
1.0e+50
1.0e+50
2.6e+00
3.5e+00
cases:0.75%
controls:0.05%
cases:0.95%
controls:0.02%
—
—
cases:0.27%
controls:0.00%
cases:0.74%
controls:0.00%
cases:0.53%
controls:0.04%
cases:1.56%
controls:0.05%
33
22
4375
44022
42
9
4367
44045
—
12
0
4397
44054
32
0
4309
43952
21
16
3971
42475
46
17
2895
34528
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
5.4e-01
1.0e+00
2.2e+00
4.5e+00
2.3e+00
1.2e+00
9.7e-01
cases:13.11%
controls:8.11%
cases:11.09%
controls:4.27%
cases:5.08%
controls:0.60%
cases:2.15%
controls:0.02%
cases:5.30%
controls:0.58%
cases:13.18%
controls:4.38%
cases:27.41%
controls:12.56%
578
3572
3830
40472
489
1882
3920
42172
224
266
4185
43788
95
11
4314
44043
230
253
4111
43699
526
1859
3466
40632
806
4340
2135
30205
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
FM1EE [2001303307]
6.0e-01
1.2e+00
2.0e+00
4.3e+00
2.0e+00
1.5e+00
1.1e+00
cases:8.08%
controls:4.60%
cases:6.19%
controls:1.99%
cases:1.38%
controls:0.19%
cases:1.02%
controls:0.01%
cases:1.52%
controls:0.22%
cases:7.44%
controls:1.84%
cases:15.40%
controls:5.55%
356
2028
4052
42016
273
875
4136
43179
61
84
4348
43970
45
6
4364
44048
66
96
4275
43856
297
780
3695
41711
453
1917
2488
32628
Shortness of breath/dyspnoea
R02 [2002000883]
R02 [2002000883]
1.3e+00
2.2e+00
3.8e+00
—
2.2e+00
1.8e+00
1.4e+00
cases:4.83%
controls:1.38%
cases:4.51%
controls:0.51%
cases:1.27%
controls:0.03%
—
—
cases:0.39%
controls:0.05%
cases:2.83%
controls:0.49%
cases:7.48%
controls:1.99%
213
607
4195
43437
199
223
4210
43831
56
13
4353
44041
—
17
20
4324
43932
113
207
3879
42284
220
688
2721
33857
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
8.9e-01
1.3e+00
2.0e+00
3.0e+00
2.3e+00
1.6e+00
1.4e+00
cases:3.92%
controls:1.65%
cases:3.58%
controls:0.97%
cases:1.56%
controls:0.22%
cases:0.27%
controls:0.01%
cases:2.21%
controls:0.22%
cases:5.09%
controls:1.04%
cases:10.00%
controls:2.61%
173
726
4235
43318
158
427
4251
43627
69
95
4340
43959
12
6
4397
44048
96
96
4245
43856
203
441
3789
42050
294
900
2647
33645
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.3e+00
1.9e+00
3.0e+00
—
3.1e+00
1.7e+00
1.7e+00
cases:2.79%
controls:0.81%
cases:2.29%
controls:0.36%
cases:0.82%
controls:0.04%
—
—
cases:1.29%
controls:0.06%
cases:2.53%
controls:0.46%
cases:6.80%
controls:1.37%
123
355
4285
43689
101
159
4308
43895
36
18
4373
44036
—
56
27
4285
43925
101
195
3891
42296
200
472
2741
34073
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
1.1e+00
2.0e+00
2.9e+00
1.0e+50
3.0e+00
2.0e+00
1.6e+00
cases:2.45%
controls:0.87%
cases:2.29%
controls:0.32%
cases:0.86%
controls:0.05%
cases:1.11%
controls:0.00%
cases:0.58%
controls:0.03%
cases:3.13%
controls:0.43%
cases:7.38%
controls:1.52%
108
383
4300
43661
101
139
4308
43915
38
22
4371
44032
49
0
4360
44054
25
13
4316
43939
125
183
3867
42308
217
524
2724
34021
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
4.7e-01
1.0e+00
2.1e+00
4.0e+00
2.5e+00
1.3e+00
1.0e+00
cases:8.42%
controls:5.42%
cases:7.01%
controls:2.59%
cases:2.86%
controls:0.35%
cases:1.11%
controls:0.02%
cases:4.35%
controls:0.36%
cases:8.57%
controls:2.42%
cases:17.44%
controls:6.99%
371
2387
4037
41657
309
1142
4100
42912
126
156
4283
43898
49
9
4360
44045
189
159
4152
43793
342
1029
3650
41462
513
2415
2428
32130
Other overlap syndromes
M35.1 [45553172]
M35.1 [45553172]
2.6e+00
2.8e+00
—
1.0e+50
—
3.7e+00
3.4e+00
cases:0.25%
controls:0.02%
cases:0.29%
controls:0.02%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.58%
controls:0.01%
cases:0.68%
controls:0.02%
11
8
4397
44036
13
8
4396
44046
—
10
0
4399
44054
—
23
6
3969
42485
20
8
2921
34537
Spirometry study
18759-1 [3000492]
18759-1 [3000492]
9.5e-01
2.0e+00
2.9e+00
—
1.9e+00
2.4e+00
2.2e+00
cases:3.97%
controls:1.57%
cases:3.27%
controls:0.46%
cases:1.11%
controls:0.06%
—
—
cases:0.30%
controls:0.04%
cases:5.39%
controls:0.49%
cases:11.53%
controls:1.36%
175
693
4233
43351
144
201
4265
43853
49
27
4360
44027
—
13
19
4328
43933
215
208
3777
42283
339
471
2602
34074
fenoterol and ipratropium bromide
R03AL01 [43534843]
R03AL01 [43534843]
1.6e+00
2.0e+00
1.8e+00
—
2.6e+00
2.3e+00
2.2e+00
cases:2.47%
controls:0.53%
cases:2.15%
controls:0.31%
cases:0.57%
controls:0.10%
—
—
cases:1.15%
controls:0.09%
cases:3.38%
controls:0.35%
cases:5.81%
controls:0.65%
109
233
4299
43811
95
137
4314
43917
25
42
4384
44012
—
50
38
4291
43914
135
147
3857
42344
171
224
2770
34321
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
4.5e-01
1.0e+00
2.2e+00
4.1e+00
2.3e+00
1.4e+00
1.1e+00
cases:9.71%
controls:6.41%
cases:7.14%
controls:2.71%
cases:3.15%
controls:0.37%
cases:0.68%
controls:0.01%
cases:3.25%
controls:0.34%
cases:10.77%
controls:2.98%
cases:22.92%
controls:9.38%
428
2824
3980
41220
315
1192
4094
42862
139
161
4270
43893
30
5
4379
44049
141
150
4200
43802
430
1267
3562
41224
674
3239
2267
31306
Outpatient Visit
OP [9202]
OP [9202]
6.6e-01
9.1e-01
1.1e+00
5.0e+00
1.7e+00
1.7e+00
1.4e+00
cases:85.73%
controls:75.68%
cases:76.19%
controls:56.37%
cases:28.51%
controls:11.31%
cases:42.30%
controls:0.49%
cases:38.79%
controls:10.84%
cases:87.68%
controls:56.11%
cases:94.97%
controls:82.70%
3779
33331
629
10713
3359
24835
1050
19219
1257
4983
3152
39071
1865
214
2544
43840
1684
4764
2657
39188
3500
23840
492
18651
2793
28567
148
5978
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.6e-01
1.1e+00
2.4e+00
3.6e+00
2.3e+00
1.5e+00
1.1e+00
cases:30.33%
controls:21.54%
cases:31.57%
controls:12.95%
cases:20.68%
controls:2.38%
cases:3.70%
controls:0.10%
cases:18.66%
controls:2.26%
cases:41.28%
controls:13.47%
cases:55.97%
controls:30.48%
1337
9488
3071
34556
1392
5704
3017
38350
912
1047
3497
43007
163
45
4246
44009
810
995
3531
42957
1648
5724
2344
36767
1646
10531
1295
24014
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
C91.1 [45600564]
1.8e+00
2.0e+00
2.8e+00
1.0e+50
2.7e+00
2.0e+00
1.1e+00
cases:0.86%
controls:0.14%
cases:0.84%
controls:0.11%
cases:0.54%
controls:0.03%
cases:0.45%
controls:0.00%
cases:0.44%
controls:0.03%
cases:0.80%
controls:0.11%
cases:0.61%
controls:0.21%
38
62
4370
43982
37
49
4372
44005
24
15
4385
44039
20
0
4389
44054
19
13
4322
43939
32
45
3960
42446
18
71
2923
34474
ipratropium bromide; inhalant
R03BB01 [21603293]
R03BB01 [21603293]
1.3e+00
2.0e+00
2.2e+00
—
2.6e+00
2.3e+00
2.2e+00
cases:1.18%
controls:0.34%
cases:1.11%
controls:0.15%
cases:0.36%
controls:0.04%
—
—
cases:0.44%
controls:0.03%
cases:1.35%
controls:0.14%
cases:2.89%
controls:0.34%
52
149
4356
43895
49
68
4360
43986
16
18
4393
44036
—
19
15
4322
43937
54
61
3938
42430
85
119
2856
34426
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
1.3e+00
2.3e+00
3.2e+00
—
2.6e+00
1.6e+00
1.4e+00
cases:6.90%
controls:1.89%
cases:4.97%
controls:0.55%
cases:2.13%
controls:0.09%
—
—
cases:1.08%
controls:0.08%
cases:3.11%
controls:0.62%
cases:9.38%
controls:2.59%
304
834
4104
43210
219
241
4190
43813
94
41
4315
44013
—
47
34
4294
43918
124
265
3868
42226
276
893
2665
33652
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
29591-5 [3016881]
2.3e+00
3.5e+00
—
1.0e+50
1.0e+50
3.1e+00
3.5e+00
cases:0.77%
controls:0.08%
cases:1.22%
controls:0.04%
—
—
cases:0.20%
controls:0.00%
cases:1.04%
controls:0.00%
cases:0.80%
controls:0.04%
cases:2.11%
controls:0.07%
34
34
4374
44010
54
16
4355
44038
—
9
0
4400
44054
45
0
4296
43952
32
16
3960
42475
62
23
2879
34522
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
5.8e-01
1.1e+00
2.1e+00
4.1e+00
2.2e+00
1.3e+00
9.6e-01
cases:18.47%
controls:11.26%
cases:17.71%
controls:6.42%
cases:7.89%
controls:1.03%
cases:3.08%
controls:0.05%
cases:8.48%
controls:1.05%
cases:21.57%
controls:6.68%
cases:37.23%
controls:18.48%
814
4959
3594
39085
781
2830
3628
41224
348
454
4061
43600
136
24
4273
44030
368
462
3973
43490
861
2840
3131
39651
1095
6383
1846
28162
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
1.1e+00
1.7e+00
2.2e+00
—
3.3e+00
2.3e+00
1.6e+00
cases:2.50%
controls:0.81%
cases:1.63%
controls:0.29%
cases:0.27%
controls:0.03%
—
—
cases:0.58%
controls:0.02%
cases:2.73%
controls:0.28%
cases:4.86%
controls:1.05%
110
358
4298
43686
72
127
4337
43927
12
13
4397
44041
—
25
9
4316
43943
109
118
3883
42373
143
361
2798
34184
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
8.2e-01
1.9e+00
2.9e+00
—
3.6e+00
1.8e+00
1.3e+00
cases:5.17%
controls:2.34%
cases:4.88%
controls:0.80%
cases:2.06%
controls:0.12%
—
—
cases:4.28%
controls:0.12%
cases:5.21%
controls:0.89%
cases:11.39%
controls:3.25%
228
1031
4180
43013
215
351
4194
43703
91
51
4318
44003
—
186
53
4155
43899
208
379
3784
42112
335
1124
2606
33421
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
1.5e+00
2.8e+00
—
1.0e+50
2.9e+00
2.6e+00
2.4e+00
cases:2.59%
controls:0.59%
cases:2.95%
controls:0.18%
—
—
cases:2.31%
controls:0.00%
cases:0.35%
controls:0.02%
cases:2.30%
controls:0.17%
cases:5.92%
controls:0.55%
114
260
4294
43784
130
80
4279
43974
—
102
0
4307
44054
15
8
4326
43944
92
71
3900
42420
174
190
2767
34355
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
7.0e-01
1.2e+00
2.1e+00
3.4e+00
2.3e+00
1.5e+00
1.1e+00
cases:11.75%
controls:6.21%
cases:10.39%
controls:3.47%
cases:4.83%
controls:0.60%
cases:0.77%
controls:0.02%
cases:5.32%
controls:0.56%
cases:14.08%
controls:3.61%
cases:25.94%
controls:10.30%
518
2735
3890
41309
458
1529
3951
42525
213
264
4196
43790
34
11
4375
44043
231
247
4110
43705
562
1532
3430
40959
763
3558
2178
30987
General Practice
1 [38004446]
1 [38004446]
7.4e-01
1.1e+00
2.1e+00
4.4e+00
1.8e+00
1.1e+00
8.9e-01
cases:23.59%
controls:12.81%
cases:15.40%
controls:5.53%
cases:6.49%
controls:0.81%
cases:2.43%
controls:0.03%
cases:5.28%
controls:0.89%
cases:16.53%
controls:6.00%
cases:34.41%
controls:17.68%
1040
5643
3368
38401
679
2437
3730
41617
286
356
4123
43698
107
13
4302
44041
229
390
4112
43562
660
2548
3332
39943
1012
6106
1929
28439
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
40988-8 [3044254]
1.1e+00
1.8e+00
3.6e+00
1.0e+50
2.8e+00
1.6e+00
1.3e+00
cases:1.11%
controls:0.36%
cases:1.32%
controls:0.22%
cases:0.59%
controls:0.02%
cases:0.43%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.88%
controls:0.18%
cases:2.82%
controls:0.76%
49
159
4359
43885
58
98
4351
43956
26
7
4383
44047
19
0
4390
44054
15
9
4326
43943
35
76
3957
42415
83
262
2858
34283
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
6.2e-01
1.9e+00
2.5e+00
—
3.4e+00
2.3e+00
1.6e+00
cases:1.61%
controls:0.87%
cases:1.63%
controls:0.26%
cases:0.48%
controls:0.04%
—
—
cases:0.94%
controls:0.03%
cases:2.05%
controls:0.20%
cases:3.71%
controls:0.76%
71
384
4337
43660
72
114
4337
43940
21
18
4388
44036
—
41
14
4300
43938
82
86
3910
42405
109
261
2832
34284
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
80223-1 [21494815]
2.2e+00
3.2e+00
—
—
1.0e+50
3.8e+00
3.1e+00
cases:0.75%
controls:0.09%
cases:0.75%
controls:0.03%
—
—
—
—
cases:0.44%
controls:0.00%
cases:1.35%
controls:0.03%
cases:2.38%
controls:0.11%
33
38
4375
44006
33
13
4376
44041
—
—
19
0
4322
43952
54
13
3938
42478
70
39
2871
34506
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
1.5e+00
2.3e+00
3.5e+00
1.0e+50
—
2.6e+00
2.4e+00
cases:1.45%
controls:0.34%
cases:1.43%
controls:0.15%
cases:0.70%
controls:0.02%
cases:0.48%
controls:0.00%
—
—
cases:1.55%
controls:0.12%
cases:3.37%
controls:0.30%
64
148
4344
43896
63
67
4346
43987
31
9
4378
44045
21
0
4388
44054
—
62
52
3930
42439
99
104
2842
34441
nintedanib; oral
L01EX09 [947759]
L01EX09 [947759]
-1.0e+50
—
—
—
2.9e+00
4.7e+00
4.6e+00
cases:0.00%
controls:0.02%
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:2.78%
controls:0.03%
cases:4.49%
controls:0.05%
0
8
4408
44036
—
—
—
15
8
4326
43944
111
11
3881
42480
132
16
2809
34529
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
1.4e+00
2.3e+00
3.5e+00
1.0e+50
—
2.6e+00
2.5e+00
cases:1.41%
controls:0.34%
cases:1.43%
controls:0.15%
cases:0.70%
controls:0.02%
cases:0.48%
controls:0.00%
—
—
cases:1.55%
controls:0.12%
cases:3.37%
controls:0.30%
62
148
4346
43896
63
67
4346
43987
31
9
4378
44045
21
0
4388
44054
—
62
52
3930
42439
99
102
2842
34443
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
1.4e+00
2.3e+00
3.5e+00
1.0e+50
—
2.6e+00
2.5e+00
cases:1.41%
controls:0.34%
cases:1.43%
controls:0.15%
cases:0.70%
controls:0.02%
cases:0.48%
controls:0.00%
—
—
cases:1.55%
controls:0.12%
cases:3.37%
controls:0.30%
62
148
4346
43896
63
67
4346
43987
31
9
4378
44045
21
0
4388
44054
—
62
52
3930
42439
99
103
2842
34442
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 [3032699]
49672-9 [3032699]
3.1e+00
—
—
1.0e+50
1.0e+50
4.4e+00
4.7e+00
cases:0.52%
controls:0.02%
—
—
—
—
cases:0.66%
controls:0.00%
cases:1.87%
controls:0.00%
cases:1.35%
controls:0.02%
cases:2.41%
controls:0.02%
23
10
4385
44034
—
—
29
0
4380
44054
81
0
4260
43952
54
7
3938
42484
71
8
2870
34537
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
DM1AA [2001301740]
2.1e+00
3.5e+00
1.0e+50
1.0e+50
1.0e+50
3.4e+00
3.3e+00
cases:1.11%
controls:0.14%
cases:0.75%
controls:0.02%
cases:0.20%
controls:0.00%
cases:0.29%
controls:0.00%
cases:0.21%
controls:0.00%
cases:0.80%
controls:0.03%
cases:2.45%
controls:0.10%
49
60
4359
43984
33
10
4376
44044
9
0
4400
44054
13
0
4396
44054
9
0
4332
43952
32
12
3960
42479
72
33
2869
34512
Diffusion capacity of lung
54715006 [4182985]
54715006 [4182985]
1.8e+00
2.9e+00
—
1.0e+50
1.0e+50
4.2e+00
3.4e+00
cases:1.34%
controls:0.23%
cases:1.43%
controls:0.08%
—
—
cases:2.36%
controls:0.00%
cases:0.65%
controls:0.00%
cases:5.86%
controls:0.10%
cases:7.07%
controls:0.26%
59
101
4349
43943
63
36
4346
44018
—
104
0
4305
44054
28
0
4313
43952
234
41
3758
42450
208
89
2733
34456
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
2.1e+00
3.2e+00
—
1.0e+50
—
3.3e+00
3.5e+00
cases:1.50%
controls:0.19%
cases:1.16%
controls:0.05%
—
—
cases:0.57%
controls:0.00%
—
—
cases:1.33%
controls:0.05%
cases:4.22%
controls:0.13%
66
85
4342
43959
51
20
4358
44034
—
25
0
4384
44054
—
53
21
3939
42470
124
44
2817
34501
Congestive heart failure
I50.0 [45567179]
I50.0 [45567179]
1.2e+00
1.9e+00
2.8e+00
—
2.7e+00
2.0e+00
1.5e+00
cases:2.09%
controls:0.62%
cases:2.38%
controls:0.37%
cases:1.11%
controls:0.07%
—
—
cases:0.99%
controls:0.07%
cases:3.28%
controls:0.45%
cases:5.61%
controls:1.29%
92
274
4316
43770
105
163
4304
43891
49
31
4360
44023
—
43
29
4298
43923
131
190
3861
42301
165
444
2776
34101
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
7.8e-01
1.4e+00
2.4e+00
—
3.0e+00
2.6e+00
2.0e+00
cases:3.40%
controls:1.59%
cases:2.18%
controls:0.54%
cases:0.84%
controls:0.08%
—
—
cases:1.17%
controls:0.06%
cases:4.86%
controls:0.38%
cases:7.72%
controls:1.11%
150
702
4258
43342
96
239
4313
43815
37
35
4372
44019
—
51
27
4290
43925
194
160
3798
42331
227
385
2714
34160
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
1.7e+00
2.0e+00
2.2e+00
1.0e+50
2.8e+00
2.0e+00
1.5e+00
cases:1.79%
controls:0.34%
cases:0.93%
controls:0.13%
cases:0.20%
controls:0.02%
cases:0.14%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.75%
controls:0.11%
cases:1.73%
controls:0.39%
79
150
4329
43894
41
58
4368
43996
9
10
4400
44044
6
0
4403
44054
8
5
4333
43947
30
45
3962
42446
51
134
2890
34411
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
2518-9 [3018405]
6.9e-01
1.8e+00
3.2e+00
1.0e+50
3.1e+00
2.1e+00
1.2e+00
cases:1.13%
controls:0.57%
cases:1.11%
controls:0.19%
cases:0.66%
controls:0.03%
cases:0.91%
controls:0.00%
cases:0.71%
controls:0.03%
cases:1.65%
controls:0.20%
cases:2.99%
controls:0.91%
50
252
4358
43792
49
85
4360
43969
29
12
4380
44042
40
0
4369
44054
31
14
4310
43938
66
85
3926
42406
88
314
2853
34231
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
1.4e+00
2.2e+00
3.1e+00
—
—
3.1e+00
2.3e+00
cases:0.95%
controls:0.24%
cases:0.79%
controls:0.09%
cases:0.25%
controls:0.01%
—
—
—
—
cases:1.38%
controls:0.07%
cases:2.69%
controls:0.28%
42
106
4366
43938
35
38
4374
44016
11
5
4398
44049
—
—
55
28
3937
42463
79
95
2862
34450
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
203 [2001600201]
1.0e+00
1.3e+00
2.6e+00
—
3.5e+00
2.4e+00
1.2e+00
cases:3.22%
controls:1.15%
cases:0.98%
controls:0.28%
cases:0.27%
controls:0.02%
—
—
cases:0.39%
controls:0.01%
cases:2.33%
controls:0.22%
cases:3.06%
controls:0.92%
142
508
4266
43536
43
122
4366
43932
12
9
4397
44045
—
17
5
4324
43947
93
95
3899
42396
90
319
2851
34226
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
1.4e+00
2.2e+00
3.1e+00
—
—
3.0e+00
2.3e+00
cases:0.93%
controls:0.24%
cases:0.79%
controls:0.09%
cases:0.25%
controls:0.01%
—
—
—
—
cases:1.43%
controls:0.07%
cases:2.75%
controls:0.28%
41
105
4367
43939
35
39
4374
44015
11
5
4398
44049
—
—
57
30
3935
42461
81
95
2860
34450
leflunomide; oral
L04AK01 [955035]
L04AK01 [955035]
2.4e+00
2.4e+00
1.9e+00
—
—
2.6e+00
2.7e+00
cases:1.68%
controls:0.15%
cases:1.11%
controls:0.10%
cases:0.27%
controls:0.04%
—
—
—
—
cases:1.30%
controls:0.10%
cases:2.18%
controls:0.15%
74
68
4334
43976
49
43
4360
44011
12
18
4397
44036
—
—
52
43
3940
42448
64
52
2877
34493
Other specified pleural conditions
J94.8 [45567278]
J94.8 [45567278]
1.8e+00
2.8e+00
—
1.0e+50
2.7e+00
2.5e+00
2.2e+00
cases:0.29%
controls:0.05%
cases:0.36%
controls:0.02%
—
—
cases:0.32%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.48%
controls:0.04%
cases:0.85%
controls:0.10%
13
21
4395
44023
16
10
4393
44044
—
14
0
4395
44054
9
6
4332
43946
19
17
3973
42474
25
33
2916
34512
Immunoglobulin typing, IgG
1712009 [4062490]
1712009 [4062490]
2.0e+00
3.3e+00
—
—
—
3.8e+00
2.9e+00
cases:0.66%
controls:0.09%
cases:0.95%
controls:0.04%
—
—
—
—
—
—
cases:1.23%
controls:0.03%
cases:1.73%
controls:0.09%
29
40
4379
44004
42
16
4367
44038
—
—
—
49
12
3943
42479
51
32
2890
34513
IgG subclass 1 [Mass/volume] in Serum
2466-1 [3027135]
2466-1 [3027135]
2.0e+00
3.3e+00
—
—
—
3.8e+00
2.9e+00
cases:0.68%
controls:0.09%
cases:0.95%
controls:0.04%
—
—
—
—
—
—
cases:1.23%
controls:0.03%
cases:1.77%
controls:0.10%
30
40
4378
44004
42
16
4367
44038
—
—
—
49
12
3943
42479
52
34
2889
34511
IgG subclass 3 [Mass/volume] in Serum
2468-7 [3024139]
2468-7 [3024139]
2.0e+00
3.3e+00
—
—
—
3.8e+00
2.9e+00
cases:0.68%
controls:0.09%
cases:0.95%
controls:0.04%
—
—
—
—
—
—
cases:1.23%
controls:0.03%
cases:1.77%
controls:0.10%
30
40
4378
44004
42
16
4367
44038
—
—
—
49
12
3943
42479
52
34
2889
34511
IgG subclass 2 [Mass/volume] in Serum
2467-9 [3028192]
2467-9 [3028192]
2.0e+00
3.3e+00
—
—
—
3.8e+00
2.9e+00
cases:0.68%
controls:0.09%
cases:0.95%
controls:0.04%
—
—
—
—
—
—
cases:1.23%
controls:0.03%
cases:1.77%
controls:0.10%
30
40
4378
44004
42
16
4367
44038
—
—
—
49
12
3943
42479
52
34
2889
34511
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
5.0e-01
8.1e-01
1.5e+00
5.2e+00
1.7e+00
1.2e+00
1.1e+00
cases:7.55%
controls:4.74%
cases:6.40%
controls:2.95%
cases:2.49%
controls:0.55%
cases:3.45%
controls:0.02%
cases:2.76%
controls:0.52%
cases:9.27%
controls:3.01%
cases:15.16%
controls:5.74%
333
2086
4075
41958
282
1300
4127
42754
110
243
4299
43811
152
9
4257
44045
120
227
4221
43725
370
1280
3622
41211
446
1984
2495
32561
B-cell lymphoma in marginal zone
C83.80 [2000501237]
C83.80 [2000501237]
1.5e+00
1.7e+00
2.0e+00
—
2.7e+00
2.1e+00
2.0e+00
cases:0.23%
controls:0.05%
cases:0.23%
controls:0.04%
cases:0.14%
controls:0.02%
—
—
cases:0.16%
controls:0.01%
cases:0.30%
controls:0.04%
cases:0.37%
controls:0.05%
10
22
4398
44022
10
18
4399
44036
6
8
4403
44046
—
7
5
4334
43947
12
16
3980
42475
11
18
2930
34527
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
1.4e+00
2.3e+00
2.8e+00
—
—
3.1e+00
2.4e+00
cases:0.82%
controls:0.21%
cases:0.73%
controls:0.07%
cases:0.23%
controls:0.01%
—
—
—
—
cases:1.33%
controls:0.06%
cases:2.58%
controls:0.25%
36
92
4372
43952
32
33
4377
44021
10
6
4399
44048
—
—
53
26
3939
42465
76
87
2865
34458
Glucose [Moles/volume] in Pleural fluid
14747-0 [3036782]
14747-0 [3036782]
2.5e+00
2.0e+00
2.9e+00
1.0e+50
—
2.5e+00
2.0e+00
cases:0.48%
controls:0.04%
cases:0.34%
controls:0.05%
cases:0.20%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
cases:0.48%
controls:0.04%
cases:1.26%
controls:0.17%
21
18
4387
44026
15
20
4394
44034
9
5
4400
44049
5
0
4404
44054
—
19
17
3973
42474
37
57
2904
34488
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
9.4e-01
2.0e+00
3.2e+00
1.0e+50
2.9e+00
1.7e+00
1.2e+00
cases:1.36%
controls:0.54%
cases:1.86%
controls:0.26%
cases:0.98%
controls:0.04%
cases:0.86%
controls:0.00%
cases:0.44%
controls:0.03%
cases:1.60%
controls:0.28%
cases:4.25%
controls:1.33%
60
236
4348
43808
82
116
4327
43938
43
18
4366
44036
38
0
4371
44054
19
11
4322
43941
64
121
3928
42370
125
461
2816
34084
formoterol and beclometasone
R03AK08 [43534839]
R03AK08 [43534839]
1.4e+00
1.9e+00
2.1e+00
—
2.1e+00
2.2e+00
2.2e+00
cases:1.88%
controls:0.45%
cases:2.65%
controls:0.40%
cases:1.13%
controls:0.15%
—
—
cases:1.29%
controls:0.17%
cases:4.06%
controls:0.47%
cases:6.80%
controls:0.79%
83
199
4325
43845
117
177
4292
43877
50
64
4359
43990
—
56
73
4285
43879
162
201
3830
42290
200
273
2741
34272
Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6025-1 [3011951]
6025-1 [3011951]
2.3e+00
2.7e+00
—
—
1.0e+50
3.6e+00
3.2e+00
cases:0.29%
controls:0.03%
cases:0.39%
controls:0.02%
—
—
—
—
cases:0.39%
controls:0.00%
cases:0.70%
controls:0.02%
cases:0.99%
controls:0.04%
13
13
4395
44031
17
11
4392
44043
—
—
17
0
4324
43952
28
8
3964
42483
29
14
2912
34531
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
88518-6 [36304997]
1.3e+00
2.7e+00
3.3e+00
—
—
2.6e+00
1.8e+00
cases:1.25%
controls:0.33%
cases:1.75%
controls:0.12%
cases:0.57%
controls:0.02%
—
—
—
—
cases:1.50%
controls:0.11%
cases:2.75%
controls:0.47%
55
147
4353
43897
77
52
4332
44002
25
9
4384
44045
—
—
60
46
3932
42445
81
161
2860
34384
Wegener granulomatosis
M31.3 [45591818]
M31.3 [45591818]
2.4e+00
2.9e+00
1.0e+50
—
—
3.4e+00
3.1e+00
cases:0.23%
controls:0.02%
cases:0.36%
controls:0.02%
cases:0.25%
controls:0.00%
—
—
—
—
cases:0.50%
controls:0.02%
cases:0.68%
controls:0.03%
10
9
4398
44035
16
9
4393
44045
11
0
4398
44054
—
—
20
7
3972
42484
20
11
2921
34534
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
6.7e-01
1.8e+00
3.5e+00
—
3.0e+00
1.7e+00
1.2e+00
cases:1.11%
controls:0.57%
cases:1.75%
controls:0.30%
cases:0.95%
controls:0.03%
—
—
cases:0.74%
controls:0.04%
cases:1.83%
controls:0.34%
cases:4.11%
controls:1.31%
49
252
4359
43792
77
131
4332
43923
42
13
4367
44041
—
32
17
4309
43935
73
144
3919
42347
121
451
2820
34094
nystatin; oral
A07AA02 [21600604]
A07AA02 [21600604]
1.0e+00
1.9e+00
2.2e+00
—
2.7e+00
1.9e+00
2.0e+00
cases:2.22%
controls:0.80%
cases:1.56%
controls:0.24%
cases:0.32%
controls:0.04%
—
—
cases:0.74%
controls:0.05%
cases:2.08%
controls:0.30%
cases:5.64%
controls:0.84%
98
352
4310
43692
69
104
4340
43950
14
16
4395
44038
—
32
21
4309
43931
83
129
3909
42362
166
291
2775
34254
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
3.3e-01
9.0e-01
2.2e+00
3.7e+00
2.5e+00
1.3e+00
8.6e-01
cases:8.76%
controls:6.43%
cases:6.03%
controls:2.55%
cases:2.77%
controls:0.31%
cases:0.61%
controls:0.02%
cases:2.95%
controls:0.25%
cases:8.84%
controls:2.65%
cases:19.59%
controls:9.35%
386
2831
4022
41213
266
1124
4143
42930
122
136
4287
43918
27
7
4382
44047
128
111
4213
43841
353
1124
3639
41367
576
3229
2365
31316
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
5.3e-01
9.9e-01
2.1e+00
4.4e+00
2.0e+00
1.1e+00
6.3e-01
cases:9.80%
controls:5.99%
cases:7.53%
controls:2.92%
cases:3.24%
controls:0.40%
cases:1.43%
controls:0.02%
cases:2.95%
controls:0.43%
cases:9.02%
controls:3.18%
cases:16.35%
controls:9.47%
432
2639
3976
41405
332
1288
4077
42766
143
176
4266
43878
63
8
4346
44046
128
187
4213
43765
360
1353
3632
41138
481
3271
2460
31274
Body temperature
8310-5 [3020891]
8310-5 [3020891]
8.3e-01
1.7e+00
2.7e+00
1.0e+50
3.5e+00
1.9e+00
1.1e+00
cases:1.54%
controls:0.68%
cases:1.52%
controls:0.29%
cases:0.73%
controls:0.05%
cases:1.11%
controls:0.00%
cases:1.43%
controls:0.05%
cases:2.15%
controls:0.33%
cases:3.84%
controls:1.28%
68
298
4340
43746
67
128
4342
43926
32
21
4377
44033
49
0
4360
44054
62
20
4279
43932
86
141
3906
42350
113
442
2828
34103
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
1.1e+00
1.6e+00
2.1e+00
—
3.2e+00
2.1e+00
1.5e+00
cases:3.90%
controls:1.30%
cases:2.45%
controls:0.48%
cases:0.43%
controls:0.05%
—
—
cases:0.97%
controls:0.04%
cases:3.56%
controls:0.44%
cases:6.29%
controls:1.54%
172
573
4236
43471
108
213
4301
43841
19
23
4390
44031
—
42
17
4299
43935
142
185
3850
42306
185
531
2756
34014
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
R03AL09 [1502099]
1.4e+00
1.8e+00
1.8e+00
—
2.2e+00
2.2e+00
2.3e+00
cases:0.48%
controls:0.11%
cases:0.86%
controls:0.14%
cases:0.32%
controls:0.05%
—
—
cases:0.51%
controls:0.05%
cases:1.48%
controls:0.17%
cases:2.99%
controls:0.32%
21
50
4387
43994
38
63
4371
43991
14
23
4395
44031
—
22
24
4319
43928
59
74
3933
42417
88
110
2853
34435
Microbial culture of sputum
104173009 [4015189]
104173009 [4015189]
1.8e+00
3.7e+00
1.0e+50
—
1.0e+50
2.9e+00
3.3e+00
cases:0.25%
controls:0.04%
cases:0.48%
controls:0.01%
cases:0.16%
controls:0.00%
—
—
cases:0.18%
controls:0.00%
cases:0.30%
controls:0.02%
cases:0.68%
controls:0.03%
11
19
4397
44025
21
5
4388
44049
7
0
4402
44054
—
8
0
4333
43952
12
7
3980
42484
20
9
2921
34536
Emphysema, unspecified
J43.9 [45567264]
J43.9 [45567264]
2.1e+00
2.8e+00
—
1.0e+50
—
3.8e+00
3.0e+00
cases:0.61%
controls:0.08%
cases:0.57%
controls:0.04%
—
—
cases:1.36%
controls:0.00%
—
—
cases:2.20%
controls:0.05%
cases:2.65%
controls:0.13%
27
34
4381
44010
25
16
4384
44038
—
60
0
4349
44054
—
88
21
3904
42470
78
46
2863
34499
hydroxychloroquine; oral
P01BA02 [21604889]
P01BA02 [21604889]
1.7e+00
1.9e+00
2.0e+00
—
1.9e+00
2.1e+00
2.1e+00
cases:5.85%
controls:1.09%
cases:5.01%
controls:0.81%
cases:1.52%
controls:0.21%
—
—
cases:1.27%
controls:0.19%
cases:6.26%
controls:0.82%
cases:8.47%
controls:1.14%
258
482
4150
43562
221
357
4188
43697
67
92
4342
43962
—
55
85
4286
43867
250
348
3742
42143
249
395
2692
34150
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
6.1e-01
9.5e-01
1.6e+00
5.2e+00
1.6e+00
1.1e+00
6.9e-01
cases:12.57%
controls:7.26%
cases:9.00%
controls:3.70%
cases:2.74%
controls:0.59%
cases:4.08%
controls:0.02%
cases:3.09%
controls:0.66%
cases:10.65%
controls:3.98%
cases:17.31%
controls:9.50%
554
3196
3854
40848
397
1630
4012
42424
121
262
4288
43792
180
10
4229
44044
134
292
4207
43660
425
1691
3567
40800
509
3283
2432
31262
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
6.2e-01
1.8e+00
3.3e+00
—
2.9e+00
1.8e+00
1.2e+00
cases:1.07%
controls:0.58%
cases:1.75%
controls:0.30%
cases:0.95%
controls:0.03%
—
—
cases:0.74%
controls:0.04%
cases:2.10%
controls:0.36%
cases:4.45%
controls:1.38%
47
254
4361
43790
77
134
4332
43920
42
15
4367
44039
—
32
18
4309
43934
84
151
3908
42340
131
477
2810
34068
Chronic obstructive pulmonary disease, unspecified
J44.9 [45548115]
J44.9 [45548115]
1.6e+00
1.8e+00
2.7e+00
—
2.0e+00
2.0e+00
1.5e+00
cases:1.54%
controls:0.32%
cases:0.98%
controls:0.17%
cases:0.39%
controls:0.02%
—
—
cases:0.30%
controls:0.04%
cases:1.40%
controls:0.19%
cases:2.31%
controls:0.53%
68
143
4340
43901
43
75
4366
43979
17
11
4392
44043
—
13
18
4328
43934
56
79
3936
42412
68
183
2873
34362
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
1.1e+00
1.5e+00
2.7e+00
—
3.4e+00
1.7e+00
1.1e+00
cases:2.16%
controls:0.71%
cases:1.72%
controls:0.39%
cases:0.64%
controls:0.04%
—
—
cases:0.78%
controls:0.03%
cases:1.83%
controls:0.34%
cases:3.91%
controls:1.30%
95
312
4313
43732
76
172
4333
43882
28
18
4381
44036
—
34
12
4307
43940
73
146
3919
42345
115
448
2826
34097
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
14135-8 [3001405]
2.2e+00
3.3e+00
1.0e+50
—
—
3.0e+00
3.1e+00
cases:0.57%
controls:0.07%
cases:0.61%
controls:0.02%
cases:0.20%
controls:0.00%
—
—
—
—
cases:0.63%
controls:0.03%
cases:1.22%
controls:0.06%
25
29
4383
44015
27
10
4382
44044
9
0
4400
44054
—
—
25
13
3967
42478
36
20
2905
34525
Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29910-7 [3006262]
29910-7 [3006262]
2.8e+00
3.7e+00
—
—
1.0e+50
1.8e+00
3.2e+00
cases:0.54%
controls:0.03%
cases:0.82%
controls:0.02%
—
—
—
—
cases:0.39%
controls:0.00%
cases:0.18%
controls:0.03%
cases:1.02%
controls:0.04%
24
15
4384
44029
36
9
4373
44045
—
—
17
0
4324
43952
7
12
3985
42479
30
14
2911
34531
Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29909-9 [3012158]
29909-9 [3012158]
2.8e+00
3.7e+00
—
—
1.0e+50
1.8e+00
3.2e+00
cases:0.54%
controls:0.03%
cases:0.82%
controls:0.02%
—
—
—
—
cases:0.39%
controls:0.00%
cases:0.18%
controls:0.03%
cases:1.02%
controls:0.04%
24
15
4384
44029
36
9
4373
44045
—
—
17
0
4324
43952
7
12
3985
42479
30
14
2911
34531
Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29908-1 [3025634]
29908-1 [3025634]
2.8e+00
3.7e+00
—
—
1.0e+50
1.8e+00
3.2e+00
cases:0.54%
controls:0.03%
cases:0.82%
controls:0.02%
—
—
—
—
cases:0.39%
controls:0.00%
cases:0.18%
controls:0.03%
cases:1.02%
controls:0.04%
24
15
4384
44029
36
9
4373
44045
—
—
17
0
4324
43952
7
12
3985
42479
30
14
2911
34531
vilanterol, umeclidinium bromide and fluticasone furoate
R03AL08 [1501769]
R03AL08 [1501769]
1.7e+00
2.1e+00
2.1e+00
—
2.1e+00
2.0e+00
1.5e+00
cases:0.50%
controls:0.09%
cases:0.64%
controls:0.08%
cases:0.27%
controls:0.03%
—
—
cases:0.21%
controls:0.03%
cases:0.70%
controls:0.09%
cases:0.95%
controls:0.22%
22
41
4386
44003
28
36
4381
44018
12
14
4397
44040
—
9
11
4332
43941
28
39
3964
42452
28
75
2913
34470
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
8.7e-01
1.9e+00
2.7e+00
1.0e+50
3.2e+00
1.6e+00
1.3e+00
cases:0.52%
controls:0.22%
cases:0.75%
controls:0.12%
cases:0.20%
controls:0.01%
cases:0.29%
controls:0.00%
cases:0.28%
controls:0.01%
cases:0.60%
controls:0.13%
cases:1.87%
controls:0.50%
23
97
4385
43947
33
51
4376
44003
9
6
4400
44048
13
0
4396
44054
12
5
4329
43947
24
54
3968
42437
55
173
2886
34372
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
7.3e-01
1.3e+00
2.4e+00
1.0e+50
3.0e+00
2.4e+00
1.6e+00
cases:2.38%
controls:1.16%
cases:2.11%
controls:0.56%
cases:0.82%
controls:0.07%
cases:0.11%
controls:0.00%
cases:0.99%
controls:0.05%
cases:5.54%
controls:0.55%
cases:8.84%
controls:1.84%
105
511
4303
43533
93
245
4316
43809
36
32
4373
44022
5
0
4404
44054
43
22
4298
43930
221
234
3771
42257
260
634
2681
33911
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
5.3e-01
8.9e-01
2.0e+00
4.2e+00
2.1e+00
9.9e-01
8.0e-01
cases:4.61%
controls:2.75%
cases:4.35%
controls:1.84%
cases:2.06%
controls:0.27%
cases:0.88%
controls:0.01%
cases:2.10%
controls:0.27%
cases:5.29%
controls:2.03%
cases:13.12%
controls:6.37%
203
1213
4205
42831
192
809
4217
43245
91
121
4318
43933
39
6
4370
44048
91
119
4250
43833
211
861
3781
41630
386
2201
2555
32344
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
351
348
10.85
315.63
1.6
1.1
—
—
—
0
0
351
348
10.85
315.63
1.6
1.1
—
—
—
0
0
236
114
21.79
315.33
4.3
3.1
—
—
—
0
0
610
1167
5.89
309.41
5.0
2.4
25.37
24.27
mmol/l
7.68
595
1148
324
224
15.51
307.65
2.1
1.3
—
—
—
0
0
395
173
24.93
307.65
1.1
1.1
—
—
—
0
0
333
90
39.87
307.65
2.1
1.2
—
—
—
0
0
1161
1359
11.16
307.65
1.9
1.4
18.06
14.28
iu/ml
0.19
34
26
1240
971
17.24
307.65
3.3
2.2
—
—
—
0
0
546
828
7.37
307.65
1.4
1.2
9.63
3.00
u/ml
0.82
67
77
809
90
109.35
307.65
2.1
1.3
—
—
—
0
0
3343
16326
5.06
307.65
15.1
5.4
61.59
57.42
%
68.18
3307
15418
3381
16678
5.12
307.65
15.7
5.5
23.54
27.21
%
64.97
3337
15586
230
53
45.68
307.65
1.4
1.2
—
—
—
0
0
3365
16380
5.17
307.65
15.8
5.5
0.60
0.69
%
17.51
3316
15122
3529
17947
5.46
307.65
14.9
5.2
0.04
0.04
e9/l
2.89
3261
14951
330
85
41.81
307.65
2.1
1.2
—
—
—
0
0
438
394
12.21
307.65
5.4
2.1
612.15
1284.35
u/ml
0.52
40
26
906
321
35.08
307.65
2.1
1.1
—
—
—
0
0
1558
4401
4.88
307.65
10.7
6.4
1.48
0.58
mmol/l
13.06
1355
3554
492
609
8.95
307.65
1.4
1.2
307.70
244.15
titre
0.26
61
53
1580
4439
4.94
307.65
10.7
6.5
5.03
5.05
kpa
0.28
1532
4270
1650
5841
3.88
307.65
1.4
1.3
56.58
35.17
iu/ml
3.84
582
1690
350
100
37.86
307.65
2.1
1.1
—
—
—
0
0
794
1216
7.71
307.65
2.1
1.5
6.82
7.16
iu/ml
0.10
171
281
1339
4062
4.27
307.65
11.5
6.6
93.55
96.01
%
28.14
1293
3917
3556
20459
4.50
307.65
19.4
8.0
4.90
4.10
e9/l
64.86
3325
17313
1009
481
26.74
307.65
2.4
1.2
—
—
—
0
0
1559
5406
3.88
307.65
1.4
1.3
29.81
12.26
u/ml
2.87
495
1966
757
334
27.04
307.65
1.9
1.1
—
—
—
0
0
713
1115
7.41
307.65
1.3
1.2
1.95
0.68
u/ml
1.05
59
88
1003
379
33.76
307.65
2.1
1.2
—
—
—
0
0
493
610
8.95
307.65
1.4
1.2
217.14
53.33
titre
—
21
6
3533
18255
5.34
307.65
15.2
5.3
1.89
1.88
e9/l
0.04
3299
15552
689
908
8.78
307.65
2.0
1.3
12.52
16.29
iu/ml
0.35
33
13
636
209
35.27
307.65
2.6
1.2
—
—
—
0
0
632
497
14.63
307.65
12.0
3.9
1370.61
414.00
iu/ml
0.49
150
56
1011
464
27.80
307.65
2.4
1.2
—
—
—
0
0
557
854
7.30
307.65
1.9
1.4
0.23
0.24
g/l
1.36
535
812
3376
16351
5.25
307.65
15.6
5.4
2.58
2.95
%
19.43
3327
15097
509
514
11.04
307.65
1.6
1.3
19.11
10.92
u/ml
—
19
10
779
1580
5.75
307.65
1.7
1.2
226.47
221.44
u/ml
0.05
734
1445
1851
3469
8.36
307.65
2.9
1.5
—
—
—
0
0
956
601
19.92
307.65
2.0
1.4
—
—
—
0
0
951
1737
6.67
307.65
2.4
1.9
1.06
1.41
g/l
5.41
896
1560
1936
3730
8.35
307.65
2.8
1.5
—
—
—
0
0
1578
4437
4.93
307.65
10.7
6.5
10.13
12.88
kpa
97.38
1529
4263
798
1218
7.75
307.65
2.5
1.7
1.99
2.85
ug/l
0.54
729
1051
745
300
29.56
307.65
2.4
1.2
—
—
—
0
0
470
333
15.64
307.65
1.2
1.1
—
—
—
0
0
704
245
33.87
307.65
1.9
1.2
—
—
—
0
0
773
766
11.97
307.65
1.4
1.2
59.23
11.00
u/ml
—
16
5
319
200
17.09
307.65
2.1
1.3
—
—
—
0
0
410
222
20.22
307.65
3.6
3.2
—
—
—
0
0
610
202
34.77
307.65
2.4
1.1
—
—
—
0
0
3526
17853
5.49
307.65
14.9
5.2
0.68
0.60
e9/l
37.28
3258
14861
560
889
7.05
307.65
1.9
1.4
1.20
1.18
g/l
0.40
542
846
541
835
7.23
307.65
1.4
1.2
11.13
7.27
u/ml
0.58
100
131
1219
2196
7.24
307.65
4.9
2.3
10.18
10.93
g/l
4.89
1179
1987
1874
4189
6.95
307.65
1.6
1.3
547.71
482.83
titre
0.78
547
904
904
2236
4.81
307.65
12.6
8.3
24.76
23.94
mmol/l
9.71
884
2184
552
877
7.03
307.65
1.4
1.2
38.30
48.41
u/ml
0.23
25
43
3559
18493
5.40
307.65
15.9
5.4
0.20
0.20
e9/l
0.64
3324
15617
610
817
8.48
307.65
2.9
1.9
127.25
128.26
g/l
0.29
332
620
326
35
100.33
307.65
1.9
1.0
—
—
—
0
0
357
130
29.74
307.65
2.2
1.2
—
—
—
0
0
928
2294
4.84
307.65
6.7
3.1
5.14
5.08
kpa
1.20
900
2166
510
705
8.03
307.65
1.3
1.2
14.42
2.27
u/ml
1.39
44
50
2297
5111
8.13
307.65
3.1
1.6
—
—
—
0
0
820
1926
4.98
307.65
6.3
2.9
2.41
1.32
mmol/l
11.70
658
1348
455
652
7.65
305.67
4.9
2.3
88.51
89.77
%
2.56
446
634
499
796
6.93
303.74
5.8
2.8
7.66
8.22
kpa
9.87
488
777
649
1339
5.49
302.95
1.9
1.8
37.96
39.38
u/l
0.83
598
1145
274
200
14.52
298.79
2.3
2.2
1014.09
1039.63
e6/l
0.16
249
175
2549
13351
3.09
297.72
4.8
3.0
1945.28
1482.76
ng/l
4.21
2332
11617
254
164
16.35
296.06
1.7
1.2
—
—
—
0
0
254
164
16.35
296.06
1.7
1.2
—
—
—
0
0
254
164
16.35
296.06
1.7
1.2
—
—
—
0
0
918
2581
4.21
291.96
2.2
1.4
—
—
—
0
0
3281
19991
3.36
290.51
11.8
5.9
11.08
13.00
umol/l
13.52
3206
18989
1128
3774
3.65
278.22
13.1
7.1
121.81
120.55
g/l
1.12
1105
3686
188
74
26.47
271.76
2.1
1.4
47522.03
78767.50
u/ml
—
31
6
275
237
12.29
271.09
1.4
1.4
2.78
3.17
g/l
1.97
196
169
275
237
12.29
271.09
1.4
1.4
7.37
6.89
g/l
0.60
195
166
275
237
12.29
271.09
1.4
1.4
0.45
0.47
g/l
0.27
193
170
228
144
16.62
268.60
2.3
2.2
—
—
—
0
0
226
141
16.82
267.91
2.1
2.2
16.24
18.13
%
0.86
221
134
141
17
85.59
267.07
2.9
1.1
—
—
—
0
0
424
653
7.06
266.01
4.1
2.0
15.58
16.47
%
5.24
418
640
3018
18150
3.01
260.56
12.4
5.6
1.20
1.21
mmol/l
15.80
2902
16584
350
447
8.41
258.81
1.8
1.7
0.81
0.91
g/l
0.58
261
350
844
2430
4.04
257.68
2.0
1.5
—
—
—
0
0
197
102
20.15
255.09
1.1
1.0
—
—
—
0
0
921
2866
3.78
251.06
2.3
2.3
343.76
389.57
nmol/l
6.07
877
2633
1623
7141
2.99
249.99
2.7
1.6
1.62
1.44
mg/l
0.85
1381
5519
767
2124
4.15
246.48
2.2
1.5
—
—
—
0
0
1464
6134
3.05
245.53
7.4
2.8
0.81
0.82
mmol/l
4.62
1381
5728
305
352
9.22
244.45
1.2
1.1
53.77
47.13
u/ml
0.11
13
15
3203
20332
2.99
241.85
13.7
6.2
1.20
1.21
mmol/l
11.71
2804
17385
443
789
6.12
240.51
2.0
2.0
12.09
11.42
mg/l
0.68
415
726
802
2385
3.87
232.38
14.1
6.9
25.12
24.52
mmol/l
3.59
792
2368
1021
3587
3.39
229.13
12.3
6.0
11.04
10.57
mmol/l
1.12
983
3399
338
513
7.04
214.18
1.4
1.3
39.15
11.48
u/ml
—
8
9
188
133
14.71
208.09
2.3
2.2
103.93
91.38
e6/l
0.44
183
127
432
858
5.46
208.07
1.6
1.5
10.72
11.10
iu/ml
0.01
88
162
1373
6008
2.85
207.42
2.1
1.4
2.79
2.61
g/l
1.93
1031
3362
1204
4961
2.95
202.86
8.9
5.0
1.05
1.03
mmol/l
2.10
1131
4586
308
448
7.31
202.80
1.4
1.4
155.51
162.65
au/ml
0.38
83
141
306
442
7.35
202.76
1.2
1.1
39.83
7.50
u/ml
0.95
12
22
355
610
6.23
199.20
1.4
1.2
58.88
46.62
u/ml
0.49
52
59
2996
19418
2.62
197.95
20.8
16.9
1.32
1.33
inr
0.49
2636
16132
1145
4652
2.96
197.30
5.2
3.9
269.50
241.89
u/l
6.41
1099
4365
2629
16075
2.53
195.95
26.8
10.6
0.00
0.00
e9/l
0.65
2281
13002
2055
11248
2.52
194.41
5.5
3.2
0.37
0.43
e6/l
0.73
1673
8250
757
2424
3.55
194.33
9.0
5.7
25.05
24.22
mmol/l
6.11
733
2317
2837
18027
2.55
193.67
7.8
4.6
33.07
35.41
g/l
78.99
2687
16767
268
352
8.03
192.88
1.4
1.2
60.07
58.50
u/ml
0.02
21
18
2271
13072
2.49
191.78
5.7
3.4
96.59
100.29
e6/l
0.02
1887
9957
1760
9005
2.57
191.70
4.2
2.6
4.75
4.50
e6/l
0.32
1655
8132
360
655
5.89
190.29
7.4
3.1
2.87
2.58
mmol/l
0.97
278
402
360
655
5.89
190.29
7.4
3.1
5.02
4.89
kpa
1.92
351
637
1469
6920
2.67
189.42
3.2
2.5
11.04
12.87
umol/l
20.57
1385
6378
1334
5994
2.74
188.94
3.2
2.5
20.41
22.54
%
6.58
1258
5509
1399
6468
2.69
186.94
3.2
2.5
2.20
2.29
g/l
6.26
1307
5910
920
3426
3.12
183.80
13.2
6.4
1.46
1.34
mmol/l
1.98
899
3361
594
1695
3.88
180.32
1.7
1.3
—
—
—
0
0
2403
14522
2.40
177.50
7.1
3.9
81.82
113.54
e6/l
0.80
1928
10303
409
891
4.95
176.49
3.5
2.4
3.91
3.42
g/l
7.04
398
847
170
137
12.86
174.20
1.5
1.1
—
—
—
0
0
3290
22996
2.60
173.93
10.9
4.3
6.89
6.80
mmol/l
1.89
3207
21813
422
960
4.75
172.74
1.8
1.6
—
—
—
0
0
3684
27293
2.92
171.78
11.7
4.0
19.50
12.40
mm/h
102.44
3611
25174
2015
11424
2.38
170.14
5.7
3.0
35.25
34.52
u/l
0.16
1943
10705
971
3901
2.90
168.02
5.3
3.1
2.21
1.59
mmol/l
5.00
853
3366
134
75
18.38
167.06
47.1
23.1
153.86
113.00
ug/l
4.27
107
61
158
121
13.50
166.90
1.6
1.1
1.37
2.22
u/ml
0.33
107
59
989
4029
2.86
166.63
5.3
3.1
5.87
5.76
kpa
2.45
959
3923
151
108
14.43
165.90
1.7
1.2
—
—
—
0
0
151
108
14.43
165.90
1.7
1.2
—
—
—
0
0
151
108
14.43
165.90
1.7
1.2
—
—
—
0
0
2603
16676
2.33
162.65
3.4
2.3
—
—
—
0
0
222
285
8.14
162.64
1.4
1.1
—
—
—
0
0
149
108
14.23
162.46
1.8
1.2
—
—
—
0
0
671
2248
3.33
158.52
16.9
8.3
15.84
16.06
%
1.22
646
2163
159
139
11.82
154.70
2.4
2.1
213.78
252.63
e6/l
0.90
137
119
892
3567
2.87
154.55
2.4
2.2
65.51
66.58
g/l
3.41
837
3213
159
141
11.65
153.26
2.3
2.0
472.55
454.11
e6/l
0.14
122
113
849
3346
2.89
150.83
4.9
2.7
235.23
222.42
ng/l
0.36
795
3087
257
426
6.34
148.94
1.3
1.2
356.13
288.10
u/ml
1.46
166
260
125
78
16.45
147.67
1.8
1.3
—
—
—
0
0
125
78
16.45
147.67
1.8
1.3
—
—
—
0
0
125
78
16.45
147.67
1.8
1.3
—
—
—
0
0
199
254
8.15
146.38
1.3
1.1
—
—
—
0
0
3758
29106
2.76
142.19
18.2
7.4
80.68
81.34
u/l
0.30
3697
27362
1460
7704
2.32
139.53
6.1
3.7
417.05
632.48
ng/l
0.87
1317
6516
206
301
7.12
134.55
1.3
1.1
113.67
80.67
u/ml
—
6
9
3331
24764
2.32
131.67
7.5
4.7
629.59
2341.38
e6/l
2.41
56
368
1085
5149
2.46
130.74
3.9
2.2
1.96
1.73
%
8.25
978
4525
117
83
14.45
128.99
48.3
35.8
7.96
7.24
ug/l
1.87
108
73
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
440
1281
3.70
128.20
3.9
2.8
0.32
0.35
iu/ml
1.24
246
685
2333
15230
2.10
126.96
6.3
3.7
109.44
89.63
ng/l
0.10
1963
11660
1216
6190
2.32
124.11
3.1
1.9
29.82
29.88
s
0.13
1186
6024
356
916
4.13
123.45
3.8
2.2
91.00
88.80
%
1.04
346
880
173
229
7.82
123.27
1.3
1.1
—
—
—
0
0
129
116
11.42
123.09
2.5
2.5
36.68
36.91
%
0.03
75
67
850
3734
2.57
119.76
2.4
2.1
0.21
0.20
g/l
0.20
789
3470
1785
10742
2.10
118.49
2.9
2.3
3.11
2.86
mg/l
3.91
1601
9173
162
210
7.96
117.48
1.3
1.1
—
—
—
0
0
167
226
7.64
116.71
2.3
2.4
45.53
31.55
iu/ml
0.36
17
37
163
216
7.79
116.00
1.3
1.1
—
—
—
0
0
163
216
7.79
116.00
1.3
1.1
—
—
—
0
0
333
861
4.10
114.55
4.0
2.5
216.56
197.60
%
2.77
320
809
1698
10130
2.09
114.43
5.5
2.7
363.98
354.62
umol/l
2.86
1524
8809
158
210
7.76
112.14
1.3
1.1
—
—
—
0
0
1624
9602
2.08
111.46
7.5
3.8
84.96
85.15
%
0.11
1595
9410
1970
12503
2.02
111.06
4.0
2.1
157.68
202.56
u/l
2.12
1880
11767
644
2572
2.75
109.17
17.3
8.2
0.61
0.63
%
0.62
636
2557
2105
13750
2.00
108.61
4.8
3.3
2.34
2.36
mmol/l
10.45
1960
12322
658
2680
2.70
107.24
17.0
7.9
1.33
1.27
%
0.87
650
2664
772
3417
2.52
106.02
4.3
2.6
4.47
4.42
kpa
0.20
746
3321
126
139
9.30
103.95
2.5
1.9
0.58
0.64
e9/l
0.48
113
131
504
1816
3.00
103.15
6.6
3.9
1.70
1.56
%
2.68
481
1714
169
265
6.59
103.14
1.2
1.1
54.95
72.27
u/ml
0.27
14
14
215
429
5.21
101.97
1.4
1.2
5.66
2.96
u/ml
0.53
100
135
97
75
13.20
101.67
1.4
1.7
2000.00
3476.92
titre
—
10
13
1192
6462
2.15
101.18
4.9
3.2
1.85
1.91
e6/l
0.10
642
3241
867
4133
2.36
100.62
3.9
2.3
72.81
67.22
e9/l
3.41
613
3035
521
1939
2.91
100.47
2.3
1.5
1.64
1.48
g/l
3.02
447
1651
239
536
4.65
98.69
4.3
3.2
1.77
1.35
%
0.78
221
465
1840
11791
1.95
97.25
3.3
2.5
66.49
70.11
u/l
0.17
1735
10842
344
1020
3.57
96.86
1.5
1.2
—
—
—
0
0
2703
19710
1.93
96.06
6.0
3.9
0.00
0.00
estimate
0.80
828
4103
129
164
8.07
95.02
1.2
1.1
88.30
81.73
—
10
11
2723
19982
1.92
94.00
6.0
3.9
6.90
3.84
estimate
0.38
843
4248
201
406
5.14
93.96
1.4
1.2
4.73
3.87
u/ml
0.21
122
180
2737
20127
1.92
93.78
6.0
3.9
0.01
0.09
estimate
0.54
793
3961
116
132
8.99
93.42
1.2
1.1
—
—
—
0
0
459
1660
2.97
92.97
7.0
4.1
0.84
0.86
%
0.63
436
1561
90
73
12.56
91.61
2.2
2.0
31.07
29.86
%
0.21
85
66
2363
16763
1.86
88.45
3.4
2.3
77.82
79.37
nmol/l
1.93
2204
14814
2305
16269
1.85
87.24
4.0
2.9
204.75
142.83
ug/l
10.93
2155
14887
703
3238
2.39
87.22
5.8
3.4
1.22
1.23
mmol/l
5.55
656
2731
816
4028
2.25
86.00
5.4
3.2
—
—
—
0
0
415
1480
2.99
85.98
3.0
2.4
76.87
94.06
mg/l
0.17
315
1276
188
387
5.03
85.94
1.3
1.1
118.30
112.91
%
1.12
181
344
414
1475
2.99
85.92
3.0
2.4
46.87
40.77
mg/l
0.92
313
1270
142
225
6.48
85.74
1.4
1.1
198.97
161.43
titre
0.21
29
35
375
1285
3.09
83.26
8.3
3.2
25.11
24.46
mmol/l
4.09
353
1154
386
1346
3.04
83.14
3.5
2.0
314.97
750.80
ug/l
2.01
369
1289
817
4111
2.21
81.78
3.4
2.6
8.53
10.08
umol/l
1.26
717
3618
1217
7111
1.97
81.42
4.6
3.0
0.83
1.07
e6/l
2.30
681
3878
362
1232
3.11
81.28
3.0
1.6
—
—
—
0
0
53
18
29.78
79.95
1.2
1.1
—
—
—
0
0
374
1315
3.01
79.29
2.9
2.4
1.61
5.61
ratio
0.88
185
749
243
654
3.87
78.66
1.3
1.3
—
—
—
0
0
258
732
3.68
77.35
1.9
1.5
—
—
—
0
0
179
399
4.63
74.33
1.2
1.1
—
—
—
0
0
228
623
3.80
72.17
1.1
1.1
3.65
4.00
0.06
13
63
158
331
4.91
70.70
1.5
1.3
6.76
6.23
mmol/l
1.10
146
311
110
175
6.42
66.13
2.2
1.5
6.17
6.28
u/l
0.05
101
153
195
508
3.97
65.99
1.5
1.4
32.57
31.39
g/l
0.58
168
467
549
2562
2.30
64.94
5.3
2.6
125.05
129.31
g/l
4.38
531
2486
342
1278
2.81
64.58
4.9
3.5
1.42
1.42
mmol/l
0.00
336
1264
426
1781
2.54
64.33
2.4
1.9
3.88
3.72
g/l
1.21
401
1602
426
1784
2.53
64.10
2.4
1.9
4.12
4.21
g/l
1.37
403
1606
246
764
3.35
64.05
9.1
5.3
11.65
11.30
mmol/l
0.81
224
672
426
1785
2.53
64.02
2.4
1.9
7.89
7.32
g/l
7.59
402
1605
246
765
3.34
63.91
9.1
5.3
103.65
105.43
mmol/l
7.03
224
673
128
246
5.33
63.21
1.6
1.4
13.79
12.42
u/l
1.22
123
240
384
1541
2.63
63.06
2.5
1.9
10.56
10.22
g/l
0.72
358
1344
318
1158
2.88
62.99
2.6
1.6
—
—
—
0
0
173
430
4.14
62.41
7.9
5.4
12.11
12.25
mg/l
0.14
160
402
336
1273
2.77
61.76
2.5
2.0
0.06
0.02
g/l
0.61
311
1138
243
767
3.29
61.62
1.4
1.2
—
—
—
0
0
403
1674
2.55
61.61
2.5
1.9
3.15
2.85
g/l
7.49
379
1494
432
1861
2.46
61.09
5.0
2.8
25.66
24.97
mmol/l
3.07
407
1797
163
397
4.22
60.41
11.9
5.2
7.49
7.25
mmol/l
0.36
148
320
326
1235
2.77
59.89
2.6
2.0
0.00
0.00
g/l
0.50
291
1076
375
1538
2.57
58.79
2.7
2.0
0.60
0.92
g/l
1.13
331
1309
138
307
4.61
57.42
1.1
1.1
3.40
3.42
—
9
49
278
990
2.93
57.27
4.5
3.1
2.51
2.00
index
0.62
171
501
146
344
4.35
56.50
1.4
1.2
500.08
301.74
u/l
2.51
137
330
124
257
4.93
56.18
1.3
1.3
15.52
11.74
u/l
1.05
112
245
1473
10012
1.70
55.96
5.9
3.4
0.05
0.47
estimate
1.61
715
3142
303
1157
2.74
54.74
2.7
2.0
0.00
0.00
g/l
-0.00
291
1073
257
940
2.84
50.34
1.7
1.5
—
—
—
0
0
1163
7626
1.71
49.29
2.0
1.8
1190.31
1140.68
nmol/l
0.93
894
5662
103
206
5.09
48.64
2.0
1.7
8.15
8.19
mmol/l
0.03
103
206
214
725
3.05
48.10
2.5
2.5
31.19
33.88
umol/l
1.09
203
637
1253
8443
1.67
47.65
3.1
3.0
2.48
2.46
mmol/l
8.77
1147
7554
47
40
11.86
46.31
1.6
1.1
—
—
—
0
0
270
1058
2.65
46.26
3.7
2.6
1.83
1.63
mg/l
3.20
251
942
151
422
3.67
46.18
1.1
1.1
1.62
1.54
g/l
0.99
134
383
58
67
8.76
46.11
2.6
2.1
1.86
2.48
ratio
0.90
52
59
1422
9974
1.62
45.75
4.7
3.0
0.03
0.05
0.25
31
355
3342
28596
1.65
45.66
50.4
19.2
14.47
13.73
%
134.62
3330
28159
154
442
3.57
45.27
1.5
1.4
5127.98
4122.96
e6/l
0.12
98
314
1572
11335
1.59
44.88
6.1
4.0
0.00
0.00
estimate
0.99
756
3684
134
354
3.87
44.45
4.7
3.2
57.68
56.76
%
0.17
119
291
38
24
15.96
44.33
1.3
1.1
79.90
82.01
ng/l
0.01
24
18
270
1081
2.59
44.27
1.6
1.3
—
—
—
0
0
2705
22121
1.56
43.73
5.0
3.1
68.52
52.19
u/l
8.00
2551
20335
244
938
2.69
43.39
1.5
1.2
—
—
—
0
0
3925
35370
1.85
41.30
46.5
14.3
29.59
24.62
mg/l
20.64
3821
28817
47
48
9.88
40.96
1.1
1.1
—
—
—
0
0
546
3008
1.93
40.63
4.8
3.5
108.09
89.94
ng/l
2.80
480
2563
161
510
3.24
40.53
1.2
1.3
187.19
212.95
miu/ml
0.30
26
196
605
3454
1.87
40.33
3.3
2.3
36.94
56.01
u/l
0.75
546
2918
424
2148
2.08
39.99
4.6
2.2
0.66
0.61
%
1.50
424
2137
418
2117
2.07
39.44
5.5
3.4
44.24
45.53
%
0.47
412
2083
228
894
2.63
38.96
3.1
3.1
0.86
0.81
nmol/l
0.70
185
719
1908
14704
1.52
38.78
6.0
3.9
0.01
0.45
estimate
1.30
742
3345
142
430
3.38
38.44
3.7
2.0
0.85
0.03
mmol/l
1.52
135
412
134
398
3.44
37.40
1.5
1.4
112374.66
85758.20
e6/l
0.23
67
224
69
123
5.68
37.01
4.0
2.9
1.16
1.37
%
0.39
69
123
73
139
5.32
36.47
1.2
1.1
1.06
1.06
ratio
0.09
64
111
1664
12593
1.51
36.13
2.0
1.7
19.25
20.24
nmol/l
1.88
1471
10538
221
886
2.57
36.08
1.3
1.2
131.72
122.19
titre
0.11
29
73
128
378
3.46
36.05
1.1
1.1
8.67
15.00
au/ml
0.54
11
67
1048
7184
1.60
35.45
1.4
1.3
1.27
2.06
u/ml
2.24
273
1807
38
36
10.64
34.87
1.6
1.3
—
—
—
0
0
2213
17830
1.47
34.75
4.0
2.7
—
—
estimate
—
0
0
162
564
2.94
34.69
1.2
1.2
—
—
—
0
0
630
3817
1.76
34.12
2.6
2.2
196.57
148.08
ug/g
2.05
528
3001
230
975
2.43
33.34
1.8
1.6
15576.89
12701.26
e6/l
0.32
163
671
1287
9385
1.52
32.58
5.1
3.8
0.25
0.52
—
8
127
72
152
4.80
31.99
1.2
1.2
—
—
—
0
0
230
999
2.37
31.58
2.0
1.6
—
—
—
0
0
251
1146
2.26
30.69
1.4
1.5
269.00
258.38
ug/g
0.33
151
718
1206
8779
1.51
30.39
1.9
1.8
51478564.63
20946657.69
pmol/l
0.68
981
7123
115
357
3.28
29.97
1.2
1.2
65.33
64.60
u/l
0.04
104
308
129
431
3.05
29.73
1.8
1.5
59.62
59.54
%
0.01
77
276
34
35
9.78
29.43
1.1
1.1
—
—
—
0
0
594
3724
1.69
28.07
1.5
1.3
—
—
—
0
0
53
97
5.52
27.68
1.4
1.2
3.75
3.56
mmol/l
0.14
46
85
584
3661
1.68
27.57
2.9
2.3
11.17
7.51
ug/l
3.27
513
3203
34
39
8.78
27.15
5.5
3.1
2.81
2.55
%
0.10
34
39
70
169
4.19
26.35
1.6
1.3
—
—
—
0
0
70
169
4.19
26.35
1.6
1.3
—
—
—
0
0
525
3264
1.69
25.47
1.8
1.7
1.68
1.52
%
3.98
449
2790
105
341
3.13
25.44
1.9
1.5
36.75
27.83
%
1.44
59
221
90
268
3.41
25.10
1.7
1.5
4.54
3.92
mg/l
0.53
85
258
148
583
2.59
25.09
1.7
1.9
4.03
4.66
mmol/24h
1.68
133
508
83
236
3.56
24.85
1.4
1.2
—
—
—
0
0
51
100
5.15
24.72
1.0
1.1
11.38
7.70
u/ml
—
8
10
98
318
3.13
23.80
2.9
3.0
—
—
—
0
0
83
246
3.42
23.34
1.3
1.2
97.17
110.53
pmol/l
0.82
83
246
120
446
2.74
22.85
1.5
1.4
—
—
—
0
0
38
61
6.27
22.70
2.4
1.9
6.82
8.97
mg/l
1.22
31
49
44
82
5.41
22.57
1.0
1.3
96.42
82.12
%
2.15
26
41
57
133
4.33
22.46
1.7
1.2
—
—
—
0
0
57
133
4.33
22.46
1.7
1.2
—
—
—
0
0
44
83
5.34
22.28
1.0
1.5
98.93
82.19
%
1.98
27
43
65
170
3.86
22.00
1.7
1.4
2.71
3.38
%
0.17
14
39
1250
9650
1.41
21.76
3.4
2.3
—
—
—
0
0
70
195
3.63
21.65
1.1
1.2
120.16
90.75
u/l
0.68
64
157
72
207
3.52
21.25
1.6
1.2
—
—
—
0
0
72
210
3.47
20.79
1.6
1.2
—
—
—
0
0
68
191
3.60
20.78
1.1
1.3
58.17
23.73
u/l
1.39
60
153
54
130
4.19
20.46
1.2
1.1
11.63
25.28
u/ml
—
7
58
124
512
2.46
19.12
1.7
1.9
25.95
24.70
ug/l
0.07
119
498
52
129
4.07
18.96
1.4
1.4
60.95
73.64
%
1.26
35
105
321
1892
1.75
18.75
2.6
2.1
0.13
0.01
estimate
0.63
109
533
2192
18793
1.32
18.54
2.5
2.2
91.93
94.92
pmol/l
2.37
1235
9961
3020
27146
1.34
18.15
4.6
4.1
15.01
14.98
pmol/l
0.17
2757
24379
100
386
2.63
17.75
1.8
1.3
—
—
—
0
0
100
387
2.62
17.66
1.8
1.3
—
—
—
0
0
46
110
4.21
17.62
5.8
6.1
24.86
24.69
mmol/l
0.08
38
99
99
383
2.62
17.50
5.8
2.9
14.43
11.86
index
1.62
81
188
99
384
2.61
17.41
1.8
1.3
—
—
—
0
0
44
103
4.30
17.32
1.1
1.1
—
—
—
0
0
1751
14696
1.31
16.62
4.9
4.1
13.52
7.34
mg/mmol
4.43
1145
9216
99
397
2.53
16.29
1.8
1.3
—
—
—
0
0
100
404
2.51
16.20
1.8
1.3
—
—
—
0
0
99
401
2.50
15.96
1.8
1.3
—
—
—
0
0
174
897
1.98
15.55
1.3
1.3
—
—
—
0
0
29
52
5.61
15.53
1.3
1.1
—
—
—
0
0
296
1798
1.69
15.50
2.9
3.4
4.20
4.46
pmol/l
3.41
260
1590
62
199
3.15
15.46
1.2
1.1
32.89
28.16
u/l
0.22
57
177
1745
14751
1.30
15.33
4.0
3.4
6.89
7.44
mmol/l
7.07
1450
12310
62
200
3.13
15.33
1.5
1.5
8.41
8.26
u/l
0.03
44
160
55
167
3.32
15.01
7.6
4.7
71.07
66.65
mg/l
0.13
41
111
62
203
3.08
14.96
1.2
1.1
89.79
89.05
u/l
0.02
57
181
35
77
4.57
14.91
1.4
1.2
26.87
25.33
%
0.09
23
65
35
77
4.57
14.91
1.7
1.5
0.32
0.44
ug/l
0.96
29
46
3922
37117
1.44
14.55
47.8
19.0
138.95
139.73
mmol/l
59.83
3889
36334
84
332
2.56
14.29
1.4
1.3
—
—
—
0
0
25
43
5.84
13.98
1.3
1.1
297.44
714.32
u/l
0.25
16
32
3923
37178
1.43
13.96
48.2
19.2
4.02
4.00
mmol/l
2.37
3883
36335
18
6
30.11
13.86
2.2
1.7
46.72
40.50
umol/l
—
18
6
39
99
3.97
13.85
6.0
7.6
6.13
5.97
kpa
0.28
31
88
32
70
4.60
13.74
1.3
1.1
1.75
1.51
mmol/l
0.56
16
41
54
172
3.17
13.67
1.5
1.2
—
—
—
0
0
90
376
2.42
13.63
1.2
1.1
1.34
1.88
u/ml
0.27
54
195
498
3522
1.47
13.39
3.7
2.4
0.52
0.45
e6/l
0.19
483
3384
1694
14452
1.28
13.28
4.0
3.4
69.40
43.71
mg/l
4.07
1157
9336
64
229
2.82
13.24
1.1
1.1
—
—
—
0
0
69
262
2.66
12.76
1.1
1.1
0.77
1.46
u/ml
0.68
46
133
625
4647
1.40
12.74
3.3
4.3
11.23
26.73
ug/l
2.47
521
3886
52
170
3.08
12.63
1.5
1.2
—
—
—
0
0
20
13
15.44
12.59
1.4
1.4
—
—
—
0
0
456
3209
1.47
12.55
4.0
2.6
53.43
63.11
ml/min/173m2
6.82
238
1391
37
100
3.72
12.08
3.6
2.1
9.38
10.81
kpa
2.66
37
100
37
100
3.72
12.08
3.6
2.1
4.69
4.53
kpa
0.57
37
100
38
106
3.61
11.86
3.0
2.8
0.62
0.61
mmol/l
0.04
38
106
107
513
2.11
11.74
2.4
2.2
0.91
1.09
g/24h
0.45
74
289
48
157
3.08
11.68
1.1
1.0
12.15
14.05
iu/ml
—
6
40
39
112
3.50
11.66
1.2
1.3
102.19
1143.94
ug/l
1.53
18
51
68
269
2.55
11.62
1.4
1.1
—
—
—
0
0
26
56
4.66
11.40
1.0
1.4
97.89
83.76
%
—
9
17
33
86
3.86
11.35
1.5
1.4
9.31
9.59
ug/l
0.14
33
86
27
62
4.38
10.96
1.4
1.4
4.00
5.94
%
0.44
11
33
37
109
3.41
10.67
5.2
1.4
241.33
95.21
umol/l
0.78
21
61
219
1360
1.64
10.59
3.2
2.8
351.27
487.45
mg/l
0.46
124
585
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
25
56
4.48
10.47
1.0
1.4
77.50
77.13
%
—
8
16
37
111
3.35
10.38
1.4
1.3
—
—
—
0
0
71
306
2.34
10.14
1.1
1.0
3.57
3.64
u/ml
0.01
42
138
20
23
8.73
9.76
1.0
1.0
—
—
—
0
0
47
169
2.80
9.73
2.4
1.7
—
—
—
0
0
156
906
1.75
9.70
1.3
1.1
—
—
—
0
0
193
1190
1.65
9.62
1.8
1.5
0.42
0.32
mg/l
1.03
97
532
31
88
3.54
9.48
5.8
7.8
5.66
5.39
kpa
0.24
31
88
57
230
2.50
9.42
1.1
1.1
2.90
1.86
u/ml
0.33
38
102
54
216
2.52
9.10
1.1
1.1
1.43
3.29
u/ml
0.79
33
86
80
380
2.13
9.08
1.4
1.3
271.24
277.34
mosm/kgh2o
1.66
67
271
67
298
2.27
8.94
1.1
1.1
0.86
1.05
u/ml
0.12
36
118
63
273
2.33
8.93
3.4
2.4
35.06
36.05
mg/l
0.07
53
192
152
900
1.71
8.85
1.3
1.1
—
—
—
0
0
23
56
4.12
8.70
1.3
1.1
0.45
3.55
mmol/l
1.41
13
41
3497
33116
1.25
8.65
5.9
5.1
2.05
2.03
mu/l
0.20
3231
30010
68
313
2.19
8.38
1.3
1.5
—
—
—
0
0
383
5121
0.72
8.21
11.2
7.1
—
—
—
0
0
27
78
3.48
8.08
1.4
1.3
—
—
—
0
0
12
7
17.18
8.07
1.8
1.1
—
—
—
0
0
22
55
4.01
8.06
1.5
1.1
—
—
—
0
0
126
730
1.75
7.97
1.3
1.3
52.74
28.32
u/l
0.74
112
617
70
334
2.11
7.91
2.2
2.1
576.88
642.17
ml
0.71
49
212
48
195
2.48
7.88
1.1
1.0
0.30
0.29
u/ml
0.01
27
62
16
19
8.45
7.80
4.1
3.2
0.72
1.55
mg/l
—
10
13
3895
37493
1.29
7.56
26.3
11.7
24.83
25.56
u/l
1.97
3858
36074
3603
34389
1.24
7.40
39.0
15.9
72.74
74.37
ml/min/173m2
4.55
3463
31996
3936
37971
1.29
7.27
51.8
21.3
90.42
82.76
umol/l
16.90
3904
37451
17
38
4.49
7.17
1.1
1.8
—
—
—
0
0
23
65
3.55
7.13
2.5
4.2
8.58
8.14
mg/l
0.08
16
54
23
66
3.50
6.98
1.1
1.2
—
—
—
0
0
160
2437
0.64
6.94
2.2
2.1
3.91
3.45
ratio
0.52
132
1967
30
104
2.90
6.73
1.4
1.2
—
—
—
0
0
50
226
2.23
6.53
1.4
1.3
1.28
1.09
promille
0.40
39
181
20
55
3.65
6.46
2.1
2.9
130.38
266.48
au/ml
—
5
5
117
709
1.67
6.36
1.1
1.1
26.04
10.79
eliau/ml
—
8
62
106
1738
0.60
6.35
2.0
1.8
3.28
3.40
mmol/l
0.45
74
1263
16
39
4.11
6.08
1.2
1.0
12.50
15.53
iu/ml
—
8
15
10
8
12.52
6.08
1.2
1.1
—
—
—
0
0
69
365
1.90
5.95
1.7
1.3
146456.65
113859.84
e6/l
0.16
43
251
9
6
15.02
5.90
1.1
1.0
—
—
—
0
0
46
213
2.17
5.71
2.1
1.6
—
—
—
0
0
1025
8909
1.19
5.67
5.7
4.2
1.02
1.19
kg/l
0.50
768
5921
42
188
2.25
5.66
1.6
1.6
1.09
1.94
u/field
1.12
33
125
19
56
3.40
5.58
1.2
1.1
—
—
—
0
0
11
13
8.48
5.55
1.5
1.0
—
—
—
0
0
16
34
4.72
5.29
1.2
1.1
19.22
21.95
u/l
—
9
23
16
36
4.46
5.04
1.6
1.4
122.88
115.45
ug/l
—
8
22
178
1253
1.44
5.01
1.3
1.3
—
—
—
0
0
12
20
6.01
4.90
6.7
11.8
110.08
101.35
g/l
1.14
12
20
41
194
2.12
4.87
1.4
1.3
1.23
1.15
nmol/l
0.21
33
131
15
42
3.58
4.76
1.0
1.2
—
—
—
0
0
3940
38344
1.22
4.61
60.1
23.9
247.05
239.16
e9/l
9.93
3891
37353
3940
38349
1.22
4.57
59.8
23.8
92.53
91.71
fl
20.11
3910
37814
3940
38351
1.22
4.56
59.9
23.9
4.30
4.45
e12/l
56.98
3879
37184
3940
38351
1.22
4.56
62.2
24.3
39.17
40.22
%
11.26
3910
37801
3940
38355
1.22
4.53
60.0
23.9
8.05
6.69
e9/l
92.20
3884
37190
3940
38357
1.22
4.51
60.5
24.1
129.06
134.69
g/l
95.44
3914
37840
74
438
1.70
4.51
1.5
1.4
—
—
—
0
0
15
36
4.18
4.50
12.4
11.4
5.65
5.08
mmol/l
0.49
15
36
62
349
1.79
4.49
1.7
1.8
0.94
1.22
u/field
0.54
31
189
409
5004
0.80
4.45
5.2
5.3
32.85
33.10
%
0.16
286
3151
14
33
4.25
4.31
1.9
1.8
—
—
—
0
0
8
9
8.90
4.28
2.1
6.9
—
—
—
0
0
7
6
11.68
4.27
1.3
1.0
—
—
—
0
0
79
486
1.64
4.19
3.8
2.0
1.20
1.20
mmol/l
0.36
79
479
80
494
1.63
4.18
3.8
2.0
105.86
105.68
mmol/l
0.16
80
487
80
494
1.63
4.18
3.8
2.0
4.13
4.10
mmol/l
0.31
80
487
10
17
5.89
4.12
1.0
1.1
99.20
94.12
titre
—
10
17
19
68
2.80
4.11
1.2
1.1
0.82
98.89
mg/l
0.72
11
51
134
931
1.45
4.11
3.2
3.3
262.12
1139.41
u/ml
1.46
118
845
30
135
2.23
4.08
1.1
1.1
1447.25
1585.64
miu/ml
0.26
30
135
59
339
1.75
4.03
1.6
1.5
13.90
24.45
u/ml
—
10
64
17
58
2.94
4.00
1.1
1.1
1160.00
1085.71
titre
—
5
14
11
22
5.01
4.00
1.0
1.0
—
—
—
0
0
11
22
5.01
4.00
1.1
1.1
—
—
—
0
0
14
36
3.90
3.99
2.0
1.1
22.91
20.08
mmol/l
—
9
30
3569
34534
1.16
3.98
8.0
7.1
41.28
39.90
mmol/mol
13.18
3351
31812
162
1174
1.39
3.95
1.6
1.6
24.77
26.01
u/ml
0.05
19
214
7
8
8.76
3.77
1.1
1.0
—
—
—
0
0
82
525
1.57
3.73
3.3
1.9
29.98
26.87
mg/l
0.25
39
171
9
16
5.63
3.65
1.1
1.3
—
—
—
0
0
101
682
1.49
3.62
1.5
1.4
34.46
29.49
iu/l
0.66
80
571
57
336
1.71
3.60
2.3
1.9
176.81
5937.68
u/l
3.09
17
142
7
9
7.79
3.55
2.7
4.9
—
—
—
0
0
11
26
4.24
3.50
1.2
1.2
—
—
—
0
0
1301
14187
0.88
3.48
4.3
5.1
21.82
22.49
%
0.76
607
7748
105
724
1.46
3.41
1.2
1.2
3.78
3.81
mmol/l
0.09
97
687
95
644
1.49
3.37
1.5
1.4
9.77
9.11
u/l
0.24
72
506
22
95
2.32
3.33
1.2
1.2
19.00
29.00
%
—
7
9
231
1816
1.29
3.31
1.2
1.2
120.73
127.70
u/ml
0.10
75
656
17
65
2.62
3.30
4.9
6.7
10.28
10.50
%
0.20
17
65
33
169
1.96
3.28
1.3
1.3
—
—
—
0
0
19
78
2.44
3.21
1.2
1.2
—
—
—
0
0
30
150
2.01
3.19
1.2
1.2
60.67
65.75
%
—
6
20
27
130
2.08
3.17
1.3
1.2
33.03
39.88
g/l
1.41
13
62
116
829
1.41
3.14
1.3
1.3
756.50
585.93
mg/l
0.33
108
798
38
666
0.57
3.12
1.1
1.1
0.62
0.61
ratio
—
7
105
281
2280
1.25
3.12
2.4
2.5
29.22
23.68
au/ml
0.29
21
175
43
726
0.59
3.07
1.1
1.2
1.57
1.52
g/l
0.49
43
726
257
2071
1.26
3.04
1.3
1.3
46.68
62.11
au/ml
0.38
11
138
9
21
4.29
2.99
2.1
2.0
—
—
—
0
0
22
100
2.21
2.99
1.3
1.2
10.10
12.98
pmol/l
—
10
46
31
164
1.90
2.84
1.0
1.6
6.97
11.62
umol/l
0.63
24
110
28
146
1.92
2.69
1.3
1.2
0.61
0.52
ratio
0.33
13
88
99
710
1.40
2.68
2.0
1.5
1.08
0.77
nmol/l
2.59
81
591
956
10458
0.89
2.58
3.0
3.5
0.72
0.83
ug/l
2.87
694
7414
108
797
1.36
2.49
1.8
1.9
13.25
11.88
iu/l
0.04
39
294
21
102
2.06
2.46
2.0
2.7
3.06
417.70
ug/l
0.83
21
102
10
32
3.13
2.43
1.0
1.0
—
—
—
0
0
10
32
3.13
2.43
1.0
1.0
—
—
—
0
0
5
8
6.26
2.37
1.0
1.0
0.01
0.01
u/ml
—
5
8
131
1012
1.30
2.25
2.5
2.2
121.06
89.19
ug/min
0.52
83
569
28
156
1.80
2.25
1.4
1.2
—
—
—
0
0
17
79
2.16
2.24
1.5
1.1
—
—
—
0
0
34
201
1.70
2.24
2.2
1.5
95.53
89.70
umol/l
0.29
34
201
30
173
1.74
2.16
1.1
1.2
—
—
—
0
0
6
14
4.29
2.15
1.2
1.0
—
—
—
0
0
5
147
0.34
2.00
1.6
1.6
—
—
—
0
0
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
28
163
1.72
1.98
1.4
1.6
—
—
—
0
0
38
586
0.65
1.97
1.4
1.5
—
—
—
0
0
62
438
1.42
1.92
1.4
1.3
0.20
0.23
nmol/l
0.32
37
357
94
712
1.33
1.90
1.3
1.4
20.12
13.91
e6/l
0.25
66
533
95
721
1.32
1.90
1.3
1.4
102.04
853.82
e6/l
3.34
72
572
83
618
1.35
1.89
1.3
1.8
313.86
295.80
mu/l
0.20
73
569
71
517
1.38
1.86
1.0
1.1
72.36
427.82
iu/ml
0.51
17
93
57
402
1.42
1.80
1.4
1.3
1.58
1.48
nmol/l
0.26
51
359
7
23
3.05
1.80
1.0
1.3
—
—
—
0
0
195
1635
1.20
1.70
3.4
3.5
205.89
3475.02
u/ml
1.23
165
1417
11
48
2.29
1.70
1.5
1.3
—
—
—
0
0
15
75
2.00
1.69
1.4
1.2
277.56
285.60
pmol/l
—
9
55
15
75
2.00
1.69
1.4
1.3
72.26
65.30
mu/l
—
10
55
19
104
1.83
1.67
1.7
1.4
16.64
15.68
pmol/l
0.24
12
82
54
384
1.41
1.65
4.8
4.8
315.70
351.65
umol/l
0.93
43
321
31
198
1.57
1.59
2.4
2.3
—
—
—
0
0
67
499
1.35
1.57
1.4
1.3
14.04
4.19
nmol/l
0.32
60
482
30
192
1.57
1.53
1.0
1.1
—
—
—
0
0
32
208
1.54
1.53
2.3
2.1
28.40
120.38
ug/min
—
5
60
18
100
1.80
1.52
19.4
14.2
838.61
825.98
nmol/l
0.04
18
94
22
130
1.70
1.52
1.0
1.1
—
—
—
0
0
43
299
1.44
1.50
1.1
1.1
—
22.48
—
0
5
19
108
1.76
1.50
1.1
1.3
127.14
137.73
nmol/l
0.11
14
79
1475
15470
0.93
1.49
2.2
1.9
1.43
1.30
mmol/l
9.55
1202
12754
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
156
1.61
1.43
1.0
1.1
—
—
—
0
0
33
220
1.50
1.43
1.2
1.1
55.88
47.12
mg/l
0.42
26
186
67
509
1.32
1.41
1.4
1.3
0.15
0.31
nmol/l
—
8
40
11
212
0.52
1.39
1.5
1.4
—
—
—
0
0
3568
35084
1.08
1.37
6.0
5.7
6.09
6.06
mmol/l
0.77
3245
31635
9
41
2.20
1.37
1.7
2.2
0.56
0.44
u/field
—
9
41
5
17
2.94
1.36
2.2
2.1
—
—
—
0
0
14
75
1.87
1.34
1.0
1.1
—
—
—
0
0
9
42
2.15
1.33
1.2
1.0
14.78
51.86
iu/ml
—
9
42
174
1484
1.18
1.32
1.7
1.8
—
—
—
0
0
28
185
1.52
1.28
2.1
1.6
37.05
39.87
g/l
1.83
28
185
9
44
2.05
1.26
1.0
1.1
—
—
—
0
0
16
92
1.74
1.24
1.1
1.2
0.36
0.29
g/l
1.76
11
66
21
322
0.65
1.17
1.0
1.0
36.55
44.17
ng/l
0.28
13
221
6
129
0.46
1.16
1.7
1.7
—
—
—
0
0
21
321
0.65
1.15
1.0
1.0
768.82
698.56
ng/l
0.39
11
214
21
320
0.65
1.14
1.0
1.0
323.92
339.30
ng/l
0.07
13
220
14
229
0.61
1.05
1.4
1.3
121.73
208.91
pmol/l
1.07
14
229
14
82
1.71
1.05
1.0
1.1
—
—
—
0
0
171
1492
1.15
1.03
1.1
1.1
—
—
—
0
0
10
178
0.56
1.03
1.6
1.4
—
—
—
0
0
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
13
76
1.71
0.98
1.7
1.2
—
—
—
0
0
43
328
1.31
0.95
1.0
1.1
23.83
2.73
eliau/ml
0.76
11
120
13
78
1.67
0.91
1.3
1.4
1.18
1.17
mmol/l
0.31
13
78
14
86
1.63
0.90
1.1
1.0
—
—
—
0
0
22
151
1.46
0.90
1.6
1.7
528.82
1426.79
e6/l
0.57
11
106
22
151
1.46
0.90
1.1
1.1
1.12
1.18
u/l
0.18
12
74
153
1351
1.14
0.82
1.8
1.7
—
—
—
0
0
14
89
1.57
0.81
1.1
1.0
—
—
—
0
0
8
47
1.70
0.80
1.0
1.1
—
—
—
0
0
21
148
1.42
0.77
1.2
1.5
—
—
—
0
0
9
54
1.67
0.74
2.1
1.7
—
—
—
0
0
7
38
1.84
0.73
1.0
1.2
—
—
—
0
0
16
108
1.48
0.73
1.1
1.1
—
—
—
0
0
14
92
1.52
0.72
1.0
1.1
—
—
—
0
0
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
14
93
1.51
0.69
1.0
1.1
—
—
—
0
0
35
275
1.27
0.68
1.1
1.1
—
—
—
0
0
25
188
1.33
0.66
3.5
6.7
6.96
13.50
ug/l
0.81
15
113
370
3484
1.07
0.58
2.7
2.2
12.31
12.84
nmol/l
0.67
325
3089
6
37
1.62
0.55
1.0
1.0
—
—
—
0
0
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
133
1461
0.91
0.51
3.7
4.0
82.53
86.20
u/ml
0.05
128
1405
2885
28506
1.03
0.50
52.1
20.7
328.77
332.15
g/l
70.29
2868
28318
14
101
1.39
0.49
1.1
1.2
22.93
13.34
mm/h
0.91
14
101
3374
33432
1.04
0.49
4.8
4.5
1.34
1.26
mmol/l
10.37
3017
30110
21
164
1.28
0.46
1.0
1.1
—
—
—
0
0
11
151
0.73
0.42
1.4
1.3
6.27
6.13
mmol/l
0.13
11
141
5
33
1.52
0.41
1.4
2.8
11.22
20.40
umol/l
—
5
33
229
2156
1.07
0.40
4.8
3.4
1.02
1.02
ratio
1.43
216
1954
87
957
0.91
0.38
2.4
1.7
33.51
5.17
mg/l
6.13
80
712
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
20
161
1.24
0.37
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
15
118
1.27
0.33
1.0
1.2
—
—
—
0
0
53
592
0.89
0.32
1.6
1.5
288.09
252.14
pmol/l
0.13
53
575
31
357
0.87
0.30
1.2
1.2
7.44
7.42
mmol/l
0.01
26
291
88
818
1.08
0.26
7.0
3.2
31.81
28.76
mg/l
0.34
72
560
9
76
1.18
0.24
2.3
2.0
—
—
—
0
0
10
78
1.28
0.24
2.3
2.0
—
—
—
0
0
52
477
1.09
0.22
1.2
1.3
270.20
269.55
pmol/l
0.01
45
399
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
34.83
—
0
10
0
10
0.00
0.21
0.0
1.1
—
7.78
—
0
10
3507
35218
0.98
0.20
5.6
5.4
4.31
4.47
mmol/l
15.00
3158
32353
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
3582
35954
0.98
0.19
6.3
6.3
2.43
2.57
mmol/l
17.45
3241
32927
16
137
1.17
0.18
1.3
1.3
129.06
167.44
mmol/24h
1.33
16
137
3478
34917
0.98
0.18
5.5
5.3
1.40
1.44
mmol/l
8.43
3120
31845
7
60
1.17
0.17
2.1
4.8
—
—
—
0
0
62
653
0.95
0.13
2.0
2.0
—
—
—
0
0
16
146
1.10
0.08
2.1
1.7
6.08
10.19
nmol/l
0.51
11
127
1735
17424
0.99
0.07
5.2
6.3
3.86
3.96
ug/l
0.04
1518
15658
44
459
0.96
0.07
1.1
1.1
—
—
—
0
0
27
256
1.06
0.06
1.6
1.8
112.42
116.49
ng/l
0.07
27
256
348
3508
0.99
0.04
1.5
1.4
—
—
—
0
0
30
288
1.04
0.04
3.7
5.2
122.09
51.71
u/ml
0.51
11
86
10
91
1.10
0.04
1.3
1.5
140.70
506.25
nmol/24h
—
10
91
79
783
1.01
0.01
2.1
1.9
193.00
204.21
pmol/l
0.48
70
729
27
264
1.02
0.00
1.8
1.5
0.19
0.27
nmol/l
0.85
22
198
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
73
726
1.01
0.00
1.5
1.4
—
—
—
0
0
55
551
1.00
0.00
1.6
1.9
—
—
—
0
0
8
83
0.96
-0.00
2.8
2.1
179.50
148.83
nmol/l
—
8
75
0
8
0.00
-0.00
0.0
1.0
—
0.00
—
0
8
10
100
1.00
-0.00
1.7
2.8
1.21
1.11
ug/l
—
10
94
0
6
0.00
-0.00
0.0
1.2
—
1.63
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
27.70
—
0
6
0
5
0.00
-0.00
0.0
9.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
7.4
—
50.75
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ILD_HOSPITAL_PULM_INFECT – ILD, hospital admission 2, with pulmonary infections
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).